syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000007	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5212657840000001	57.072035697967515
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.72054212187668
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709461
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	43.22296669687591
OBESITY	1.00390625	37.66269769557422
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026712
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.516150233723735
PLUMMER-VINSON SYNDROME	1.0	37.516150233723735
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.516150233723735
DIABETES MELLITUS, NONINSULIN-DEPENDENT	1.0	37.516150233723735
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.91443075	34.30592139533666
LAFORA DISEASE	0.7715289599999999	28.944796373028623
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
EARLY MYOCLONIC ENCEPHALOPATHY	0.70941035	26.614345267958534
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6945606699999999	26.057242442155808
ROLANDIC EPILEPSY	0.6461768999999999	24.242069657961874
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	22.283407728484512
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.5833333	21.884419719133838
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260258
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228717
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517787982	19.425411721928636
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.515429128	19.336916600885218
XQ12-Q13.3 DUPLICATION SYNDROME	0.511011184	19.17117235005704
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50969036	19.12162011844073
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50969036	19.12162011844073
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845307
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50390625	18.90462257871235
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5030581	18.872803255891615
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.501811934	18.826051905019458
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.500961538	18.7941483209253
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.500541419	18.77838707340526
CREST SYNDROME	0.5	18.758075116861868
PAROXYSMAL HEMICRANIA	0.5	18.758075116861868
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.5	18.758075116861868
RESTRICTIVE DERMOPATHY	0.5	18.758075116861868
RHYNS SYNDROME	0.5	18.758075116861868
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	18.758075116861868
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
CITRULLINEMIA TYPE II	0.47673141899999993	17.885127536340292
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.44703715	16.77111287945569
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.43717484000000006	16.401116975844136
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.4242421	15.915930359070446
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42357369	15.890854189092723
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42126578400000003	15.804270440871413
SPINOCEREBELLAR ATAXIA TYPE 10	0.409852838	15.376100644126034
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38965681	14.618423423553544
PLACENTAL INSUFFICIENCY	0.38310061	14.372460039391205
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.38140101	14.308697590453967
PERIORAL MYOCLONIA WITH ABSENCES	0.36508484399999996	13.69657785555959
CHROMOSOME 17Q12 DELETION SYNDROME	0.362413984	13.59637747054635
CHROMOSOME 5Q12 DELETION SYNDROME	0.358088191	13.434090370478359
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.41268624376936
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.41268624376936
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.30701225243702
MENTAL RETARDATION, X-LINKED 12; MRX12	0.353337972	13.25588044083127
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348302828	13.066981222078836
COG4-CDG	0.3480389	13.057079659579948
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34754076199999995	13.038391439534822
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34552988399999995	12.962951038385132
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.343806829	12.898308648144162
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34326541	12.87799669160077
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.34268041	12.856049743714044
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841272
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34037525	12.769569014841272
PREECLAMPSIA	0.33962231	12.741321604684291
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.336913343	12.639691591734092
OROFACIODIGITAL SYNDROME TYPE 3	0.33643859	12.621880686862182
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.33462	12.553654191208633
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.33385793399999997	12.52506440866462
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.505370905857832
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857832
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857832
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.333333	12.505370905857832
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.333333	12.505370905857832
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.316190844	11.862263206031905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30169739799999995	11.31852490849154
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.2760734	10.357211149934905
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.2760734	10.357211149934905
PALLISTER-HALL SYNDROME	0.27433443399999996	10.291971840227566
ESOPHAGEAL ATRESIA	0.27222219999999997	10.212728952154787
DISTAL MONOSOMY 12Q	0.268661872	10.079159152025456
BETA-KETOTHIOLASE DEFICIENCY	0.26314042899999995	9.87201586693051
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.256097019	9.6077742392128
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255609334	9.589478175486068
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	9.477765059386002
LYSINURIC PROTEIN INTOLERANCE	0.251811934	9.447014346588526
DYSTONIA 6, TORSION	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430934
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.25	9.379037558430934
HEMOPHILIA B	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
SEVERE HEMOPHILIA A	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
TRICHOTHIODYSTROPHY	0.244895088	9.187520912908994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24302453400000004	9.117344928024702
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23852347200000004	8.948482409821397
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.236282169	8.8643973497541
LENNOX-GASTAUT SYNDROME	0.233096244	8.744873708820725
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.22440085	8.418656001175304
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.22433443400000003	8.416164328541381
GITELMAN SYNDROME	0.22350960000000003	8.385219732279499
JUVENILE MYOCLONIC EPILEPSY	0.22143680000000002	8.307456256075035
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.220732694	8.28104090959857
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.2192308	8.224695628659441
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.218319744	8.190516314892106
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.216493709	8.122010511500068
COHEN SYNDROME	0.215213751	8.073991414879211
KEPPEN-LUBINSKY SYNDROME	0.214851769	8.060411243785307
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.21344093000000003	8.007481995905712
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.212989481	7.9905453673988465
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2117647	7.944596299399436
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.20520833000000002	7.698626537491557
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.697875089002376
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.204783931	7.682704720848514
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.202188528	7.585335191983457
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.20152905000000002	7.560594116259622
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095549
ROMANO-WARD SYNDROME	0.200541419	7.523542003288139
PITUITARY GIGANTISM	0.2	7.503230046744747
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744747
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744747
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744747
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	7.503230046744747
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	7.503230046744747
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.503230046744747
X-LINKED ACROGIGANTISM	0.2	7.503230046744747
MYOCLONIC EPILEPSY OF INFANCY	0.18379836	6.895406886472038
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18379836	6.895406886472038
PFAPA SYNDROME	0.18064726	6.777189745470552
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17994293	6.750765995376433
EHLERS-DANLOS SYNDROME, TYPE VI	0.179537528	6.73555687303938
ACUTE ADRENAL INSUFFICIENCY	0.17493073900000003	6.562727884820315
ADDISON DISEASE	0.17370374900000002	6.516695943645039
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.172902528	6.486637216238623
GRANULOMATOSIS WITH POLYANGIITIS	0.172416749	6.468412658294236
PEMPHIGUS VULGARIS	0.17187533000000002	6.448100701750844
UNILATERAL POLYMICROGYRIA	0.1710598	6.417505155750735
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.16992188100000002	6.374814815592927
GITELMAN SYNDROME	0.168495419	6.321299452898228
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.168478934	6.320680999161625
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.2527042110040325
PITYRIASIS RUBRA PILARIS	0.166667	6.2527042110040325
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	6.2527042110040325
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16599404999999998	6.227457717704247
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164135494	6.1577318515904595
PRADER-WILLI SYNDROME	0.16247836900000004	6.095562901134402
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.16127993399999999	6.050602233629047
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335267
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335267
ACROOTOOCULAR SYNDROME	0.15732986	5.902410664010721
WRINKLY SKIN SYNDROME	0.15716734999999998	5.896313914436239
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15589384799999997	5.84853702208129
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.155312838	5.826739763633997
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.706816463152179
RESTRICTIVE DERMOPATHY, LETHAL	0.15126035999999998	5.674706390167135
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.15056904899999998	5.6487710628329095
1P21.3 MICRODELETION SYNDROME	0.14982135	5.620720274819305
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14975354999999999	5.618176679833458
DE BARSY SYNDROME	0.14973808999999996	5.617596680150844
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.149250978	5.599322113178196
CHRONIC HICCUP	0.14806533	5.554841164685881
BRAIN-LUNG-THYROID SYNDROME	0.14720209999999997	5.522456098319624
CONGENITAL MYASTHENIC SYNDROME	0.14545240299999998	5.456814202804128
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.14545240299999998	5.456814202804128
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14495823800000002	5.438275034423881
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.144144	5.407727959289873
COMBINED SAPOSIN DEFICIENCY	0.143818538	5.395517878002505
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.143381934	5.37913817674586
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	5.359444673939071
CHOANAL ATRESIA	0.14285699999999998	5.359444673939071
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	5.359444673939071
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.359444673939071
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.359444673939071
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.359444673939071
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.133003634	4.989784314775206
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.122219064	4.585188766449096
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12133179799999999	4.55190196189582
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.12115313	4.545199026365862
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12106874	4.542033038447638
PRADER-WILLI SYNDROME; PWS	0.12029926700000002	4.513165373778844
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11867818399999999	4.452348580409508
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602718
AICARDI SYNDROME; AIC	0.117369528	4.403252845309244
TEMPLE SYNDROME	0.11668989800000001	4.377755744125899
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.114847224	4.308625709510121
15Q OVERGROWTH SYNDROME	0.113099869	4.243071676818474
BILATERAL POLYMICROGYRIA	0.11305566	4.241413125332791
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.11120909100000001	4.172136965311854
INSULINOMA	0.110681319	4.1523369916707
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.1099565	4.125144573174444
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.10881664	4.082381414169031
PRADER-WILLI-LIKE SYNDROME	0.10797281300000001	4.050724273665759
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.106776594	4.005846741949324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10673824400000001	4.004407997587861
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.105269784	3.949317031615647
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.10507549000000001	3.942027868722136
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10479347400000001	3.931447714097822
MODY	0.10463885	3.9256468168840826
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.10408483800000001	3.9048624194607973
AROMATASE DEFICIENCY	0.09900425000000002	3.7142583167771437
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.09876743	3.705373742078792
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326797
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810905
WILSON DISEASE	0.097929364	3.673932732117016
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.09788360000000002	3.6722158430177205
LEPRECHAUNISM	0.09770855	3.665648640919307
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.09653641400000001	3.6216746106489515
INSULIN-RESISTANCE SYNDROME TYPE B	0.09611743	3.6059559439594246
ADRENOCORTICAL CARCINOMA	0.09611743	3.6059559439594246
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.09608958900000002	3.6049114568207674
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.0959655	3.600256115254415
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0956507	3.5884460311608386
SCHINZEL-GIEDION SYNDROME	0.09560006000000001	3.586546213313003
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.09545965000000001	3.581278570658686
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.09544160000000002	3.580601404146967
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.09544160000000002	3.580601404146967
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09445900900000001	3.543738372572662
SMITH-MAGENIS SYNDROME; SMS	0.09293699100000001	3.4866381166262306
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.09197545300000001	3.4505649125627964
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0909091	3.4105594532126147
HEPATIC VENO-OCCLUSIVE DISEASE	0.0909091	3.4105594532126147
HELLP SYNDROME	0.0909091	3.4105594532126147
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.09032868399999999	3.3887844793585566
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.09032868399999999	3.3887844793585566
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.09003566900000003	3.3777916845978235
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.08994645000000001	3.3744445311901203
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.08975706900000001	3.3673396851427078
49,XXXYY SYNDROME	0.08792327400000001	3.2985427564248564
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.08711866000000001	3.268356736720699
YUNIS-VARON SYNDROME	0.086287998	3.237193496335253
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.08627051000000001	3.2365374138999656
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0861345	3.231434842306677
49,XYYYY SYNDROME	0.08508522400000001	3.1920700462540363
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.08486235000000002	3.183708671786846
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.08486235000000002	3.183708671786846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.083884438	3.147021178279484
YUNIS-VARON SYNDROME	0.08381965000000001	3.1445905819381412
ISOLATED BILIARY ATRESIA	0.08375382900000002	3.142121231413608
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.083693588	3.1398612210073775
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08337539	3.127923657035307
OVARIAN DYSGENESIS 8; ODG8	0.08333330000000001	3.12634460227197
PRIMARY DYSTONIA, DYT4 TYPE	0.08333330000000001	3.12634460227197
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.08280545	3.106541702371099
RAMOS-ARROYO SYNDROME	0.081513074	3.0580567301966397
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.081000237	3.0388170602592277
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.08082935000000001	3.0324060378942375
BARDET-BIEDL SYNDROME 21; BBS21	0.08082935000000001	3.0324060378942375
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.08082935000000001	3.0324060378942375
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.08057010900000001	3.022680313591497
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0799812	3.0005867150735046
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07978419999999999	2.9931960334774605
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.07941368800000001	2.979295849622064
16P13.2 MICRODELETION SYNDROME	0.07927645300000001	2.9741473207447386
KENNERKNECHT SYNDROME	0.078977084	2.9629161483654185
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.07869265	2.9522452796898397
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.078484788	2.9444470976699577
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.077884638	2.9219317801071885
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.07692310000000001	2.8858585760437543
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.07692310000000001	2.8858585760437543
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07692310000000001	2.8858585760437543
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.07692310000000001	2.8858585760437543
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437543
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.07692310000000001	2.8858585760437543
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437543
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.07692310000000001	2.8858585760437543
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002474
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.074340564	2.788971767483754
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.780987805487914
MARFAN SYNDROME	0.07331114	2.7503517420455528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07291507200000001	2.735492795454783
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.07247295	2.718906080081148
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.072286361	2.711905979125188
KEUTEL SYNDROME; KTLS	0.072077819	2.7040822861231466
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07206639999999999	2.7036538892036273
TUBEROUS SCLEROSIS COMPLEX	0.07205513399999999	2.7032312322550944
WERNER SYNDROME	0.07204970000000001	2.703027369494725
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071798093	2.693588043482868
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845593
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.6535825841326863
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.070481	2.6441757846230827
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07014222799999999	2.6314663633761026
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07014222799999999	2.6314663633761026
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06891523799999999	2.585434422200826
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.577123169310348
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.068249338	2.56045241776019
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067628238	2.5371511368500235
CITRULLINEMIA TYPE I	0.067551459	2.534270684351229
WHITE-SUTTON SYNDROME; WHSUS	0.067343052	2.5264520560294694
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.066868353	2.508643177029671
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.066842691	2.507680437582373
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865897
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865897
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865897
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865897
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865897
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865897
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865897
STICKLER SYNDROME	0.06641459	2.4916197361511654
EMANUEL SYNDROME	0.065878901	2.4715227471486125
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.065339734	2.451295276975546
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0653291	2.450896330233961
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687572
CHROMOSOME 1P36 DELETION SYNDROME	0.06424412099999999	2.410192095069525
KAGAMI-OGATA SYNDROME	0.063582213	2.385359855100622
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.06259785000000001	2.3484303449081034
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081034
CHRISTIANSON SYNDROME	0.0624202	2.341765600819082
MEIER-GORLIN SYNDROME 1; MGORS1	0.062261894	2.335826569140182
CONGENITAL ANALBUMINEMIA	0.06207722	2.3288983116119195
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.061971169000000006	2.324919686363483
KNIEST-LIKE DYSPLASIA, LETHAL	0.06103496	2.2897967288693186
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.2897967288693186
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.2897967288693186
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.277969387346635
MOMO SYNDROME	0.06061415299999999	2.274009670237916
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.2523158438168145
LUSCAN-LUMISH SYNDROME; LLS	0.059532981	2.2334482590574205
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.059461850000000004	2.2307796977751453
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.059461850000000004	2.2307796977751453
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.059153990000000004	2.219229975764191
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.058613700000000005	2.198960374954413
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1676047517505683
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.057609584000000005	2.161289808246327
DISTAL MONOSOMY 7Q36	0.057324009	2.1505761336433316
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0571706	2.1448208185521263
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0571706	2.1448208185521263
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.1325155212754647
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.1203054399880963
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.056386034	2.115386922627854
ZUNICH NEUROECTODERMAL SYNDROME	0.056129421	2.1057597907679275
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.056080534	2.1039257387314514
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.056080534	2.1039257387314514
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.056080534	2.1039257387314514
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.056080534	2.1039257387314514
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.055555600000000004	2.084232235924662
GRANGE SYNDROME	0.055555600000000004	2.084232235924662
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.055555600000000004	2.084232235924662
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.055555600000000004	2.084232235924662
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.055555600000000004	2.084232235924662
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924662
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924662
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924662
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.054820127999999996	2.0566401578799645
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.054712549	2.052604207953971
SHPRINTZEN OMPHALOCELE SYNDROME	0.053807928	2.0186663106133897
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.053593138	2.010608216704688
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.05282775	1.9818938055095987
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.052704438	1.977267613991978
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.052645449999999996	1.975054611321991
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412538
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9745350126412538
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9745350126412538
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.05232459	1.963017179357998
PEHO SYNDROME	0.05231289	1.9625782404002639
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052222132000000004	1.9591733496373516
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.05188166	1.946400150934975
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051482088	1.931409747753786
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.051280200000000005	1.9238356872154
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340924
MAN1B1-CDG	0.050336759	1.8884414129227451
SLC35A2-CDG	0.05006959	1.8784182605809514
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04984660999999999	1.8700529094018352
ERYTHERMALGIA, PRIMARY	0.0494995	1.8570306784942079
FAMILIAL THROMBOCYTOSIS	0.049228049	1.8468468819971133
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.048809500000000006	1.8311445348329385
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.048568964000000006	1.8221205501203197
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379164
PELIZAEUS-MERZBACHER DISEASE	0.048063433	1.8031549731765149
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.048047328	1.802550775577001
SILVER-RUSSELL SYNDROME	0.04802755	1.8018087811576784
BECKWITH-WIEDEMANN SYNDROME	0.04788381	1.7964162097230827
3P25.3 MICRODELETION SYNDROME	0.04728696	1.7740246954560848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.047238867	1.7722204312428942
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04718773400000001	1.7703021179329936
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.047146333	1.7687489117971669
GANGLIOCYTOMA	0.0470086	1.7635816998770253
248100 MACROSOMIA ADIPOSA CONGENITA	0.046946550000000004	1.761253822755023
SCHAAF-YANG SYNDROME; SHFYNG	0.04684581300000001	1.7574745583289284
ALG13-CDG	0.046377537999999996	1.7399066830782308
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04611104	1.7299087040732444
MENTAL RETARDATION, X-LINKED 98; MRX98	0.045968823	1.7245732697354548
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.04586214	1.7205709342800704
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.045685279999999995	1.7139358279497339
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.045657097	1.712878510287697
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.045434671999999995	1.7045339805719608
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.045322580999999994	1.7003287577761126
ZIMMERMANN-LABAND SYNDROME 1	0.04518508699999999	1.6951705122158767
FG SYNDROME TYPE 1	0.044927578999999995	1.685509803401491
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866576
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.04473844	1.678414036262435
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503031
LASSA FEVER	0.044019719000000006	1.6514503912503031
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.044003234	1.6508319375137002
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.043963257	1.6493321543758064
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.6414216114859739
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043664738	1.6381328707241856
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04359198	1.6354032706654802
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.631138434706911
YELLOW FEVER	0.043478300000000004	1.631138434706911
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.631138434706911
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.631138434706911
ASHERMAN SYNDROME	0.043478300000000004	1.631138434706911
HYDATIDIFORM MOLE	0.043478300000000004	1.631138434706911
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.631138434706911
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.631138434706911
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.631138434706911
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.042782089999999995	1.6050193157526895
AICARDI SYNDROME	0.042473029999999995	1.5934245743614548
CAMURATI-ENGELMANN DISEASE	0.0424603	1.5929469937689795
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0424603	1.5929469937689795
COSTELLO SYNDROME; CSTLO	0.042047344	1.5774544744330619
COG2-CDG	0.041666699999999994	1.5631741769434964
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.041477022	1.5560581885994644
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.04146750900000001	1.5557012974622912
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.041316007	1.5500175256695814
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04105227399999999	1.5401232788199903
TEMPLE SYNDROME	0.04088782	1.5339535978494536
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.040377984	1.514826513878893
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.040229641000000003	1.5092612556047718
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04014259	1.5059954372107758
16P13.11 MICRODELETION SYNDROME	0.04014259	1.5059954372107758
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0400951	1.5042137952361765
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.04001682200000001	1.501277106028181
JOUBERT SYNDROME 32; JBTS32	0.039593838	1.4854083747377196
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379243
NOONAN SYNDROME 7; NS7	0.039065931	1.465603336416285
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.038986434	1.4626209150211547
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.038705173999999995	1.4520691226064175
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983417
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143654
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143654
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4429274122143654
MAL DE MELEDA	0.0384615	1.4429274122143654
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143654
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143654
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143654
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143654
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143654
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143654
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4429274122143654
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143654
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143654
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143654
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143654
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143654
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143654
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.038375787999999994	1.439711827945532
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038371772	1.4395611630861938
FRYNS-SMEETS-THIRY SYNDROME	0.038368124	1.4394243041701413
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.038319664	1.4376062715298148
ADNP SYNDROME	0.038290719	1.4365203665612998
CANAVAN DISEASE	0.03826399	1.4355175973817025
LISSENCEPHALY 2; LIS2	0.03826399	1.4355175973817025
7Q11.23 MICRODUPLICATION SYNDROME	0.038215096999999996	1.433683320248325
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.038182437	1.4324580427816915
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03814045	1.4308828521818282
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698601
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032167
MONOSOMY 9Q22.3	0.037867543000000004	1.4206444321699936
PROTEUS SYNDROME	0.037682553	1.413704319538257
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.037495841	1.406699604095818
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.037466429999999995	1.4055962166012936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.037284678	1.398777581264014
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.037214063	1.3961283783152596
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.036858628	1.382793825456936
17Q24.2 MICRODELETION SYNDROME	0.036823919000000004	1.381491677398474
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.036672644000000004	1.3758164217718674
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03654973	1.3712051616820393
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.036263234	1.3604569347046782
CUTIS LAXA	0.03613013	1.355463385043969
ALPERS-HUTTENLOCHER SYNDROME	0.03604704	1.3523461681210487
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.03602274900000001	1.3514348633157214
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.03585674	1.345206844731571
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735489
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735489
DOORS SYNDROME	0.0355983	1.3355111708651675
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.035428074000000004	1.3291249466754818
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.035302951	1.3244308134097873
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.035026984	1.3140775939782372
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.034995169	1.3128840176585514
MONOSOMY 18Q	0.034986969	1.312576385226635
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.03490175	1.3093792964198672
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457722
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.034778017	1.304737310602998
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03477208999999999	1.3045149523805624
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03467435	1.3008481238567184
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.034643699	1.2996982163359045
CORNELIA DE LANGE SYNDROME	0.034611909	1.2985055779199748
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034594184	1.2978406041570818
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034594184	1.2978406041570818
22Q11.2 DISTAL DELETION SYNDROME	0.034592044	1.2977603195955816
15Q24 RECURRENT MICRODELETION SYNDROME	0.034592044	1.2977603195955816
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.034587397	1.2975859820454454
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.034557738000000005	1.2964732905456637
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.034518359000000005	1.2949959420656099
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.034444590000000004	1.2922284131790183
KOSAKI OVERGROWTH SYNDROME; KOGS	0.034368039999999996	1.2893565518786263
CENTRAL PRECOCIOUS PUBERTY	0.03420925	1.2833993623830133
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034070034	1.2781765140120753
DWARFISM, LEVI TYPE	0.034067110000000005	1.2780668167887923
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0340536	1.2775599735991345
CHROMOSOME 19P13.13 DELETION SYNDROME	0.033950008999999996	1.2736736380802727
NEUROFIBROMATOSIS, TYPE I	0.033902519	1.2718919961056732
PITT-HOPKINS SYNDROME	0.033823469	1.2689263444296974
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.033730384	1.2654341535851912
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.033594764	1.2603462132904935
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.03355788099999999	1.2589625051214228
NETHERTON SYNDROME; NETH	0.033545099999999994	1.2584830112052856
MARFANOID HYPERMOBILITY SYNDROME	0.0334256	1.253999831252356
TUBEROUS SCLEROSIS 2; TSC2	0.033324453	1.2502051852046654
TUBEROUS SCLEROSIS-1	0.033324453	1.2502051852046654
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03331631	1.2498996911933122
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.03321795	1.2462096026563234
MARSHALL-SMITH SYNDROME; MRSHSS	0.032988102	1.2375865905574022
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.230511682397876
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.230511682397876
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032783033999999996	1.229893228661273
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032783033999999996	1.229893228661273
HYDROXYKYNURENINURIA	0.032783033999999996	1.229893228661273
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.032743343	1.2284041751423462
COCKAYNE SYNDROME	0.032721453	1.22758294661373
15Q26 OVERGROWTH SYNDROME	0.032356984	1.213909472854195
SOTOS SYNDROME	0.032330313	1.2129088796113112
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03231701	1.212409802264752
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544834
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544834
INFANTILE MYOFIBROMATOSIS	0.0322581	1.2101997258544834
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544834
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544834
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544834
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544834
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544834
DESMOID TUMOR	0.0322581	1.2101997258544834
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544834
WEST SYNDROME	0.0322581	1.2101997258544834
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.2101997258544834
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544834
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544834
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544834
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544834
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544834
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544834
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544834
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.032193547	1.2077779458084459
CK SYNDROME	0.032128341	1.2053316677163055
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03204225	1.2021018648265342
PERLMAN SYNDROME	0.031907474	1.1970455881626338
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.031813218000000004	1.1935094659062042
SOTOS SYNDROME 2	0.031789472	1.1926186074027538
MENINGIOMA	0.031684050000000005	1.1886635798128147
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.031677834	1.1884303794229616
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031636280999999995	1.1868714708322994
CLAPO SYNDROME	0.03158999999999999	1.1851351858833323
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.03138745	1.1775362896534918
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.031369352999999996	1.1768573598827121
MCDONOUGH SYNDROME	0.031363034	1.1766202953293852
AMISH INFANTILE EPILEPSY SYNDROME	0.031317849999999994	1.1749251655972246
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949697
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.0311529	1.168736876616172
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.031129650000000002	1.167864626123238
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.030995500000000002	1.162831834569384
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.030995500000000002	1.162831834569384
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.03093264	1.160473569365692
PEHO-LIKE SYNDROME; PEHOL	0.03092511	1.160191072754432
FAMILIAL MULTIPLE LIPOMATOSIS	0.030844418999999998	1.1571638570759226
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030835900000000003	1.1568442569920818
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.030680119	1.1509999535925217
PETERS-PLUS SYNDROME; PTRPLS	0.030584859000000002	1.1474261651212574
EPILEPSY, PYRIDOXINE-DEPENDENT	0.030509271999999997	1.1445904318735407
OSTEOPENIA AND SPARSE HAIR	0.030491262000000005	1.1439147660078317
CLASSICAL EHLERS-DANLOS SYNDROME	0.030415800000000003	1.1410837222788943
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.030302999999999997	1.1368519005325302
BECKWITH-WIEDEMANN SYNDROME	0.030302999999999997	1.1368519005325302
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.030302999999999997	1.1368519005325302
SCLEROSTEOSIS 1; SOST1	0.030302999999999997	1.1368519005325302
ESTROGEN RESISTANCE SYNDROME	0.030302999999999997	1.1368519005325302
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.030302999999999997	1.1368519005325302
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.030302999999999997	1.1368519005325302
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.030302999999999997	1.1368519005325302
NIEVERGELT SYNDROME	0.030302999999999997	1.1368519005325302
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.030302999999999997	1.1368519005325302
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.030219120000000002	1.1337050458509257
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.030138699999999997	1.1306879970491295
NEMALINE MYOPATHY 2; NEM2	0.03010045	1.1292530043026894
DISTAL NEBULIN MYOPATHY	0.03010045	1.1292530043026894
NEMALINE MYOPATHY 3; NEM3	0.03010045	1.1292530043026894
15Q13.3 MICRODELETION SYNDROME	0.030071143000000005	1.12815351848779
20Q13.33 MICRODELETION SYNDROME	0.029998073	1.1254122133902116
MALAN OVERGROWTH SYNDROME	0.029946249	1.1234679764204991
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.029886519	1.1212271367670386
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.029839319000000003	1.119456374476007
MENKES DISEASE	0.029805691000000006	1.1181947813759476
NORRIE DISEASE	0.029764809000000003	1.1166610461220923
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029690352999999996	1.11386774364029
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.029625409000000002	1.111431294779511
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02962469	1.1114043206674928
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.02962385	1.1113728071012967
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.029589734000000003	1.110092906119923
EDINBURGH MALFORMATION SYNDROME	0.029589734000000003	1.110092906119923
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.029532938	1.1079621388512486
2P15P16.1 MICRODELETION SYNDROME	0.029361148000000004	1.1015172394025972
WILLIAMS-BEUREN SYNDROME; WBS	0.029262122	1.0978021651095524
TRISOMY 18P	0.02918545	1.0949257268388322
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.02906504	1.0904084071891897
PEDIATRIC-ONSET GRAVES DISEASE	0.02892116	1.0850105834935615
WOLF-HIRSCHHORN SYNDROME	0.028888299	1.083777765280731
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.028853559	1.0824744542216114
MCCUNE-ALBRIGHT SYNDROME	0.0287139	1.07723498619612
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901078
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901078
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0285948	1.0727668127032832
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0285714	1.0718889347878142
SILLENCE SYNDROME	0.0285714	1.0718889347878142
CAMURATI-ENGELMANN DISEASE	0.0285714	1.0718889347878142
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0285714	1.0718889347878142
THORACOLARYNGOPELVIC DYSPLASIA	0.0285714	1.0718889347878142
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.028529956999999998	1.0703341529736778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.028513471999999998	1.0697156992370749
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.02841066	1.0658585887992456
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.028302734000000003	1.0618096207691208
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.028302734000000003	1.0618096207691208
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028302734000000003	1.0618096207691208
MAPLE SYRUP URINE DISEASE; MSUD	0.028254881000000003	1.0600143604319863
MENKES DISEASE	0.028014473	1.0509951777865971
FUMARASE DEFICIENCY; FMRD	0.027993178	1.05019627136737
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.027952124	1.0486560833356746
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.027946943000000002	1.0484617121613138
COHEN SYNDROME	0.027802043000000002	1.0430256219924474
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.042116117962331
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.042116117962331
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.042116117962331
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.042116117962331
OROFACIAL CLEFT 3	0.027777800000000002	1.042116117962331
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.042116117962331
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.042116117962331
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.042116117962331
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.042116117962331
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.042116117962331
CLEFT CHIN	0.027777800000000002	1.042116117962331
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.042116117962331
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.042116117962331
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.042116117962331
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.042116117962331
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.042116117962331
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.042116117962331
DIMPLES, FACIAL	0.027777800000000002	1.042116117962331
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.042116117962331
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.042116117962331
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.042116117962331
NASAL BONES, ABSENCE OF	0.027777800000000002	1.042116117962331
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.027759599000000003	1.0414332865119271
XP22.13P22.2 DUPLICATION SYNDROME	0.027698309000000004	1.0391339216641022
MGAT2-CDG	0.02769079	1.0388518377304947
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027551934	1.033642495173641
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027551934	1.033642495173641
BOHRING-OPITZ SYNDROME	0.027512797000000002	1.0321742256019437
PERMANENT NEONATAL DIABETES MELLITUS	0.02712942	1.0177913964737892
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668512
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668512
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668512
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.02697144	1.0118645950598657
SLC39A8-CDG	0.026741618999999998	1.0032425958970008
1P36 DELETION SYNDROME	0.026717393	1.0023337296414387
PITT-HOPKINS SYNDROME	0.026592547	0.9976499883493594
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.026549693000000003	0.9960422712472433
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.026529050000000002	0.9952678253579686
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.026475841000000003	0.9932716285201825
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.026471319	0.9931019804888255
L-2-HYDROXYGLUTARIC ACIDURIA	0.026466429	0.9929185265141826
ANGELMAN SYNDROME	0.026466429	0.9929185265141826
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.026430930000000005	0.9915867406970357
JACOBSEN SYNDROME	0.026418913000000002	0.9911359091196771
CARDIOFACIOCUTANEOUS SYNDROME	0.026390234000000002	0.990059983447124
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.026066353	0.9779092151932752
RETT SYNDROME; RTT	0.025924619000000003	0.9725919011560489
6Q16 MICRODELETION SYNDROME	0.02589309	0.9714090544553297
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.025885880000000007	0.9711385630121447
SMITH-KINGSMORE SYNDROME; SKS	0.025837391	0.9693194424034615
3Q27.3 MICRODELETION SYNDROME	0.025832889999999997	0.9691505822112593
HYPOTONIA-CYSTINURIA SYNDROME	0.025811918000000003	0.9683637935085578
SECONDARY SHORT BOWEL SYNDROME	0.02572613	0.965145358012307
8Q24.3 MICRODELETION SYNDROME	0.025676167	0.9632709385981795
HOOFT DISEASE	0.025524934000000003	0.9575972586498829
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.025517257	0.9573092471645386
TURNER SYNDROME	0.0255087	0.9569882214669885
MOSAIC MONOSOMY X	0.0255087	0.9569882214669885
MONOSOMY X	0.0255087	0.9569882214669885
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0255087	0.9569882214669885
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.0254346	0.9542082747346697
CLASSIC HOMOCYSTINURIA	0.025322703000000002	0.9500103300719667
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.025193619	0.9451675953351967
MICROHYDRANENCEPHALY; MHAC	0.025185350000000002	0.9448573742889141
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.025185350000000002	0.9448573742889141
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.9379037558430934
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.9379037558430934
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.9379037558430934
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.9379037558430934
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.9379037558430934
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.9379037558430934
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.9379037558430934
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.9379037558430934
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.9379037558430934
ALKAPTONURIA	0.025	0.9379037558430934
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.9379037558430934
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.9379037558430934
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.9379037558430934
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.9379037558430934
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.9379037558430934
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	0.9379037558430934
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.9379037558430934
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.9379037558430934
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02498774	0.9374438078412279
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.024942269	0.9357379109739501
WITTEVEEN-KOLK SYNDROME	0.024934141000000003	0.9354329797048505
CONGENITAL TOXOPLASMOSIS	0.024877669	0.9333143676688517
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.024875853	0.9332462383400272
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.024875853	0.9332462383400272
FRYNS SYNDROME; FRNS	0.024875853	0.9332462383400272
JUVENILE POLYPOSIS OF INFANCY	0.024805088000000003	0.9305914079687378
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.024718093000000003	0.9273276904791551
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.024589431000000005	0.9225007875577838
TRANSIENT NEONATAL DIABETES MELLITUS	0.024548764	0.9209751182762287
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02443913	0.9168620726615047
XYLT1-CDG	0.02440085	0.9154259544305577
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024350919000000002	0.9135527355332377
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024350919000000002	0.9135527355332377
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024350919000000002	0.9135527355332377
FACIOCARDIOMELIC SYNDROME	0.024334434000000002	0.9129342817966348
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.02425635	0.9100048707217846
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.02425635	0.9100048707217846
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217846
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02425635	0.9100048707217846
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.02425635	0.9100048707217846
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.02425635	0.9100048707217846
CRANIOPHARYNGIOMA	0.024203403000000002	0.9080185031153596
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.024203403000000002	0.9080185031153596
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.9073153379115289
2Q23.1 MICRODELETION SYNDROME	0.024104799000000003	0.9043192606377136
XQ27.3Q28 DUPLICATION SYNDROME	0.024090590000000002	0.9037861936590427
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.024081758999999998	0.9034548885363284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.023950137999999996	0.8985169753264154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.023950137999999996	0.8985169753264154
SALT-AND-PEPPER SYNDROME	0.023890678	0.8962862650335184
ALLAN-HERNDON-DUDLEY SYNDROME	0.023862600000000005	0.8952328865672561
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.023850450000000002	0.8947770653419161
ABCD SYNDROME	0.0238095	0.8932407789898452
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0238095	0.8932407789898452
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0238095	0.8932407789898452
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.0238095	0.8932407789898452
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0238095	0.8932407789898452
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.02372683	0.8901393188500233
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.023678469	0.8883250003085701
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.023584998000000003	0.8848183282300738
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.023549918000000003	0.8835022616798747
CARTILAGE-HAIR HYPOPLASIA	0.02352823	0.8826886114136058
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.023447044	0.8796428252407306
ATKIN-FLAITZ SYNDROME	0.023335509	0.8754584614244122
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.023252234	0.8723343040136989
SCLERODERMA	0.023202249	0.8704590592442663
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02313705	0.8680130437651775
OBESITY DUE TO SIM1 DEFICIENCY	0.02313705	0.8680130437651775
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.02313705	0.8680130437651775
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.02313705	0.8680130437651775
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.02313705	0.8680130437651775
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02311827	0.8673084904637883
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.023108474	0.8669409822560987
PIERPONT SYNDROME	0.023027553	0.8639051378630356
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.022995464	0.8627012821181856
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.022968340000000004	0.8616836940592463
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022929188	0.8602148617452954
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.022801371	0.8554196599708715
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.022756819000000005	0.8537482404456589
BRITTLE CORNEA SYNDROME	0.0227273	0.8526408012069093
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.0227273	0.8526408012069093
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0227273	0.8526408012069093
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0227273	0.8526408012069093
MARFANOID HABITUS WITH SITUS INVERSUS	0.0227273	0.8526408012069093
STICKLER SYNDROME, TYPE I	0.0227273	0.8526408012069093
19P13.3 MICRODUPLICATION SYNDROME	0.022686539999999998	0.8511116429233826
DIENCEPHALIC SYNDROME	0.02266083	0.8501471027008737
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.022586379000000004	0.8473539877998228
ANGELMAN SYNDROME	0.022562287	0.846450148708392
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.8430077793113961
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.022462817	0.8427184172446432
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02244973	0.8422274433865347
11Q22.2Q22.3 MICRODELETION SYNDROME	0.022338829	0.8380668648094645
TETRASOMY 12P	0.022286520000000004	0.8361044325068888
HALLERMANN-STREIFF SYNDROME; HSS	0.022282094	0.835938386025954
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.02224123	0.8344053260628032
PALLISTER-KILLIAN SYNDROME	0.022195537	0.8326911006101738
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.022178639	0.8320571527035242
MELAS	0.02215814	0.831288109139883
WEAVER-WILLIAMS SYNDROME	0.02214584	0.8308266604920083
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.022118019	0.8297829236763558
GAUCHER DISEASE, PERINATAL LETHAL	0.022102679	0.8292074259317707
AL KAISSI SYNDROME; ALKAS	0.022082341000000002	0.8284444224683172
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.022075441000000005	0.8281855610317046
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.022072256999999998	0.8280661096093602
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.022012077999999997	0.8258084252044449
LYSINURIC PROTEIN INTOLERANCE; LPI	0.021994028000000002	0.8251312586927264
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.824141657681861
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.824141657681861
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.021916131000000002	0.8222088631379699
RENPENNING SYNDROME	0.021851803	0.819795524225735
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02174815	0.8159068627055588
HYPOTONIA-CYSTINURIA SYNDROME	0.02174479	0.8157808084407735
6P22 MICRODELETION SYNDROME	0.021234290000000003	0.7966288137464577
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02118466	0.7947668872103578
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021111063	0.7920058111016063
SIMPSON-GOLABI-BEHMEL SYNDROME	0.020954593000000004	0.7861356590745359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.020940518	0.785607619259996
PEHO SYNDROME; PEHO	0.020933767000000002	0.7853543477297682
SMITH-MAGENIS SYNDROME	0.020905493	0.7842936160980598
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.020861110000000002	0.7826285368022365
CHUDLEY-LOWRY-HOAR SYNDROME	0.0208307	0.7814876706736289
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.020811843000000003	0.7807802286286717
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.02080775	0.780626675025765
CLARK-BARAITSER SYNDROME	0.020802343	0.7804238252014513
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.020753559999999997	0.7785936748445994
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.020753559999999997	0.7785936748445994
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751288
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751288
PHELAN-MCDERMID SYNDROME	0.020679057	0.7757986091037364
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.020596209	0.7726904710891728
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020582497000000005	0.7721760496371682
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020558749	0.7712851161014176
48,XXXY SYNDROME	0.020497459000000003	0.7689857512535927
HIRSCHSPRUNG DISEASE	0.020439164	0.7667987472757176
HEART AND BRAIN MALFORMATION SYNDROME	0.020401057000000004	0.7653691193387613
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.020392347999999998	0.7650423911863755
WILLIAMS SYNDROME	0.020364074	0.7639816595546673
GROWTH HORMONE INSENSITIVITY SYNDROME	0.020330434	0.762719616260805
PRADER-WILLI SYNDROME (TYPE 1)	0.020270424000000002	0.7604682720852792
PRADER-WILLI SYNDROME (TYPE 2)	0.020270424000000002	0.7604682720852792
DISTAL MONOSOMY 10Q	0.020222273	0.7586618319353751
OLIVER SYNDROME	0.0200656	0.7527840641298068
OROFACIODIGITAL SYNDROME XVII	0.02005445	0.7523657590547009
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.02004755	0.7521068976180882
MYHRE SYNDROME	0.020033843000000003	0.7515926637468346
PRIMROSE SYNDROME; PRIMS	0.020004972000000003	0.7505095349734368
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020004972000000003	0.7505095349734368
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.019954369	0.7486111052231595
GABRIELE-DE VRIES SYNDROME	0.0198644	0.7452358147027817
20P13 MICRODELETION SYNDROME	0.019837293	0.7442188644183961
CUSHING DISEASE	0.0198055	0.7430261134540154
ACTH-INDEPENDENT CUSHING SYNDROME	0.0198055	0.7430261134540154
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0198055	0.7430261134540154
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.019772219	0.7417775384580868
6Q TERMINAL DELETION SYNDROME	0.019754359	0.7411075000149124
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.019651229000000003	0.7372384594413086
WILSON-TURNER SYNDROME	0.019584853000000003	0.734748287453395
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.019584853000000003	0.734748287453395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.019584853000000003	0.734748287453395
ALSTRM SYNDROME	0.019584853000000003	0.734748287453395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.019584853	0.7347482874533948
LOEYS-DIETZ SYNDROME 5	0.019583060000000003	0.734681020996026
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.019581669	0.7346288360310508
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.019560039999999997	0.7338173992176453
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.019386681000000003	0.7273136369292775
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01935961	0.7262980372263003
KLEINE-LEVIN HIBERNATION SYNDROME	0.0192308	0.7214655819146942
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0192308	0.7214655819146942
FRONTOTEMPORAL DEMENTIA; FTD	0.0192308	0.7214655819146942
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.0192308	0.7214655819146942
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.0192308	0.7214655819146942
EARLY-ONSET SCHIZOPHRENIA	0.0192308	0.7214655819146942
MOSAIC TRISOMY 8	0.0191761	0.7194134484969097
MEGALENCEPHALY	0.019043434	0.7144363309100025
LARON SYNDROME	0.019043434	0.7144363309100025
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.019043434	0.7144363309100025
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.019043434	0.7144363309100025
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.019022779	0.7136614348269249
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.019009751000000002	0.71317267442168
TEEBI-SHALTOUT SYNDROME; TBSH	0.0188981	0.7089839587319344
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018845438	0.7070082832283261
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.018717609	0.7022126312600994
NEONATAL ADRENOLEUKODYSTROPHY	0.018717609	0.7022126312600994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.018716047	0.7021540310334343
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.018701124	0.7015941775234964
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.018701124	0.7015941775234964
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.018701124	0.7015941775234964
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.01866125	0.7000982585490769
TEMPLE-BARAITSER SYNDROME; TMBTS	0.018656037	0.6999026868579086
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149315
C SYNDROME	0.018528293	0.6951102237624518
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0185185	0.694742828103213
ALSTROM SYNDROME; ALMS	0.0185185	0.694742828103213
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0185185	0.694742828103213
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0185185	0.694742828103213
CUSHING SYNDROME	0.0185185	0.694742828103213
BARATELA-SCOTT SYNDROME	0.0185185	0.694742828103213
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0185185	0.694742828103213
SHORT STATURE DUE TO PRIMARY ACID-LABILE SUBUNIT DEFICIENCY	0.0185185	0.694742828103213
MOSAIC TRISOMY 15	0.01846839	0.6928628938150011
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01845865	0.6924974865117246
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.01839085	0.689953891525878
TYSHCHENKO SYNDROME	0.01835801	0.6887218611522026
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018333239999999997	0.6877925861109131
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.018289286999999998	0.6861436387596903
CORNELIA DE LANGE SYNDROME 1	0.018263883	0.685190578479153
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.01820002	0.6827946845767766
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.018184478	0.682211608569844
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.018184478	0.682211608569844
TRISOMY 20P	0.018176190000000002	0.681900674716707
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.018176190000000002	0.681900674716707
TRISOMY 4P	0.018176190000000002	0.681900674716707
GRANT SYNDROME	0.018176190000000002	0.681900674716707
ARIMA SYNDROME	0.018114618000000002	0.6795907303145162
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.018114618000000002	0.6795907303145162
MYOTONIC DYSTROPHY 1	0.018114618000000002	0.6795907303145162
KOOLEN-DE VRIES SYNDROME; KDVS	0.018029801	0.6764087230001424
FOUNTAIN SYNDROME	0.018015553	0.6758741928916122
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.018015553	0.6758741928916122
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.0179835	0.6746716877281708
48,XXYY SYNDROME	0.017964293000000003	0.6739511150306317
CHROMOSOME 18Q DELETION SYNDROME	0.017960781	0.6738193583110107
COFFIN-LOWRY SYNDROME; CLS	0.017941831000000002	0.6731084272640817
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.017910738000000002	0.6719419376048646
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.017879489	0.6707695954262108
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.017872829	0.6705197378656542
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.017848582	0.6696100837709372
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.017766446999999998	0.6665286947714901
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017764	0.6664368927518682
LESCH-NYHAN SYNDROME	0.01771238	0.6645003090768036
8P INVERTED DUPLICATION/DELETION SYNDROME	0.017666699	0.6627865338179768
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.017559239999999997	0.658755085830011
GAUCHER DISEASE	0.017528500000000002	0.6576018393718265
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.017490619000000002	0.6561806900848228
ENDOCARDIAL FIBROELASTOSIS	0.017490619000000002	0.6561806900848228
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.017482627	0.6558808610121548
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.6555622363482199
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.017474134000000002	0.6555622363482199
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.017474134000000002	0.6555622363482199
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.017474134000000002	0.6555622363482199
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.017474134000000002	0.6555622363482199
RING CHROMOSOME 8 SYNDROME	0.017474134000000002	0.6555622363482199
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.017474134000000002	0.6555622363482199
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.017474134000000002	0.6555622363482199
TEMTAMY SYNDROME	0.017474134000000002	0.6555622363482199
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.017474134000000002	0.6555622363482199
HEART-HAND SYNDROME TYPE 2	0.017474134000000002	0.6555622363482199
20Q11.2 MICRODUPLICATION SYNDROME	0.017465869000000002	0.6552521653665381
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.01746194	0.6551047644122697
MARTSOLF SYNDROME	0.01745514	0.6548496545906805
DESMOSTEROLOSIS	0.017371274	0.6517033251351789
RUBINSTEIN-TAYBI SYNDROME	0.017301303	0.649078282587175
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.017264744000000002	0.6477067296507805
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.017263048	0.647643102259984
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397243
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397243
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397243
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397243
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397243
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397243
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397243
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397243
DIASTEMATOMYELIA	0.0172414	0.6468309526397243
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397243
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397243
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397243
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397243
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397243
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397243
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397243
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397243
SICKLE CELL ANEMIA	0.0172414	0.6468309526397243
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397243
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397243
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397243
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397243
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397243
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397243
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397243
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397243
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397243
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397243
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397243
MOTION SICKNESS	0.0172414	0.6468309526397243
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397243
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397243
CERVICAL RIB	0.0172414	0.6468309526397243
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397243
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397243
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397243
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397243
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397243
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397243
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397243
PALMOMENTAL REFLEX	0.0172414	0.6468309526397243
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397243
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397243
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397243
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397243
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397243
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397243
TRANSSEXUALITY	0.0172414	0.6468309526397243
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397243
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397243
FG SYNDROME 2; FGS2	0.01722294	0.6461384045064097
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.01722294	0.6461384045064097
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01721309	0.6457688704266077
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.017203791	0.6454200077455843
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.017173907000000002	0.6442988751119997
STEINERT MYOTONIC DYSTROPHY	0.01715308	0.6435175262510819
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.017046023	0.63950115975551
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.016999292	0.6377479925389379
FREE SIALIC ACID STORAGE DISEASE	0.016999243	0.6377461542475765
GALACTOSEMIA	0.016999243	0.6377461542475765
MULTIPLE MYELOMA	0.01697303	0.6367627434015
JACKSON-WEISS SYNDROME	0.0169492	0.6358687335414304
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0169492	0.6358687335414304
WHITE FORELOCK WITH MALFORMATIONS	0.0169492	0.6358687335414304
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0169492	0.6358687335414304
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0169492	0.6358687335414304
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.0169492	0.6358687335414304
GAPO SYNDROME	0.0169492	0.6358687335414304
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0169492	0.6358687335414304
DEAFNESS-CRANIOFACIAL SYNDROME	0.0169492	0.6358687335414304
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0169492	0.6358687335414304
GAMMA-HEAVY CHAIN DISEASE	0.0169492	0.6358687335414304
MUCKLE-WELLS SYNDROME	0.0169492	0.6358687335414304
DYSOSTOSIS, STANESCU TYPE	0.0169492	0.6358687335414304
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0169492	0.6358687335414304
FAMILIAL TUMORAL CALCINOSIS	0.0169492	0.6358687335414304
XFE PROGEROID SYNDROME; XFEPS	0.016947	0.6357861980109161
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.016837447000000002	0.6316761912043609
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.016837447000000002	0.6316761912043609
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016826444	0.6312634010033392
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.016821223	0.6310675291829689
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.016804909	0.6304554907080561
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.016759884	0.6287663260437826
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.016757419000000003	0.6286738487334566
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.016574900000000004	0.6218264385089476
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.016493709000000002	0.6187804647553213
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.016474309	0.6180526514407869
HYPOPHOSPHATASIA	0.016474309	0.6180526514407869
HOLOPROSENCEPHALY	0.016474309	0.6180526514407869
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.016474309	0.6180526514407869
MUCOPOLYSACCHARIDOSIS TYPE 3	0.016467509	0.6177975416191978
KAPUR-TORIELLO SYNDROME	0.016467509	0.6177975416191978
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.016467509	0.6177975416191978
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.016467509	0.6177975416191978
LAMBERT SYNDROME	0.016457824	0.617434197704184
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.016428309	0.6163269085300356
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.016420391	0.616029855652485
HAREL-YOON SYNDROME; HAYOS	0.016411871999999997	0.6157102555686439
MENTAL RETARDATION, X-LINKED 41	0.016411871999999997	0.6157102555686439
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.016368299	0.6140755643545098
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.016366263	0.613999181472634
48,XYYY SYNDROME	0.01635185	0.6134584611993155
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965497
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965497
DUPLICATION OF THE PITUITARY GLAND	0.01626349	0.6101435341646635
ALAZAMI SYNDROME; ALAZS	0.01626349	0.6101435341646635
BALLER-GEROLD SYNDROME	0.016234949999999998	0.609072823236993
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.016216	0.6083618921900641
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0162124	0.6082268340492225
SUMMITT SYNDROME	0.016195884000000004	0.6076072173119625
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.016182243	0.6070954595066241
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.016182243	0.6070954595066241
RING CHROMOSOME 10 SYNDROME	0.016182243	0.6070954595066241
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.016173422	0.6067645295454126
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.016102847	0.6041168272426675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.016102846999999997	0.6041168272426674
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.016084987000000002	0.6034467887994933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016055357	0.602335185268068
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.016036180999999997	0.6016157755711858
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.016023697	0.6011474239516683
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.015992784	0.5999876871994931
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01597967	0.5994957004053282
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015959369	0.5987340850394333
SCHWARTZ-JAMPEL SYNDROME	0.015942884	0.5981156313028303
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.015932889999999998	0.5977406948973943
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.015932889999999998	0.5977406948973943
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.015926090000000004	0.5974855850758053
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.015926090000000004	0.5974855850758053
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.015926090000000004	0.5974855850758053
%203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1;;AMR SYNDROME	0.015926090000000004	0.5974855850758053
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.015926090000000004	0.5974855850758053
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.015926090000000004	0.5974855850758053
FACIOCARDIORENAL SYNDROME	0.015926090000000004	0.5974855850758053
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.015926090000000004	0.5974855850758053
ALLAN-HERNDON-DUDLEY SYNDROME	0.015926090000000004	0.5974855850758053
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.015926090000000004	0.5974855850758053
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.015926090000000004	0.5974855850758053
260150 PALANT CLEFT PALATE SYNDROME	0.015926090000000004	0.5974855850758053
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.015926090000000004	0.5974855850758053
MACS SYNDROME	0.01591394	0.5970297638504655
EPILEPSY, HOT WATER, 1	0.015887127999999997	0.5960238808303987
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015886938	0.5960167527618544
MICROPHTHALMIA WITH LIMB ANOMALIES	0.01586903	0.5953449135434689
CRANIOFACIOFRONTODIGITAL SYNDROME	0.015829740000000002	0.5938709040007859
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.015794598000000003	0.5925525114492726
OGDEN SYNDROME	0.015794598000000003	0.5925525114492726
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.015772253	0.5917142130722998
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015772253	0.5917142130722998
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.015717319	0.5896533008753604
19Q13.11 MICRODELETION SYNDROME	0.015700834	0.5890348471387575
INFANTILE NEUROAXONAL DYSTROPHY	0.015657309	0.5874019566998347
DISTAL TRISOMY 15Q	0.015587093000000002	0.5847677226950235
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015561427999999999	0.5838048706992749
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.015550447000000002	0.5833929058535586
SIALURIA	0.015522646999999999	0.5823499568770609
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015510533999999998	0.5818955237492798
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015450523999999998	0.579644179573754
MYOCLONIC-ATONIC EPILEPSY	0.015450333999999998	0.5796370515052096
NIEMANN-PICK DISEASE TYPE B	0.015450333999999998	0.5796370515052096
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.015374479000000002	0.5767912639292306
NEUROFIBROMATOSIS TYPE 1	0.015364219000000002	0.5764063482278327
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.015346428	0.5757388983990244
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015313617	0.5745079559937057
VELO-FACIAL-SKELETAL SYNDROME	0.01529991	0.573993722122452
INTERMEDIATE NEMALINE MYOPATHY	0.01529991	0.573993722122452
VASCULAR EHLERS-DANLOS SYNDROME	0.01529991	0.573993722122452
OSTEOGLOSPHONIC DYSPLASIA	0.015230833999999999	0.5714022565289073
COSTELLO SYNDROME	0.015230833999999999	0.5714022565289073
MENTAL RETARDATION, X-LINKED 102	0.015185790999999999	0.5697124165739297
MAJEED SYNDROME	0.0151759	0.569341344331968
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0151759	0.569341344331968
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.015141308999999999	0.5680436231792332
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.015115890000000002	0.5670900001564423
TRISOMY 18	0.015115890000000002	0.5670900001564423
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.015115890000000002	0.5670900001564423
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.015079591000000002	0.5657282014191083
GENITOPATELLAR SYNDROME; GTPTS	0.015009028000000002	0.5630809493101661
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014985599999999998	0.5622020209424903
MOYNAHAN SYNDROME	0.014955253000000002	0.5610635183313476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984201
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.014890969000000002	0.5586518301297229
ACROCALLOSAL SYNDROME	0.014870290000000001	0.5578760336590397
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014851768999999999	0.5571811970405609
HYPERPROLINEMIA, TYPE I	0.014749180999999998	0.5533324902203836
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.014732164	0.5526940778918563
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.014714910000000001	0.5520467742357237
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.0147059	0.5517087537221178
CONGENITAL ADRENAL HYPERPLASIA	0.0147059	0.5517087537221178
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.0147059	0.5517087537221178
GLYCOGEN STORAGE DISEASE VI	0.0147059	0.5517087537221178
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0147059	0.5517087537221178
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0147059	0.5517087537221178
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0147059	0.5517087537221178
COMMON VARIABLE IMMUNODEFICIENCY	0.0147059	0.5517087537221178
CYSTINOSIS, NEPHROPATHIC; CTNS	0.0147059	0.5517087537221178
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0147059	0.5517087537221178
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0147059	0.5517087537221178
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.014692670000000001	0.5512124150545257
SCHISIS ASSOCIATION	0.014692670000000001	0.5512124150545257
DIETHYLSTILBESTROL SYNDROME	0.014692670000000001	0.5512124150545257
BRONCHOPULMONARY DYSPLASIA	0.014692670000000001	0.5512124150545257
RETINOPATHY OF PREMATURITY	0.014692670000000001	0.5512124150545257
MEIER-GORLIN SYNDROME 7	0.01468695	0.5509978226751888
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.01468695	0.5509978226751888
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.014660857	0.5500189137671402
N-ACETYLASPARTATE DEFICIENCY; NACED	0.014660857	0.5500189137671402
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.014660857	0.5500189137671402
XERODERMA PIGMENTOSUM	0.014648919000000002	0.54957104596565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.014644372	0.5494004600305372
TAY-SACHS DISEASE	0.014588909000000002	0.5473197017901243
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014547309000000001	0.5457590299404014
17P13.3 MICRODUPLICATION SYNDROME	0.014520740000000002	0.5447622633448416
RING CHROMOSOME 14 SYNDROME	0.014509821999999999	0.5443526620165897
KRABBE DISEASE	0.014467589999999999	0.542768279959919
MICROSPORIDIOSIS	0.014430319	0.541370015524558
WHIPPLE DISEASE	0.014430319	0.541370015524558
CRONKHITE-CANADA SYNDROME	0.014430319	0.541370015524558
SYSTEMIC SCLEROSIS	0.014430319	0.541370015524558
FLYNN-AIRD SYNDROME	0.014430319	0.541370015524558
SECKEL SYNDROME	0.014413834	0.540751561787955
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.014413834	0.540751561787955
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.014413834	0.540751561787955
NEONATAL MARFAN SYNDROME	0.014412850000000001	0.5407146458961251
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014267771999999998	0.5352718778525168
8P23.1 MICRODELETION SYNDROME	0.014243149	0.534348117685312
SECKEL SYNDROME 2; SCKL2	0.01422582	0.5336980003179117
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.01422582	0.5336980003179117
RAMON SYNDROME	0.014224253	0.5336392125104955
FILIPPI SYNDROME; FLPIS	0.014224253	0.5336392125104955
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.014224246999999999	0.5336389874135941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014223533999999998	0.5336122383984774
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014223533999999998	0.5336122383984774
MENTAL RETARDATION, X-LINKED 77	0.014223533999999998	0.5336122383984774
AYM-GRIPP SYNDROME	0.014223533999999998	0.5336122383984774
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.014223533999999998	0.5336122383984774
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.014119438	0.5297069572237477
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.014117691	0.5296414165092894
COG5-CDG	0.014116509	0.5295970724197132
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.014029441	0.5263306162511633
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014029441	0.5263306162511633
INFANTILE SIALIC ACID STORAGE DISEASE	0.013949357	0.5233261728758457
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.013947852	0.5232697110697441
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013896744	0.5213523356635988
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.013888900000000001	0.5210580589811655
NIJMEGEN BREAKAGE SYNDROME	0.013888900000000001	0.5210580589811655
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.5210580589811655
BETHLEM MYOPATHY	0.013888900000000001	0.5210580589811655
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.013888900000000001	0.5210580589811655
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.5210580589811655
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.013888900000000001	0.5210580589811655
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.5210580589811655
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.5210580589811655
WOLMAN DISEASE	0.013888900000000001	0.5210580589811655
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.5210580589811655
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.013888900000000001	0.5210580589811655
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.013888900000000001	0.5210580589811655
PRIMARY MYELOFIBROSIS	0.013888900000000001	0.5210580589811655
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.013888900000000001	0.5210580589811655
AREDYLD SYNDROME	0.013888900000000001	0.5210580589811655
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.013888900000000001	0.5210580589811655
MULIBREY NANISM	0.013888900000000001	0.5210580589811655
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.0138609	0.5200076067746213
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.013818684000000001	0.5184238249763544
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.013792591000000002	0.5174449160683059
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.013744533	0.5156419649203735
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013742837999999999	0.5155783750457273
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.013742837999999999	0.5155783750457273
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013742837999999999	0.5155783750457273
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013699319	0.5139457097037059
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013699319	0.5139457097037059
MIRAGE SYNDROME; MIRAGE	0.013699319	0.5139457097037059
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.013699319	0.5139457097037059
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5139187355916879
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.013682834	0.5133272559671029
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.013682834	0.5133272559671029
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.013682834	0.5133272559671029
GRANGE SYNDROME; GRNG	0.013682834	0.5133272559671029
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.013682828	0.5133270308702016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.013682828	0.5133270308702016
POTOCKI-LUPSKI SYNDROME	0.013666417	0.512711353328716
ROIFMAN SYNDROME; RFMN	0.013649988000000002	0.5120950004965261
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.013556993	0.508606186105541
TRISOMY X	0.013533109000000001	0.5077101503733588
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0135306	0.5076160223524223
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.013516624000000001	0.5070916966367558
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.013516624000000001	0.5070916966367558
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013435609	0.5040523257255706
SYNDROMIC DIARRHEA	0.01341245	0.5031834892023078
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.013361919000000002	0.5012877606148476
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.013345434000000002	0.5006693068782447
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013332987000000001	0.5002023433562856
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01333156	0.5001488078099019
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.013306233999999998	0.4991986737890826
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.013306233999999998	0.4991986737890826
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.013293750000000002	0.4987303221695649
LOEYS-DIETZ SYNDROME	0.013293750000000002	0.4987303221695649
MARFAN SYNDROME; MFS	0.013293750000000002	0.4987303221695649
THANATOPHORIC DYSPLASIA TYPE 1	0.013262709	0.49756578335015983
THANATOPHORIC DYSPLASIA	0.013262709	0.49756578335015983
COHEN-GIBSON SYNDROME; COGIS	0.013251172000000002	0.4971329595249135
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013246224	0.49694732961355687
PYRIDOXINE-DEPENDENT EPILEPSY	0.013246224	0.49694732961355687
RING CHROMOSOME 12 SYNDROME	0.01318586	0.49468270472084847
SPONDYLOOCULAR SYNDROME; SOS	0.0131579	0.49363375316031344
SHORT STATURE DUE TO GHSR DEFICIENCY	0.0131579	0.49363375316031344
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0131579	0.49363375316031344
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0131579	0.49363375316031344
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.49363375316031344
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0131579	0.49363375316031344
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.49363375316031344
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.49363375316031344
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0131579	0.49363375316031344
SECKEL SYNDROME 4	0.0131579	0.49363375316031344
FORSYTHE-WAKELING SYNDROME; FWS	0.0131579	0.49363375316031344
RUIJS-AALFS SYNDROME; RJALS	0.0131579	0.49363375316031344
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.49363375316031344
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0131579	0.49363375316031344
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.49363375316031344
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.49363375316031344
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.013112569000000001	0.4919331085540686
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.013067903	0.490257412187729
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.013052979999999999	0.48969755867779113
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012997256999999998	0.4876070462383173
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.012997256999999998	0.4876070462383173
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.012997256999999998	0.4876070462383173
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.012997256999999998	0.4876070462383173
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.012989480999999999	0.48731532065409994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012980771999999998	0.48698859250171433
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012980771999999998	0.48698859250171433
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.012963088000000001	0.4863251569009813
OSTEOGENESIS IMPERFECTA, TYPE X	0.012963088	0.4863251569009812
PELGER-HUET ANOMALY; PHA	0.012919224	0.48467954848712924
1Q44 MICRODELETION SYNDROME	0.01290388	0.48410390067794296
DIGEORGE SYNDROME; DGS	0.012873269	0.4829554938031384
BARDET-BIEDL SYNDROME 1; BBS1	0.012856784	0.48233704006653544
47,XYY SYNDROME	0.012831053000000002	0.4813717120048716
CHIME SYNDROME	0.012831053000000002	0.4813717120048716
AUTISM, SUSCEPTIBILITY TO, 18	0.012831053	0.4813717120048716
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012820607	0.48097981829953007
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.012820500000000002	0.4809758040714551
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.012820500000000002	0.4809758040714551
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012781299999999999	0.4795051709822931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012781299999999999	0.4795051709822931
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012780451	0.47947331977074464
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012780451	0.47947331977074464
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.012772392	0.47917097711601114
THANATOPHORIC DYSPLASIA, TYPE I	0.01272129	0.47725382680676737
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.01272129	0.47725382680676737
LATHOSTEROLOSIS	0.012720441	0.4772219755952189
COG1-CDG	0.012718038	0.47713182428620726
LATHOSTEROLOSIS	0.012520969000000002	0.4697385540757977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012455837999999999	0.4672950896949249
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.012455837999999999	0.4672950896949249
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.012455837999999999	0.4672950896949249
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.012455837999999999	0.4672950896949249
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012455837999999999	0.4672950896949249
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.012455837999999999	0.4672950896949249
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012455837999999999	0.4672950896949249
9Q33.3Q34.11 MICRODELETION SYNDROME	0.012418939	0.4659107812674508
ARGININEMIA	0.012418939	0.4659107812674508
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822000000002	0.4653436496243676
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.012403822000000002	0.4653436496243676
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.01236485	0.46388157021745885
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.012352273	0.4634097295959694
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012328871000000002	0.4625317766481998
MENTAL RETARDATION, X-LINKED 90	0.012328871	0.4625317766481997
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.012306119	0.46167820919808206
GABA-TRANSAMINASE DEFICIENCY	0.012306119	0.46167820919808206
KLIPPEL-TRNAUNAY SYNDROME	0.012289634	0.46105975546147915
WEAVER SYNDROME	0.012289634	0.46105975546147915
MEHMO SYNDROME; MEHMO	0.012223451	0.4585768240905606
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.012179022000000001	0.4569100190518265
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01217166	0.45663382515380585
OCULOPHARYNGODISTAL MYOPATHY	0.01210488	0.4541284966411977
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012050369	0.4520834537758072
MUCOPOLYSACCHARIDOSIS, TYPE II	0.012035718999999999	0.4515338421748831
AICARDI-GOUTIRES SYNDROME	0.012035718999999999	0.4515338421748831
LISSENCEPHALY 4	0.012035718999999999	0.4515338421748831
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.012035718999999999	0.4515338421748831
WARBURG MICRO SYNDROME 3; WARBM3	0.012035718999999999	0.4515338421748831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.012035718999999999	0.4515338421748831
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.012035718999999999	0.4515338421748831
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.012035718999999999	0.4515338421748831
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012035718999999999	0.4515338421748831
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.012035718999999999	0.4515338421748831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.012035718999999999	0.4515338421748831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.012035718999999999	0.4515338421748831
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.451421781434135
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012032732	0.451421781434135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012032732	0.451421781434135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.012026811000000002	0.4511996483086012
WEAVER SYNDROME	0.012026811000000002	0.4511996483086012
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012019233999999998	0.45091538843828016
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012019233999999998	0.45091538843828016
BETA-UREIDOPROPIONASE DEFICIENCY	0.012019233999999998	0.45091538843828016
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.012019233999999998	0.45091538843828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012019233999999998	0.45091538843828016
JOUBERT SYNDROME 10	0.012019233999999998	0.45091538843828016
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.012019233999999998	0.45091538843828016
ACROCALLOSAL SYNDROME; ACLS	0.012014571	0.4507404506297404
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.011923128	0.4473098613039179
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01184276	0.4442947633419341
MENTAL RETARDATION, X-LINKED 19	0.011840822	0.4442220570427811
INFANTILE REFSUM DISEASE	0.011827339000000001	0.44371622678917977
TRISOMY 13	0.011770549000000002	0.44158568461740666
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.011764700000000001	0.4413662526546896
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.011764700000000001	0.4413662526546896
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.011764700000000001	0.4413662526546896
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.011764700000000001	0.4413662526546896
SOMATOMAMMOTROPINOMA	0.011764700000000001	0.4413662526546896
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.011764700000000001	0.4413662526546896
SCLEROSTEOSIS	0.011764700000000001	0.4413662526546896
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.011764700000000001	0.4413662526546896
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.011764700000000001	0.4413662526546896
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.011764700000000001	0.4413662526546896
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.011764700000000001	0.4413662526546896
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.011764700000000001	0.4413662526546896
46,XY SEX REVERSAL 1; SRXY1	0.011764700000000001	0.4413662526546896
46,XX SEX REVERSAL 1; SRXX1	0.011764700000000001	0.4413662526546896
PREMATURE OVARIAN FAILURE 2B	0.011764700000000001	0.4413662526546896
ACROMEGALY	0.011764700000000001	0.4413662526546896
DIABETIC EMBRYOPATHY	0.011764700000000001	0.4413662526546896
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.011764700000000001	0.4413662526546896
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.011764700000000001	0.4413662526546896
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.011764338	0.44135267180830495
ZELLWEGER SYNDROME	0.011760829	0.44122102763713483
DIAMOND-BLACKFAN ANEMIA 1	0.011744344	0.44060257390053187
MARDEN-WALKER SYNDROME	0.011680481000000001	0.4382066799981556
TRICHOHEPATOENTERIC SYNDROME 2	0.01164135	0.4367386355233598
TRICHOHEPATOENTERIC SYNDROME 1	0.01164135	0.4367386355233598
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.011583519	0.4345690390391933
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.011561887	0.43375748967733735
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.01149764	0.4313471895732713
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.43122188563149066
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.011494299999999999	0.43122188563149066
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.43122188563149066
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.43122188563149066
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.43122188563149066
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.011494299999999999	0.43122188563149066
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.011494299999999999	0.43122188563149066
DPM3-CDG	0.011494299999999999	0.43122188563149066
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.43122188563149066
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.011494299999999999	0.43122188563149066
RICHIERI COSTA-DA SILVA SYNDROME	0.011494299999999999	0.43122188563149066
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.43122188563149066
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.011494299999999999	0.43122188563149066
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.011494299999999999	0.43122188563149066
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.011494299999999999	0.43122188563149066
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.43122188563149066
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.011494299999999999	0.43122188563149066
SPINOCEREBELLAR ATAXIA 47; SCA47	0.011493451	0.4311900344199422
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011493451	0.4311900344199422
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011486524000000001	0.4309301600472733
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.011486524000000001	0.4309301600472733
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.011486524000000001	0.4309301600472733
2Q33.1 DELETION SYNDROME	0.011367333	0.4264585725847655
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011315888	0.42452855423599156
17Q23.1Q23.2 MICRODELETION SYNDROME	0.011285920000000001	0.42340427024578736
JABERI-ELAHI SYNDROME; JABELS	0.011251401	0.4221092502558694
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.011125283	0.4173777884206926
W SYNDROME	0.011107289999999999	0.41670276032953724
13Q12.3 MICRODELETION SYNDROME	0.0110756	0.4155138735286305
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011073241000000001	0.41542537293022924
NEURONAL CEROID LIPOFUSCINOSIS	0.011065273	0.4151264442451669
METACHROMATIC LEUKODYSTROPHY	0.011065273	0.4151264442451669
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.011042100000000001	0.4142570824958008
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.010968517	0.4114965316131527
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.010968517	0.4114965316131527
VAN MALDERGEM SYNDROME 2; VMLDS2	0.010952032	0.4108780778765498
VAN MALDERGEM SYNDROME 1; VMLDS1	0.010952032	0.4108780778765498
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010913497000000001	0.4094323930272933
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.010895769	0.40876730671594974
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010893948	0.40869898980637415
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.010893948	0.40869898980637415
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.010799821	0.4051677071333244
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01078831	0.4047358587279841
ADAMS-OLIVER SYNDROME	0.010756713000000001	0.4035504609290491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.010745732000000001	0.4031384960833326
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.010745732000000001	0.4031384960833326
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010726467	0.4024157474490799
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.010726467	0.4024157474490799
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010651898	0.3996182056423013
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.010651898	0.3996182056423013
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.01063441	0.39896212320701396
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.010600349	0.3976842856139032
HEREDITARY FOLATE MALABSORPTION	0.010600349	0.3976842856139032
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.010540339000000001	0.3954329414383774
FAMILIAL DYSAUTONOMIA	0.010540339000000001	0.3954329414383774
ISOLATED CEREBELLAR AGENESIS	0.010540339000000001	0.3954329414383774
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010531913	0.39511683035650796
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.010523854000000001	0.39481448770177446
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.010523854000000001	0.39481448770177446
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.010523854000000001	0.39481448770177446
MONOSOMY 18P	0.010523854000000001	0.39481448770177446
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.010517778	0.39458653957295436
BIOTINIDASE DEFICIENCY	0.01048625	0.3934037303883855
ROBERTS SYNDROME	0.010457344	0.3923192885497294
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010431251	0.39134037964168095
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010425510999999998	0.39112503693933925
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01035435	0.38845535017255733
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01035435	0.38845535017255733
SHORT SYNDROME	0.01035435	0.38845535017255733
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.01035435	0.38845535017255733
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.010330019	0.38754254472122057
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010330019	0.38754254472122057
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.010330019	0.38754254472122057
MENTAL RETARDATION, X-LINKED 97; MRX97	0.010313534	0.3869240909846176
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.010308948	0.38675204191964574
JOHANSON-BLIZZARD SYNDROME; JBS	0.010289772	0.38603263222276396
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.010274887	0.3854742043265349
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010258402	0.384855750589932
601095 HARROD SYNDROME	0.010237534	0.3840728635668546
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.010231779	0.38385695812225956
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.010231779	0.38385695812225956
FUCOSIDOSIS	0.010226039	0.3836416154199179
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.010220798	0.383444993276543
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.010185048	0.3821037909056874
GALLOWAY-MOWAT SYNDROME	0.010171769	0.3816056139467338
X SMALL RINGS	0.01014784	0.38070788998779104
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010111703000000001	0.379352168866795
SARCOSINEMIA	0.01010035	0.37892624801319147
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01010035	0.37892624801319147
CHROMOSOME 16Q22 DELETION SYNDROME	0.010066898	0.3776712577555729
22Q11.2 DELETION SYNDROME	0.010019759	0.37590278394970544
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010006979000000001	0.3754233275497185
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.01000214	0.3752417868987375
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009999181	0.37513077661019584
HELSMOORTEL-VAN DER AA SYNDROME	0.009999181	0.37513077661019584
20Q11.2 MICRODELETION SYNDROME	0.009998920000000001	0.3751209848949849
HOLOPROSENCEPHALY 5; HPE5	0.009990494	0.37480487381311556
ELSAHY-WATERS SYNDROME; ESWS	0.009990494	0.37480487381311556
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009964401	0.3738259649050669
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009964401	0.3738259649050669
ACROPECTOROVERTEBRAL DYSPLASIA	0.00995465	0.3734601449241379
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00994739	0.37318777767344113
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00994739	0.37318777767344113
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009936319	0.37277243637420354
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.009936319	0.37277243637420354
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.009936319	0.37277243637420354
HEREDITARY METHEMOGLOBINEMIA	0.009936319	0.37277243637420354
SHPRINTZEN-GOLDBERG SYNDROME	0.009935474000000001	0.3727407352272561
KAGAMI-OGATA SYNDROME	0.009906317000000001	0.3716468768348914
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.009901988	0.3714844694205296
HADDAD SYNDROME	0.009869652999999999	0.3702713847027221
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009846251	0.36939343175495254
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.009838283	0.36909450306989017
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.009838283	0.36909450306989017
NEUROCUTANEOUS MELANOCYTOSIS	0.009838283	0.36909450306989017
LANDAU-KLEFFNER SYNDROME	0.009838283	0.36909450306989017
1Q41Q42 MICRODELETION SYNDROME	0.009838283	0.36909450306989017
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.009838283	0.36909450306989017
5Q35 MICRODUPLICATION SYNDROME	0.009838283	0.36909450306989017
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.009815721999999999	0.3682481012044671
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650126
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650126
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0097886	0.3672305881778281
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.0097886	0.3672305881778281
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.009784194	0.3670652920198983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.009784194	0.3670652920198983
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.009784194	0.3670652920198983
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009784194	0.3670652920198983
CARNOSINEMIA	0.009784194	0.3670652920198983
HYDROXYLYSINURIA	0.009784194	0.3670652920198983
CARNOSINASE DEFICIENCY	0.009784194	0.3670652920198983
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.009784194	0.3670652920198983
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009764929	0.36634254338564565
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.009764838000000001	0.3663391294159744
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009741787	0.3654743446369368
PEMPHIGOID GESTATIONIS	0.00969036	0.3635450015788671
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.3635450015788671
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009630350000000001	0.3612936574033414
CHROMOSOME 9P DELETION SYNDROME	0.009610012000000001	0.36053065393988787
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009586769000000002	0.35965866606000546
CHROMOSOME 10Q26 DELETION SYNDROME	0.009544191	0.3580613034153539
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.009544191	0.3580613034153539
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.009529359	0.35750486387508734
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009529359	0.35750486387508734
MUENKE SYNDROME	0.009491953000000001	0.3561015347594447
PARTINGTON SYNDROME	0.009481868999999999	0.3557232219004878
MICROFORM HOLOPROSENCEPHALY	0.009469713000000001	0.35526717557824666
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009465560000000001	0.35511137100632606
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.009465560000000001	0.35511137100632606
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.009465560000000001	0.35511137100632606
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.009465560000000001	0.35511137100632606
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.009465560000000001	0.35511137100632606
DISTAL 17P13.1 MICRODELETION SYNDROME	0.009465560000000001	0.35511137100632606
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009457762	0.35481882006680343
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009439467	0.3541324620982775
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.009439467	0.3541324620982775
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.009422982	0.3535140083616745
ADDUCTED THUMBS SYNDROME	0.009387138000000001	0.352169279472697
LEGIUS SYNDROME	0.009387138	0.3521692794726969
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009364898	0.3513349202914989
NEMALINE MYOPATHY 10	0.009364898	0.3513349202914989
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.3513349202914989
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00934741	0.35067883785621157
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00934741	0.35067883785621157
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00934741	0.35067883785621157
DYSTONIA, JUVENILE-ONSET	0.00934741	0.35067883785621157
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.34940100026310067
SNEDDON SYNDROME	0.009313349	0.34940100026310067
PINEOBLASTOMA	0.009313349	0.34940100026310067
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.009313349	0.34940100026310067
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.34940100026310067
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.34940100026310067
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.34940100026310067
CRYPTOCOCCOSIS	0.009313349	0.34940100026310067
MENTAL RETARDATION, X-LINKED 93	0.009311668	0.3493379356145578
HSD10 DISEASE, ATYPICAL TYPE	0.009296864	0.34878254652649776
NANCE-HORAN SYNDROME	0.009296864	0.34878254652649776
FAMILIAL PAROXYSMAL ATAXIA	0.009296864	0.34878254652649776
FETAL ALCOHOL SYNDROME	0.009296864	0.34878254652649776
ADULT POLYGLUCOSAN BODY DISEASE	0.009296864	0.34878254652649776
MENTAL RETARDATION, X-LINKED 105; MRX105	0.009296864	0.34878254652649776
ABETAL34V AMYLOIDOSIS	0.009296864	0.34878254652649776
NEUROFERRITINOPATHY	0.009296864	0.34878254652649776
HISTIDINEMIA	0.009296864	0.34878254652649776
SPINOCEREBELLAR ATAXIA TYPE 21	0.009296864	0.34878254652649776
SHORT SYNDROME	0.00927337	0.3479011420929066
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131088
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131088
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131088
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131088
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3473717892131088
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131088
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131088
GAUCHER DISEASE TYPE 3	0.00925926	0.3473717892131088
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131088
MERRF	0.00925926	0.3473717892131088
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131088
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00925926	0.3473717892131088
PAINE SYNDROME	0.00925926	0.3473717892131088
PGM3-CDG	0.009239819	0.34664243773641495
LIG4 SYNDROME	0.00922351	0.3460305868422532
KOOLEN-DE VRIES SYNDROME	0.009189893000000001	0.3447694064198461
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.009163500000000002	0.3437792426667275
FONTAINE PROGEROID SYNDROME; FPS	0.009145088000000001	0.3430884953086241
THYROTOXIC PERIODIC PARALYSIS	0.00911458	0.34194395259729365
CARCINOMA OF ESOPHAGUS	0.00911458	0.34194395259729365
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009079267	0.34061914478409017
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.009079267	0.34061914478409017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.009079267	0.34061914478409017
MENTAL RETARDATION, X-LINKED 91; MRX91	0.009034819	0.3389516269385016
CHROMOSOME 16P13.3 DELETION SYNDROME	0.009015643	0.3382322172416197
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.009002863	0.33775276084163275
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009002863	0.33775276084163275
15Q14 MICRODELETION SYNDROME	0.009002863	0.33775276084163275
CEREBROFACIOARTICULAR SYNDROME	0.00898794	0.3371929073316948
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.3371929073316948
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00898794	0.3371929073316948
ISOLATED OXYCEPHALY	0.00898794	0.3371929073316948
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00898794	0.3371929073316948
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3355736727714571
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.3355736727714571
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714571
SCARF SYNDROME	0.008940449999999999	0.33541126535709526
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.008940449999999999	0.33541126535709526
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.008940449999999999	0.33541126535709526
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.008940449999999999	0.33541126535709526
2P21 MICRODELETION SYNDROME	0.008937759	0.3353103093968164
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008932828	0.3351253172600139
GMS SYNDROME	0.008928294	0.33495521903485415
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008928294	0.33495521903485415
CINCA SYNDROME	0.008928294	0.33495521903485415
MICROPHTHALMIA, SYNDROMIC 1	0.008924441	0.33481066930800363
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008898048	0.33382050555488496
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008898048	0.33382050555488496
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.008884712999999999	0.3333202276915182
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.008780249	0.32940114057350256
MEHMO SYNDROME	0.008780249	0.32940114057350256
KLEEFSTRA SYNDROME	0.008780249	0.32940114057350256
HUNTINGTON DISEASE	0.00877193	0.3290890437197082
HISTIDINEMIA	0.00877193	0.3290890437197082
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.3290890437197082
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.3290890437197082
KEIPERT SYNDROME	0.00877193	0.3290890437197082
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.3290890437197082
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.3290890437197082
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.3290890437197082
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.3290890437197082
RHEUMATIC FEVER	0.00877193	0.3290890437197082
CORTICOBASAL SYNDROME	0.00877193	0.3290890437197082
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.3290890437197082
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.3290890437197082
BREATH-HOLDING SPELLS	0.00877193	0.3290890437197082
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.3290890437197082
LOCKED-IN SYNDROME	0.00877193	0.3290890437197082
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.3290890437197082
CAFFEY DISEASE	0.00877193	0.3290890437197082
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.3290890437197082
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.3290890437197082
MILROY DISEASE	0.00877193	0.3290890437197082
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.3290890437197082
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.3290890437197082
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.3290890437197082
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.3290890437197082
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.008708484	0.3267087940519794
EAR-PATELLA-SHORT STATURE SYNDROME	0.008708484	0.3267087940519794
OROFACIODIGITAL SYNDROME TYPE 4	0.008708484	0.3267087940519794
PETTIGREW SYNDROME	0.008673587	0.3253995929572731
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.008648474000000001	0.32445744987645364
3C SYNDROME	0.008648474000000001	0.32445744987645364
OCCIPITAL HORN SYNDROME	0.008648474000000001	0.32445744987645364
DISTAL MONOSOMY 9P	0.008648474000000001	0.32445744987645364
2Q24 MICRODELETION SYNDROME	0.008642663	0.32423944352744544
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008642663	0.32423944352744544
FRIED SYNDROME	0.00863839	0.3240791370174967
COACH SYNDROME	0.008612297	0.32310022810944816
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.008606921	0.3228985412857917
WOLF-HIRSCHHORN SYNDROME	0.008582652999999999	0.3219880993519197
OROFACIODIGITAL SYNDROME TYPE 2	0.0085713	0.32156217849831625
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.008537848	0.3203071882406977
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008528721999999999	0.31996481585366465
KLEEFSTRA SYNDROME	0.008514797000000001	0.31944240346166014
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.008496224	0.31874561600336915
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.008496224	0.31874561600336915
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0084934	0.3186396703951091
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.0084934	0.3186396703951091
KABUKI SYNDROME	0.008490709	0.3185387144348302
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.008477929	0.3180592580348432
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008477929	0.3180592580348432
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.008477929	0.3180592580348432
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.008477838000000001	0.318055844065172
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.008461444	0.3174408042982403
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.008461444	0.3174408042982403
CRANIOECTODERMAL DYSPLASIA 1	0.0084256	0.3160960754092627
RAPADILINO SYNDROME	0.0084256	0.3160960754092627
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0084256	0.3160960754092627
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0084256	0.3160960754092627
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0084256	0.3160960754092627
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.0084256	0.3160960754092627
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.0084256	0.3160960754092627
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.31526171622806465
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806465
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806465
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806465
HEC SYNDROME	0.00840336	0.31526171622806465
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806465
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806465
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806465
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31526171622806465
HYDROLETHALUS	0.00840336	0.31526171622806465
RENAL TUBULAR DYSGENESIS	0.00840336	0.31526171622806465
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806465
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31526171622806465
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806465
OMPHALOCELE	0.00840336	0.31526171622806465
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806465
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806465
EBSTEIN MALFORMATION	0.00840336	0.31526171622806465
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806465
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.31526171622806465
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806465
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806465
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806465
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806465
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806465
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31526171622806465
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806465
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806465
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806465
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806465
FATCO SYNDROME	0.00840336	0.31526171622806465
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806465
COFFIN-SIRIS SYNDROME 6; CSS6	0.008383022	0.31449871276461117
CHROMOSOME 18P DELETION SYNDROME	0.008343294000000001	0.3130082711481258
CRI-DU-CHAT SYNDROME	0.008343294000000001	0.3130082711481258
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.008317201	0.31202936224007727
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.008307552000000001	0.3116673689064721
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008307552000000001	0.3116673689064721
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00826924	0.31023005015871763
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.31023005015871763
AMISH LETHAL MICROCEPHALY	0.00826924	0.31023005015871763
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00826924	0.31023005015871763
MYOPATHIC EHLERS-DANLOS SYNDROME	0.008183550000000001	0.3070152912451899
16P12.1P12.3 TRIPLICATION SYNDROME	0.008183550000000001	0.3070152912451899
LATERAL MENINGOCELE SYNDROME	0.00812354	0.3047639470696641
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00812354	0.3047639470696641
DISTAL MONOSOMY 15Q	0.008117729	0.30454594072065594
MEIER-GORLIN SYNDROME 6; MGORS6	0.008101244	0.303927486984053
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.008081987	0.30320503847900215
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008081987	0.30320503847900215
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.008041234000000001	0.3016761428085273
HYPERCALCEMIA, INFANTILE, 1	0.007981802	0.2994464829678365
GAPO SYNDROME; GAPOS	0.007962903	0.2987374652445694
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.007962903	0.2987374652445694
16Q24.3 MICRODELETION SYNDROME	0.007952819	0.2983591523856125
PMM2-CDG	0.007947443	0.29815746556195605
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.007947443	0.29815746556195605
HUNTER-MACDONALD SYNDROME	0.00793651	0.29774730149145073
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.00793651	0.29774730149145073
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.007887433000000001	0.2959061213864303
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.007842627999999999	0.2942252102752082
THREE M SYNDROME 2; 3M2	0.00781836	0.29331476834133624
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00781836	0.29331476834133624
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007792267	0.2923358594332877
3Q29 MICRODUPLICATION SYNDROME	0.0077286429999999995	0.2899489318908172
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.0077286429999999995	0.2899489318908172
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0077223199999999995	0.2897117172728894
AICA-RIBOSIDURIA	0.007712049	0.2893263888938389
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.007712049	0.2893263888938389
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007710768999999999	0.28927836822153963
EAST SYNDROME	0.007710768999999999	0.28927836822153963
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007690049	0.28850103358869694
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007666647	0.28762308064092734
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.007664559	0.2875447469192393
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007650759	0.28702702404601393
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.007650759	0.28702702404601393
FRAGILE X SYNDROME	0.007650759	0.28702702404601393
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268334
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268334
TRANSALDOLASE DEFICIENCY	0.00757631	0.2842339841772634
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.007567184	0.2838916117902305
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.007567184	0.2838916117902305
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.007567184	0.2838916117902305
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.007567184	0.2838916117902305
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.007553259	0.28336919939822586
XQ21 MICRODELETION SYNDROME	0.007505769	0.28158755742362634
WOLCOTT-RALLISON SYNDROME	0.0075016729999999995	0.281433891272269
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.007463191	0.27999019477897485
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.007463191	0.27999019477897485
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.007450689999999999	0.27952120538490305
LOWRY-MACLEAN SYNDROME	0.007437969000000001	0.2790439624377799
QAZI-MARKOUIZOS SYNDROME	0.007437969000000001	0.2790439624377799
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007424597	0.2785422964768545
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.007421484000000001	0.27842550870117694
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.007421484000000001	0.27842550870117694
HALLERMANN-STREIFF SYNDROME	0.007421484000000001	0.27842550870117694
OCULO-PALATO-CEREBRAL SYNDROME	0.007421484000000001	0.27842550870117694
OROFACIODIGITAL SYNDROME TYPE 5	0.007421484000000001	0.27842550870117694
BARBER-SAY SYNDROME; BBRSAY	0.007421484000000001	0.27842550870117694
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.007421484000000001	0.27842550870117694
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.007411399999999999	0.27804719584222004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.007385307	0.2770682869341715
XQ25 MICRODUPLICATION SYNDROME	0.007385307	0.2770682869341715
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.007385307	0.2770682869341715
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007379930999999999	0.27686660011051495
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.007355663	0.275956158176643
GLYCEROL KINASE DEFICIENCY; GKD	0.007355663	0.275956158176643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.007355663	0.275956158176643
BANGSTAD SYNDROME	0.007355663	0.275956158176643
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007319920999999999	0.27461525593498926
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.007319920999999999	0.27461525593498926
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.007319920999999999	0.27461525593498926
FANCONI ANEMIA	0.007262314	0.2724540630684751
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.007250848000000001	0.2720239028898953
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.007250848000000001	0.2720239028898953
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00716935	0.2689664116781472
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00714863	0.2681890770453044
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.007125228	0.2673111240975349
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00712314	0.26723279037584685
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00710934	0.2667150675026215
16P11.2P12.2 MICRODELETION SYNDROME	0.00710934	0.2667150675026215
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00710934	0.2667150675026215
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.007097047	0.2662538814677983
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007097047	0.2662538814677983
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2641981089834409
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.2641981089834409
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.2641981089834409
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2641981089834409
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2641981089834409
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2641981089834409
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.2641981089834409
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.2641981089834409
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2641981089834409
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2641981089834409
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2641981089834409
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2641981089834409
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.007036749	0.26399173264100523
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.007036749	0.26399173264100523
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007036749	0.26399173264100523
CENTRAL DIABETES INSIPIDUS	0.007036749	0.26399173264100523
CLASSIC GALACTOSEMIA	0.007020264	0.2633732789044023
TRISOMY 5P	0.00701184	0.26305724285483345
CHOREOACANTHOCYTOSIS	0.006976739	0.2617403884654795
LYNCH SYNDROME	0.006976739	0.2617403884654795
FAMILIAL COLORECTAL CANCER TYPE X	0.006976739	0.2617403884654795
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006976739	0.2617403884654795
GM1 GANGLIOSIDOSIS	0.006976739	0.2617403884654795
MULTIPLE CARBOXYLASE DEFICIENCY	0.006976739	0.2617403884654795
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.006964349999999999	0.2612756008802339
MONOSOMY 13Q34	0.006964349999999999	0.2612756008802339
GALACTOSE EPIMERASE DEFICIENCY	0.006960254	0.2611219347288765
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006921772	0.25967823823558234
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00689655	0.25873200589438744
CLEIDOCRANIAL DYSPLASIA; CCD	0.00689655	0.25873200589438744
RADIO-RENAL SYNDROME	0.00689655	0.25873200589438744
600736 VELOFACIOSKELETAL SYNDROME	0.00689655	0.25873200589438744
PHOCOMELIA, SCHINZEL TYPE	0.00689655	0.25873200589438744
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00689655	0.25873200589438744
SIMOSA CRANIOFACIAL SYNDROME	0.00689655	0.25873200589438744
FAMILIAL ANETODERMA	0.00689655	0.25873200589438744
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00689655	0.25873200589438744
STICKLER SYNDROME, TYPE II	0.00689655	0.25873200589438744
CHILDHOOD APRAXIA OF SPEECH	0.00689655	0.25873200589438744
CENANI-LENZ SYNDROME	0.00689655	0.25873200589438744
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00689655	0.25873200589438744
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00689655	0.25873200589438744
MESOMELIA-SYNOSTOSES SYNDROME	0.00689655	0.25873200589438744
CLEIDOCRANIAL DYSPLASIA	0.00689655	0.25873200589438744
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00689655	0.25873200589438744
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00689655	0.25873200589438744
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.006883178	0.25823033993346206
ROIFMAN SYNDROME	0.006843887999999999	0.256756330390779
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006838512	0.25655464356712254
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.006830729000000001	0.2562626553698535
ROTHMUND-THOMSON SYNDROME	0.0068142440000000006	0.2556442016332506
OLIVER-MCFARLANE SYNDROME	0.0068142440000000006	0.2556442016332506
FANCONI ANEMIA	0.0068142440000000006	0.2556442016332506
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0068142440000000006	0.2556442016332506
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0068142440000000006	0.2556442016332506
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0068142440000000006	0.2556442016332506
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0068142440000000006	0.2556442016332506
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.006778502	0.25430329939159674
JOUBERT SYNDROME 1	0.006778502	0.25430329939159674
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.006737379999999999	0.2527605602616856
HUNTINGTON DISEASE-LIKE 1	0.006711287	0.251781651353637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006705109	0.2515498765774931
19P13.13 MICRODELETION SYNDROME	0.006660443	0.24987418021115362
DYSOSTEOSCLEROSIS	0.006660443	0.24987418021115362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006660442999999999	0.24987418021115357
DESBUQUOIS DYSPLASIA 1	0.006619712	0.2483461098959838
JOUBERT SYNDROME 8	0.006619712	0.2483461098959838
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.006501653	0.24391699071554057
ACRODERMATITIS ENTEROPATHICA	0.00649533	0.24367977609761274
MUCOLIPIDOSIS TYPE II	0.00649533	0.24367977609761274
RETICULAR DYSGENESIS	0.00649533	0.24367977609761274
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00649533	0.24367977609761274
X-LINKED AGAMMAGLOBULINEMIA	0.00649533	0.24367977609761274
CRYPTOSPORIDIOSIS	0.00649533	0.24367977609761274
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.006463059	0.24246909241342024
JUVENILE DERMATOMYOSITIS	0.00643532	0.241428431922087
POLYMYOSITIS	0.00643532	0.241428431922087
DERMATOMYOSITIS	0.00643532	0.241428431922087
FRAGILE X MENTAL RETARDATION SYNDROME	0.006423768999999999	0.24099508287073723
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.006423768999999999	0.24099508287073723
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006423768999999999	0.24099508287073723
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.006423768999999999	0.24099508287073723
HSD10 DISEASE	0.006423768999999999	0.24099508287073723
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.006423768999999999	0.24099508287073723
BRANCHIOSKELETOGENITAL SYNDROME	0.006423768999999999	0.24099508287073723
MENTAL RETARDATION, X-LINKED 21	0.006423768999999999	0.24099508287073723
SAETHRE-CHOTZEN SYNDROME	0.006423768999999999	0.24099508287073723
PACHYGYRIA, FRONTOTEMPORAL	0.006423768999999999	0.24099508287073723
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006423768999999999	0.24099508287073723
MENTAL RETARDATION, X-LINKED 14	0.006423768999999999	0.24099508287073723
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.006423768999999999	0.24099508287073723
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.006418393	0.24079339604708075
6Q25 MICRODELETION SYNDROME	0.0064155689999999994	0.24068745043882067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.006407284	0.24037662913413432
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.006407284	0.24037662913413432
MICRO SYNDROME	0.006403049	0.24021774823789452
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.006403049	0.24021774823789452
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006360471	0.23862038559324303
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.006358383	0.23854205187155497
FILIPPI SYNDROME	0.006358383	0.23854205187155497
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.006358383	0.23854205187155497
SILVER-RUSSELL SYNDROME; SRS	0.00628931	0.23595069882646097
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00628931	0.23595069882646097
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00628931	0.23595069882646097
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00628931	0.23595069882646097
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00628931	0.23595069882646097
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00628931	0.23595069882646097
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00628931	0.23595069882646097
PANCREATIC AGENESIS 2; PAGEN2	0.00628931	0.23595069882646097
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00628931	0.23595069882646097
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00628931	0.23595069882646097
BOWEN-CONRADI SYNDROME	0.00628931	0.23595069882646097
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00628931	0.23595069882646097
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00628931	0.23595069882646097
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00628931	0.23595069882646097
SECKEL SYNDROME 9; SCKL9	0.00628931	0.23595069882646097
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00628931	0.23595069882646097
ISOLATED CLEFT LIP	0.00628931	0.23595069882646097
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00628931	0.23595069882646097
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.006253568	0.23460979658480727
LARSEN-LIKE SYNDROME	0.006253568	0.23460979658480727
2Q37 MICRODELETION SYNDROME	0.006199593	0.232584862375942
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.006199593	0.232584862375942
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.0061636899999999994	0.23123792003410062
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0061636899999999994	0.23123792003410062
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.006160999	0.2311369640738217
CONO-SPONDYLAR DYSPLASIA	0.006160999	0.2311369640738217
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.006160999	0.2311369640738217
TEMPLE-BARAITSER SYNDROME	0.006137597	0.23025901112605204
FETAL TRIMETHADIONE SYNDROME	0.006119024	0.22956222366776113
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776113
CEREBROOCULONASAL SYNDROME	0.006119024	0.22956222366776113
12Q14 MICRODELETION SYNDROME	0.0060970239999999995	0.2287368683626192
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006092930999999999	0.22858331475971252
WIEACKER-WOLFF SYNDROME	0.006090106999999999	0.22847736915145248
WIEDEMANN-STEINER SYNDROME; WDSTS	0.006070931	0.22775795945457067
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.006070931	0.22775795945457067
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.006070931	0.22775795945457067
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.005895547	0.22117822696197925
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.005895547	0.22117822696197925
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005895547	0.22117822696197925
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.005895547	0.22117822696197925
GRACILE BONE DYSPLASIA; GCLEB	0.005893459	0.22109989324029122
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00588235	0.22068312632734477
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00588235	0.22068312632734477
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00588235	0.22068312632734477
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00588235	0.22068312632734477
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734477
MOSAIC TRISOMY 1	0.00588235	0.22068312632734477
CARPENTER-WAZIRI SYNDROME	0.00588235	0.22068312632734477
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11	0.00588235	0.22068312632734477
PROTEUS SYNDROME	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00588235	0.22068312632734477
GMEZ-LPEZ-HERNNDEZ SYNDROME	0.00588235	0.22068312632734477
NANCE-HORAN SYNDROME	0.00588235	0.22068312632734477
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00588235	0.22068312632734477
DISTAL TRISOMY 5Q	0.00588235	0.22068312632734477
X-LINKED INTELLECTUAL DISABILITY-MACROCEPHALY-MACROORCHIDISM SYNDROME	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00588235	0.22068312632734477
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00588235	0.22068312632734477
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00588235	0.22068312632734477
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00588235	0.22068312632734477
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00588235	0.22068312632734477
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00588235	0.22068312632734477
MYOPATHY AND DIABETES MELLITUS	0.00588235	0.22068312632734477
SPASTIC PARAPLEGIA-PRECOCIOUS PUBERTY SYNDROME	0.00588235	0.22068312632734477
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00588235	0.22068312632734477
SPINOCEREBELLAR ATAXIA TYPE 35	0.00588235	0.22068312632734477
HYPERTRYPTOPHANEMIA; HYPTRP	0.00588235	0.22068312632734477
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.00588235	0.22068312632734477
OTOFACIOCERVICAL SYNDROME 2	0.00588235	0.22068312632734477
GARDNER SYNDROME	0.00588235	0.22068312632734477
MARSHALL-SMITH SYNDROME	0.005876974	0.2204814395036883
2Q32Q33 MICRODELETION SYNDROME	0.00586163	0.21990579169450203
MONOSOMY 5P	0.00586163	0.21990579169450203
SCHINDLER DISEASE, TYPE I	0.005835537	0.21892688278645345
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005833449	0.21884854906476545
NEUROFACIODIGITORENAL SYNDROME	0.005816964	0.21823009532816254
FAMILIAL LAMBDOID SYNOSTOSIS	0.005816964	0.21823009532816254
NATIVE AMERICAN MYOPATHY	0.00581414	0.2181241497199025
NOCARDIOSIS	0.005749749	0.2157084472902028
MALIGNANT ATROPHIC PAPULOSIS	0.005749749	0.2157084472902028
JUVENILE HUNTINGTON DISEASE	0.005749749	0.2157084472902028
TAKAYASU ARTERITIS	0.005749749	0.2157084472902028
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005749749	0.2157084472902028
ACUTE INTERMITTENT PORPHYRIA	0.005749749	0.2157084472902028
BEHET DISEASE	0.005749749	0.2157084472902028
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005749749	0.2157084472902028
TSH-SECRETING PITUITARY ADENOMA	0.005749749	0.2157084472902028
RIFT VALLEY FEVER	0.005749749	0.2157084472902028
ERYTHROKERATODERMIA VARIABILIS	0.005733264	0.21508999355359984
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.005718183999999999	0.21452425000807526
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.005674658999999999	0.21289135956915245
19P13.12 MICRODELETION SYNDROME	0.005674658999999999	0.21289135956915245
KALLMANN SYNDROME	0.005674658999999999	0.21289135956915245
DOWN SYNDROME	0.005658174	0.21227290583254954
COWDEN SYNDROME 6; CWS6	0.005653502999999999	0.21209766789480775
COWDEN SYNDROME 5; CWS5	0.005653502999999999	0.21209766789480775
RING CHROMOSOME 13 SYNDROME	0.005596178	0.2099470545826596
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0055940899999999995	0.20986872086097155
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0055940899999999995	0.20986872086097155
FRANK-TER HAAR SYNDROME; FTHS	0.0055940899999999995	0.20986872086097155
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0055940899999999995	0.20986872086097155
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0055940899999999995	0.20986872086097155
NASODIGITOACOUSTIC SYNDROME	0.0055940899999999995	0.20986872086097155
OGDEN SYNDROME; OGDNS	0.0055940899999999995	0.20986872086097155
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0055940899999999995	0.20986872086097155
17P11.2 MICRODUPLICATION SYNDROME	0.005572089999999999	0.20904336555582964
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.005572089999999999	0.20904336555582964
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.005572089999999999	0.20904336555582964
DESANTO-SHINAWI SYNDROME	0.005567997	0.20888981195292303
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005567997	0.20888981195292303
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.005567997	0.20888981195292303
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.005567997	0.20888981195292303
COFFIN-SIRIS SYNDROME 7; CSS7	0.005551512	0.2082713582163201
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.005551512	0.2082713582163201
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.005551512	0.2082713582163201
MENTAL RETARDATION, X-LINKED 99	0.005551512	0.2082713582163201
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0055486879999999995	0.20816541260806004
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0055486879999999995	0.20816541260806004
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0055486879999999995	0.20816541260806004
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0055486879999999995	0.20816541260806004
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0055486879999999995	0.20816541260806004
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0055486879999999995	0.20816541260806004
C SYNDROME	0.0055459969999999996	0.2080644566477811
OROFACIODIGITAL SYNDROME VI	0.0055295119999999994	0.20744600291117812
HADZISELIMOVIC SYNDROME	0.0055295119999999994	0.20744600291117812
JOUBERT SYNDROME 2	0.0055295119999999994	0.20744600291117812
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0055295119999999994	0.20744600291117812
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005458943	0.20479852570533452
SHOX-RELATED SHORT STATURE	0.0054353	0.20391153136535858
NON-DISTAL MONOSOMY 20Q	0.005409207	0.20293262245731003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005409207	0.20293262245731003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005409207	0.20293262245731003
MICROTRIPLICATION 11Q24.1	0.005392722	0.20231416872070712
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.005392722	0.20231416872070712
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005354128	0.20086627041858676
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00535204	0.20078793669689876
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00535204	0.20078793669689876
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00535204	0.20078793669689876
HYPERLYSINEMIA, TYPE I	0.005351442999999999	0.2007655395552092
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00529203	0.19853659252137296
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00529203	0.19853659252137296
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00529203	0.19853659252137296
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.005246628	0.19683328426846144
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.005246628	0.19683328426846144
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.005246628	0.19683328426846144
HEPATOCELLULAR CARCINOMA	0.00520833	0.19539649074681031
MANTLE CELL LYMPHOMA	0.00520833	0.19539649074681031
PERITONEAL CYSTIC MESOTHELIOMA	0.00520833	0.19539649074681031
MALIGNANT PERITONEAL MESOTHELIOMA	0.00520833	0.19539649074681031
GIANT CELL ARTERITIS	0.00520833	0.19539649074681031
MALT LYMPHOMA	0.00520833	0.19539649074681031
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.19539649074681031
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.19539649074681031
EOSINOPHILIC GASTROENTERITIS	0.00520833	0.19539649074681031
NON-FUNCTIONING PARAGANGLIOMA	0.00520833	0.19539649074681031
PSEUDOMYXOMA PERITONEI	0.00520833	0.19539649074681031
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681031
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.19539649074681031
PLEURAL MESOTHELIOMA	0.00520833	0.19539649074681031
FELTY SYNDROME	0.00520833	0.19539649074681031
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00520833	0.19539649074681031
PERRY SYNDROME	0.00520833	0.19539649074681031
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00520833	0.19539649074681031
SYSTEMIC CAPILLARY LEAK SYNDROME	0.00520833	0.19539649074681031
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.19539649074681031
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.19539649074681031
FOCAL MYOSITIS	0.00520833	0.19539649074681031
GRFOMA	0.00520833	0.19539649074681031
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00520833	0.19539649074681031
CLASSIC HODGKIN LYMPHOMA	0.00520833	0.19539649074681031
THYMIC CARCINOMA	0.00520833	0.19539649074681031
ACUTE MONOBLASTIC LEUKEMIA	0.00520833	0.19539649074681031
LEISHMANIASIS	0.00520833	0.19539649074681031
PRIMARY SCLEROSING CHOLANGITIS	0.00520833	0.19539649074681031
RIDDLE SYNDROME	0.00520833	0.19539649074681031
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.19539649074681031
HERMANSKY-PUDLAK SYNDROME	0.00520833	0.19539649074681031
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.19539649074681031
MARBURG HEMORRHAGIC FEVER	0.00520833	0.19539649074681031
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.19539649074681031
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.19539649074681031
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.19539649074681031
BUDD-CHIARI SYNDROME	0.00520833	0.19539649074681031
OROMANDIBULAR DYSTONIA	0.00520833	0.19539649074681031
STEVENS-JOHNSON SYNDROME	0.00520833	0.19539649074681031
YAO SYNDROME	0.00520833	0.19539649074681031
MU-HEAVY CHAIN DISEASE	0.00520833	0.19539649074681031
THYMIC NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.19539649074681031
BRONCHIAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.19539649074681031
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00520833	0.19539649074681031
NEPHROBLASTOMA	0.00520833	0.19539649074681031
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.19539649074681031
MAST CELL SARCOMA	0.00520833	0.19539649074681031
KAPOSI SARCOMA	0.00520833	0.19539649074681031
PULMONARY BLASTOMA	0.00520833	0.19539649074681031
REACTIVE ARTHRITIS	0.00520833	0.19539649074681031
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00520833	0.19539649074681031
NEUROENDOCRINE TUMOR OF STOMACH	0.00520833	0.19539649074681031
JEJUNAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00520833	0.19539649074681031
OSTEOSARCOMA	0.00520833	0.19539649074681031
MEDULLARY THYROID CARCINOMA	0.00520833	0.19539649074681031
BULLOUS PEMPHIGOID	0.00520833	0.19539649074681031
ANAPLASTIC THYROID CARCINOMA	0.00520833	0.19539649074681031
PARATHYROID CARCINOMA	0.00520833	0.19539649074681031
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.00520833	0.19539649074681031
RAT-BITE FEVER	0.00520833	0.19539649074681031
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.19539649074681031
POLYCYTHEMIA VERA	0.00520833	0.19539649074681031
EOSINOPHILIC FASCIITIS	0.00520833	0.19539649074681031
PANCREATOBLASTOMA	0.00520833	0.19539649074681031
LIPOSARCOMA	0.00520833	0.19539649074681031
ISAAC SYNDROME	0.00520833	0.19539649074681031
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.19539649074681031
RHABDOID TUMOR	0.00520833	0.19539649074681031
MNTRIER DISEASE	0.00520833	0.19539649074681031
HODGKIN LYMPHOMA	0.00520833	0.19539649074681031
CARNEY-STRATAKIS SYNDROME	0.00520833	0.19539649074681031
ILEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
TUBERCULOSIS	0.00520833	0.19539649074681031
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00520833	0.19539649074681031
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681031
VIPOMA	0.00520833	0.19539649074681031
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.19539649074681031
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.00520833	0.19539649074681031
POEMS SYNDROME	0.00520833	0.19539649074681031
FAMILIAL PANCREATIC CARCINOMA	0.00520833	0.19539649074681031
ZOLLINGER-ELLISON SYNDROME	0.00520833	0.19539649074681031
THYMIC EPITHELIAL NEOPLASM	0.00520833	0.19539649074681031
FOLLICULAR LYMPHOMA	0.00520833	0.19539649074681031
GLUCAGONOMA	0.00520833	0.19539649074681031
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00520833	0.19539649074681031
PPOMA	0.00520833	0.19539649074681031
POLYARTERITIS NODOSA	0.00520833	0.19539649074681031
TOXIC EPIDERMAL NECROLYSIS	0.00520833	0.19539649074681031
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00520833	0.19539649074681031
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00520833	0.19539649074681031
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.19539649074681031
GALLBLADDER NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00520833	0.19539649074681031
CAP POLYPOSIS	0.00520833	0.19539649074681031
ATTRV30M AMYLOIDOSIS	0.00520833	0.19539649074681031
ERDHEIM-CHESTER DISEASE	0.00520833	0.19539649074681031
LARYNGEAL NEUROENDOCRINE TUMOR	0.00520833	0.19539649074681031
CASTLEMAN DISEASE	0.00520833	0.19539649074681031
SARCOIDOSIS	0.00520833	0.19539649074681031
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00520833	0.19539649074681031
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00520833	0.19539649074681031
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00520833	0.19539649074681031
ALPORT SYNDROME	0.00520833	0.19539649074681031
SOMATOSTATINOMA	0.00520833	0.19539649074681031
NEUROENDOCRINE TUMOR OF THE COLON	0.00520833	0.19539649074681031
PYOMYOSITIS	0.00520833	0.19539649074681031
KLATSKIN TUMOR	0.00520833	0.19539649074681031
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.19539649074681031
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.19539649074681031
PERRY SYNDROME	0.00520833	0.19539649074681031
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.19539649074681031
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.19539649074681031
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.19539649074681031
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.19539649074681031
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.19539649074681031
DISTAL TRISOMY 17Q	0.005176059	0.19418580706261782
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.005176059	0.19418580706261782
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576
ACHONDROPLASIA	0.00513324	0.19257940302576
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00513324	0.19257940302576
DISTAL MONOSOMY 1Q	0.005131393	0.1925101106962783
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.005131393	0.1925101106962783
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0051285689999999995	0.19240416508801828
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.005112083999999999	0.1917857113514153
1Q21.1 MICRODELETION SYNDROME	0.005109393	0.19168475539113639
WIEDEMANN-STEINER SYNDROME	0.005109393	0.19168475539113639
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.005109393	0.19168475539113639
HENNEKAM-BEEMER SYNDROME	0.005109393	0.19168475539113639
ALEXANDER DISEASE	0.005109393	0.19168475539113639
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.005026578	0.18857785540953056
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005026578	0.18857785540953056
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.005026578	0.18857785540953056
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.005026578	0.18857785540953056
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.005026578	0.18857785540953056
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005026578	0.18857785540953056
RIGID SPINE MUSCULAR DYSTROPHY 1	0.005004578	0.18775250010438865
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.005004578	0.18775250010438865
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005004578	0.18775250010438865
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.004972603	0.18655292120066533
11P15.4 MICRODUPLICATION SYNDROME	0.004972603	0.18655292120066533
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.004972603	0.18655292120066533
MONOSOMY 22Q13.3	0.004972603	0.18655292120066533
CHROMOSOME 2Q37 DELETION SYNDROME	0.004972603	0.18655292120066533
DISTAL 16P11.2 MICRODELETION SYNDROME	0.004972603	0.18655292120066533
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004972603	0.18655292120066533
BOHRING-OPITZ SYNDROME	0.004934009	0.18510502289854497
XQ28 (MECP2) DUPLICATION	0.004934009	0.18510502289854497
RETT SYNDROME	0.004934009	0.18510502289854497
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004934009	0.18510502289854497
PITT-HOPKINS-LIKE SYNDROME	0.004934009	0.18510502289854497
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004934009	0.18510502289854497
HALL-RIGGS SYNDROME	0.004934009	0.18510502289854497
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004886518999999999	0.18332338092394543
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.004873999	0.18285367872301925
4Q21 MICRODELETION SYNDROME	0.004873999	0.18285367872301925
5Q14.3 MICRODELETION SYNDROME	0.004873999	0.18285367872301925
14Q12 MICRODELETION SYNDROME	0.004873999	0.18285367872301925
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004873999	0.18285367872301925
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.004873999	0.18285367872301925
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004873999	0.18285367872301925
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004873999	0.18285367872301925
MEND SYNDROME	0.004843941	0.18172601827929397
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004843941	0.18172601827929397
OROFACIODIGITAL SYNDROME TYPE 6	0.004843941	0.18172601827929397
ZTTK SYNDROME; ZTTKS	0.004843941	0.18172601827929397
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004783931	0.1794746741037682
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004783931	0.1794746741037682
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004783931	0.1794746741037682
EMANUEL SYNDROME	0.004783931	0.1794746741037682
KABUKI SYNDROME 1	0.004783931	0.1794746741037682
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00463464	0.17387385051922533
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00463464	0.17387385051922533
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004608547	0.1728949416111768
TRISOMY 8P	0.004608547	0.1728949416111768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004608547	0.1728949416111768
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.004608547	0.1728949416111768
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004608547	0.1728949416111768
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.004608547	0.1728949416111768
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.004608547	0.1728949416111768
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004608547	0.1728949416111768
LISSENCEPHALY 3; LIS3	0.004608547	0.1728949416111768
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.004608547	0.1728949416111768
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.004608547	0.1728949416111768
MOWAT-WILSON SYNDROME; MOWS	0.004608547	0.1728949416111768
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004608547	0.1728949416111768
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004606459	0.1728166078894888
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004606459	0.1728166078894888
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004606459	0.1728166078894888
WEBB-DATTANI SYNDROME; WEDAS	0.004606459	0.1728166078894888
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.17219815415288584
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004589974	0.17219815415288584
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.17219815415288584
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004589974	0.17219815415288584
PETERS PLUS SYNDROME	0.004589974	0.17219815415288584
ZECHI-CEIDE SYNDROME	0.004589974	0.17219815415288584
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.004589974	0.17219815415288584
ZECHI-CEIDE SYNDROME	0.004589974	0.17219815415288584
KEIPERT SYNDROME; KPTS	0.004589974	0.17219815415288584
LARSEN SYNDROME	0.004589974	0.17219815415288584
NOONAN SYNDROME 5; NS5	0.004589974	0.17219815415288584
OPITZ G/BBB SYNDROME	0.004589974	0.17219815415288584
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00458715	0.1720922085446258
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00458715	0.1720922085446258
FRONTOOCULAR SYNDROME	0.00458715	0.1720922085446258
14Q11.2 MICRODELETION SYNDROME	0.00458715	0.1720922085446258
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00458715	0.1720922085446258
MOEBIUS SYNDROME; MBS	0.00458715	0.1720922085446258
17Q21.31 MICRODUPLICATION SYNDROME	0.004567974	0.17137279884774392
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.004567974	0.17137279884774392
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.004567974	0.17137279884774392
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004561057	0.17111329963657726
SPINOCEREBELLAR ATAXIA TYPE 13	0.004561057	0.17111329963657726
TEMTAMY SYNDROME; TEMTYS	0.004561057	0.17111329963657726
PELIZAEUS-MERZBACHER DISEASE	0.004541881	0.17039388993969537
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004541881	0.17039388993969537
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004541881	0.17039388993969537
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.004541881	0.17039388993969537
LEIGH SYNDROME; LS	0.004541881	0.17039388993969537
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004541881	0.17039388993969537
FOLATE MALABSORPTION, HEREDITARY	0.004541881	0.17039388993969537
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004541881	0.17039388993969537
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.004541881	0.17039388993969537
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.004541881	0.17039388993969537
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004541881	0.17039388993969537
ADIPOSIS DOLOROSA	0.004447669	0.16685941839387577
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.004447669	0.16685941839387577
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.004447669	0.16685941839387577
BARDET-BIEDL SYNDROME 14; BBS14	0.004431184	0.16624096465727287
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.004431184	0.16624096465727287
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 13; BBS13	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 9; BBS9	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 8; BBS8	0.004431184	0.16624096465727287
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004431184	0.16624096465727287
URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.16624096465727287
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.004431184	0.16624096465727287
CARPENTER SYNDROME	0.004431184	0.16624096465727287
BIEMOND SYNDROME TYPE 2	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 16; BBS16	0.004431184	0.16624096465727287
LAURENCE-MOON SYNDROME	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 4; BBS4	0.004431184	0.16624096465727287
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.004431184	0.16624096465727287
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.004431184	0.16624096465727287
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.004431184	0.16624096465727287
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 3; BBS3	0.004431184	0.16624096465727287
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME	0.004431184	0.16624096465727287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.004431184	0.16624096465727287
RETINITIS PIGMENTOSA	0.004431184	0.16624096465727287
WAGR SYNDROME	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 6; BBS6	0.004431184	0.16624096465727287
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.004431184	0.16624096465727287
MACROCEPHALY/AUTISM SYNDROME	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 2	0.004431184	0.16624096465727287
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 19; BBS19	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 7; BBS7	0.004431184	0.16624096465727287
BARDET-BIEDL SYNDROME 20	0.004431184	0.16624096465727287
ATKIN-FLAITZ SYNDROME	0.004431184	0.16624096465727287
CHOPS SYNDROME; CHOPS	0.004431184	0.16624096465727287
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00439259	0.16479306635515253
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.004345099999999999	0.16301142438055297
ALAGILLE SYNDROME	0.004345099999999999	0.16301142438055297
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.004345099999999999	0.16301142438055297
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.004345099999999999	0.16301142438055297
DOUBLE OUTLET RIGHT VENTRICLE	0.004345099999999999	0.16301142438055297
CYSTINOSIS	0.004345099999999999	0.16301142438055297
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.004345099999999999	0.16301142438055297
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.004345099999999999	0.16301142438055297
AARSKOG-SCOTT SYNDROME	0.004345099999999999	0.16301142438055297
ALAGILLE SYNDROME 1; ALGS1	0.004345099999999999	0.16301142438055297
JUVENILE POLYPOSIS SYNDROME	0.004345099999999999	0.16301142438055297
CONGENITAL HYPOTHYROIDISM	0.00433258	0.16254172217962676
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00433258	0.16254172217962676
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00433258	0.16254172217962676
ATHYREOSIS	0.00433258	0.16254172217962676
THYROID ECTOPIA	0.00433258	0.16254172217962676
THYROID HYPOPLASIA	0.00433258	0.16254172217962676
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00433258	0.16254172217962676
REFSUM DISEASE	0.00433258	0.16254172217962676
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004319007	0.1620325154725044
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004302522	0.16141406173590148
ERMINE PHENOTYPE	0.00428509	0.16076008020502722
CAT-EYE SYNDROME	0.00428509	0.16076008020502722
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00428509	0.16076008020502722
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00428509	0.16076008020502722
TRANSKETOLASE DEFICIENCY	0.00428509	0.16076008020502722
GERODERMA OSTEODYSPLASTICA	0.00428509	0.16076008020502722
DENT DISEASE	0.00428509	0.16076008020502722
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.0042589970000000005	0.1597811712969787
LISSENCEPHALY, X-LINKED, 2	0.0042589970000000005	0.1597811712969787
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0042589970000000005	0.1597811712969787
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004242512	0.15916271756037575
ARTERIAL TORTUOSITY SYNDROME	0.004242512	0.15916271756037575
DUBOWITZ SYNDROME	0.004242512	0.15916271756037575
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004171943	0.1565152403545321
OROFACIODIGITAL SYNDROME XVI; OFD16	0.004067128	0.1525829850677843
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004067128	0.1525829850677843
SCHOLTE SYNDROME; SHLTS	0.004067128	0.1525829850677843
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.004067128	0.1525829850677843
JOUBERT SYNDROME 14	0.004067128	0.1525829850677843
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.004067128	0.1525829850677843
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.004067128	0.1525829850677843
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004067128	0.1525829850677843
SAUL-WILSON SYNDROME; SWILS	0.00406504	0.1525046513460963
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.1525046513460963
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.1525046513460963
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00406504	0.1525046513460963
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00406504	0.1525046513460963
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.1525046513460963
CRANIOSYNOSTOSIS 4; CRS4	0.00406504	0.1525046513460963
STEEL SYNDROME; STLS	0.00406504	0.1525046513460963
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00406504	0.1525046513460963
HYPERTELORISM, TEEBI TYPE	0.00406504	0.1525046513460963
AXENFELD-RIEGER SYNDROME	0.00406504	0.1525046513460963
268650 RUDIGER SYNDROME	0.00406504	0.1525046513460963
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00406504	0.1525046513460963
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.1525046513460963
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00406504	0.1525046513460963
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00406504	0.1525046513460963
HYPERTELORISM, TEEBI TYPE; TBHS	0.00406504	0.1525046513460963
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00406504	0.1525046513460963
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.1525046513460963
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00406504	0.1525046513460963
ODONTOCHONDRODYSPLASIA; ODCD	0.00406504	0.1525046513460963
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.1525046513460963
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00406504	0.1525046513460963
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.1525046513460963
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00406504	0.1525046513460963
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00406504	0.1525046513460963
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0040430399999999995	0.15167929604095437
NEUTRAL LIPID STORAGE MYOPATHY	0.004019638	0.15080134309318477
NOONAN SYNDROME 6; NS6	0.004019638	0.15080134309318477
VERVERI-BRADY SYNDROME; VERBRAS	0.004019638	0.15080134309318477
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.004019638	0.15080134309318477
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.004019638	0.15080134309318477
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.004019638	0.15080134309318477
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.004019638	0.15080134309318477
VICI SYNDROME; VICIS	0.004016947	0.15070038713290584
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004016947	0.15070038713290584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004016947	0.15070038713290584
GLUTARIC ACIDEMIA I; GA1	0.004016947	0.15070038713290584
HYPOPHOSPHATASIA, INFANTILE	0.004016947	0.15070038713290584
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004016947	0.15070038713290584
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004016947	0.15070038713290584
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004016947	0.15070038713290584
PEROXISOME BIOGENESIS DISORDER 3B	0.004000462	0.15008193339630288
WARBURG MICRO SYNDROME 1	0.004000462	0.15008193339630288
NIEMANN-PICK DISEASE, TYPE A	0.004000462	0.15008193339630288
GALACTOSE EPIMERASE DEFICIENCY	0.004000462	0.15008193339630288
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00390625	0.14654746185048334
ACROCEPHALOSYNDACTYLY	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 5; BBS5	0.00390625	0.14654746185048334
ULNAR-MAMMARY SYNDROME	0.00390625	0.14654746185048334
SHEEHAN SYNDROME	0.00390625	0.14654746185048334
HALOTHANE HEPATITIS	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 11; BBS11	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 10; BBS10	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 17; BBS17	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 18; BBS18	0.00390625	0.14654746185048334
SERTOLI CELL-ONLY SYNDROME	0.00390625	0.14654746185048334
BARDET-BIEDL SYNDROME 12; BBS12	0.00390625	0.14654746185048334
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00390625	0.14654746185048334
PERIPARTUM CARDIOMYOPATHY	0.00390625	0.14654746185048334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00390625	0.14654746185048334
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00390625	0.14654746185048334
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00390625	0.14654746185048334
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00390625	0.14654746185048334
IMMUNODEFICIENCY 61; IMD61	0.00390625	0.14654746185048334
ADENOCARCINOMA OF THE ESOPHAGUS	0.00390625	0.14654746185048334
MLLERIAN APLASIA AND HYPERANDROGENISM	0.00390625	0.14654746185048334
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00390625	0.14654746185048334
POLYCYSTIC OVARY SYNDROME 1	0.00390625	0.14654746185048334
SECONDARY POLYCYTHEMIA	0.00390625	0.14654746185048334
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00390625	0.14654746185048334
RING CHROMOSOME Y SYNDROME	0.00390625	0.14654746185048334
NARCOLEPSY 7; NRCLP7	0.00390625	0.14654746185048334
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00390625	0.14654746185048334
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00390625	0.14654746185048334
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.00390625	0.14654746185048334
SUMMITT SYNDROME	0.00390625	0.14654746185048334
RETINITIS PIGMENTOSA 71; RP71	0.00390625	0.14654746185048334
ADIPOSIS DOLOROSA	0.00390625	0.14654746185048334
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00390625	0.14654746185048334
DYSBETALIPOPROTEINEMIA	0.00390625	0.14654746185048334
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00390625	0.14654746185048334
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.00390625	0.14654746185048334
OBESITY-HYPOVENTILATION SYNDROME	0.00390625	0.14654746185048334
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.00390625	0.14654746185048334
SENIOR-LOKEN SYNDROME 9	0.00390625	0.14654746185048334
NARCOLEPSY TYPE 1	0.00390625	0.14654746185048334
ULNAR-MAMMARY SYNDROME; UMS	0.00390625	0.14654746185048334
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.003882403	0.1456528142158597
MOSAIC TRISOMY 14	0.003882403	0.1456528142158597
HARROD SYNDROME	0.003882403	0.1456528142158597
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.003882403	0.1456528142158597
COWDEN SYNDROME	0.003882403	0.1456528142158597
MONOSOMY 9P	0.0038223930000000003	0.14340147004033396
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0038223930000000003	0.14340147004033396
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0038223930000000003	0.14340147004033396
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0038223930000000003	0.14340147004033396
COFFIN-LOWRY SYNDROME	0.0038223930000000003	0.14340147004033396
VICI SYNDROME	0.0038223930000000003	0.14340147004033396
COFFIN-SIRIS SYNDROME 1; CSS1	0.003822393	0.14340147004033393
TARP SYNDROME; TARPS	0.0037775879999999997	0.14172055892911195
CLASSIC MULTIMINICORE MYOPATHY	0.0037775879999999997	0.14172055892911195
NEMALINE MYOPATHY 7; NEM7	0.003717578	0.1394692147535862
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.003717578	0.1394692147535862
NEMALINE MYOPATHY 4	0.003717578	0.1394692147535862
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.003647009	0.13682173754774254
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.003647009	0.13682173754774254
CHILDHOOD DISINTEGRATIVE DISORDER	0.003647009	0.13682173754774254
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.003647009	0.13682173754774254
RENIER-GABREELS-JASPER SYNDROME	0.003647009	0.13682173754774254
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.003647009	0.13682173754774254
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.003647009	0.13682173754774254
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.003647009	0.13682173754774254
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.003647009	0.13682173754774254
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003647009	0.13682173754774254
INTELLECTUAL DISABILITY, WOLFF TYPE	0.003647009	0.13682173754774254
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.003647009	0.13682173754774254
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003647009	0.13682173754774254
SECKEL SYNDROME 7; SCKL7	0.003647009	0.13682173754774254
RETT SYNDROME, CONGENITAL VARIANT	0.003647009	0.13682173754774254
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.003647009	0.13682173754774254
BAND HETEROTOPIA; BH	0.003647009	0.13682173754774254
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.003647009	0.13682173754774254
CLASSIC PHENYLKETONURIA	0.003647009	0.13682173754774254
NARP SYNDROME	0.003647009	0.13682173754774254
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.003630524	0.1362032838111396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.003630524	0.1362032838111396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.003630524	0.1362032838111396
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003599519	0.135040095573143
CENTRAL BILATERAL MACROGYRIA	0.003599519	0.135040095573143
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.003599519	0.135040095573143
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.003599519	0.135040095573143
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.135040095573143
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003599519	0.135040095573143
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.003599519	0.135040095573143
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.003599519	0.135040095573143
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.003599519	0.135040095573143
BRANCHIOOCULOFACIAL SYNDROME	0.003599519	0.135040095573143
KEUTEL SYNDROME	0.003599519	0.135040095573143
MENTAL RETARDATION, X-LINKED 9	0.003599519	0.135040095573143
DARIER-WHITE DISEASE; DAR	0.003599519	0.135040095573143
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.003599519	0.135040095573143
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.003599519	0.135040095573143
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0035830339999999997	0.13442164183654007
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0035830339999999997	0.13442164183654007
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0035830339999999997	0.13442164183654007
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0035803429999999997	0.13432068587626111
1Q21.1 MICRODUPLICATION SYNDROME	0.0035803429999999997	0.13432068587626111
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0035803429999999997	0.13432068587626111
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0035803429999999997	0.13432068587626111
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0035803429999999997	0.13432068587626111
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0035803429999999997	0.13432068587626111
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0035803429999999997	0.13432068587626111
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.003556941	0.13344273292849154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.003556941	0.13344273292849154
MEND SYNDROME; MEND	0.003556941	0.13344273292849154
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.003556941	0.13344273292849154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.003556941	0.13344273292849154
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0034755280000000003	0.13038843058951338
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0034755280000000003	0.13038843058951338
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0034755280000000003	0.13038843058951338
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0034755280000000003	0.13038843058951338
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0034755280000000003	0.13038843058951338
GLYCOGEN STORAGE DISEASE IV	0.0034755280000000003	0.13038843058951338
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0034755280000000003	0.13038843058951338
MEVALONIC ACIDURIA; MEVA	0.0034755280000000003	0.13038843058951338
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0034755280000000003	0.13038843058951338
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0034755280000000003	0.13038843058951338
CAMPOMELIC DYSPLASIA	0.0034755280000000003	0.13038843058951338
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0034755280000000003	0.13038843058951338
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0034755280000000003	0.13038843058951338
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0034755280000000003	0.13038843058951338
PORPHYRIA, ACUTE HEPATIC	0.0034755280000000003	0.13038843058951338
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.0033574689999999996	0.12595931140907018
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0033574689999999996	0.12595931140907018
TETRASOMY 5P	0.0033574689999999996	0.12595931140907018
TURNPENNY-FRY SYNDROME; TPFS	0.003340984	0.12534085767246725
MCKUSICK-KAUFMAN SYNDROME	0.003340984	0.12534085767246725
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.003340984	0.12534085767246725
3Q29 MICRODELETION SYNDROME	0.003340984	0.12534085767246725
MENTAL RETARDATION, BUENOS AIRES TYPE	0.003340984	0.12534085767246725
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003314891	0.12436194876441868
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003314891	0.12436194876441868
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.003314891	0.12436194876441868
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003314891	0.12436194876441868
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003314891	0.12436194876441868
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.003314891	0.12436194876441868
STT3A-CDG	0.003314891	0.12436194876441868
STT3B-CDG	0.003314891	0.12436194876441868
SSR4-CDG	0.003314891	0.12436194876441868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.003314891	0.12436194876441868
TARP SYNDROME	0.003314891	0.12436194876441868
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.003314891	0.12436194876441868
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003314891	0.12436194876441868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003314891	0.12436194876441868
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003314891	0.12436194876441868
PONTINE TEGMENTAL CAP DYSPLASIA	0.003314891	0.12436194876441868
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.003314891	0.12436194876441868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003314891	0.12436194876441868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003314891	0.12436194876441868
ETHYLMALONIC ENCEPHALOPATHY	0.003314891	0.12436194876441868
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.003314891	0.12436194876441868
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003314891	0.12436194876441868
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.003297459	0.12370796723354441
FETAL GAUCHER DISEASE	0.003297459	0.12370796723354441
MOWAT-WILSON SYNDROME	0.003297459	0.12370796723354441
DISTAL MONOSOMY 3P	0.003297459	0.12370796723354441
PYRUVATE DEHYDROGENASE DEFICIENCY	0.003297459	0.12370796723354441
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003280974	0.12308951349694149
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.003280974	0.12308951349694149
8Q21.11 MICRODELETION SYNDROME	0.003280974	0.12308951349694149
CRANIOFRONTONASAL DYSPLASIA	0.003280974	0.12308951349694149
GERMAN SYNDROME	0.003280974	0.12308951349694149
CAREY-FINEMAN-ZITER SYNDROME	0.003280974	0.12308951349694149
TRISOMY 17P	0.003280974	0.12308951349694149
GRISCELLI SYNDROME, TYPE 1	0.0032548810000000003	0.12211060458889295
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0032548810000000003	0.12211060458889295
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0032548810000000003	0.12211060458889295
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0032548810000000003	0.12211060458889295
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0032548810000000003	0.12211060458889295
ADAMS-OLIVER SYNDROME 1; AOS1	0.0032548810000000003	0.12211060458889295
ELEJALDE DISEASE	0.0032548810000000003	0.12211060458889295
KETOADIPICACIDURIA	0.0032548810000000003	0.12211060458889295
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0032548810000000003	0.12211060458889295
NEURAMINIDASE DEFICIENCY	0.0032548810000000003	0.12211060458889295
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0032548810000000003	0.12211060458889295
NIEMANN-PICK DISEASE, TYPE C2	0.0032548810000000003	0.12211060458889295
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0032548810000000003	0.12211060458889295
KLEEFSTRA SYNDROME 2; KLEFS2	0.0032548810000000003	0.12211060458889295
SALLA DISEASE	0.0032548810000000003	0.12211060458889295
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0032548810000000003	0.12211060458889295
HOLOPROSENCEPHALY 2; HPE2	0.0032548810000000003	0.12211060458889295
ASPARTYLGLUCOSAMINURIA; AGU	0.0032548810000000003	0.12211060458889295
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0032548810000000003	0.12211060458889295
PYRUVATE CARBOXYLASE DEFICIENCY	0.0032548810000000003	0.12211060458889295
OHDO SYNDROME	0.0032548810000000003	0.12211060458889295
CYCLIC VOMITING SYNDROME	0.0032548810000000003	0.12211060458889295
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0032548810000000003	0.12211060458889295
METACHROMATIC LEUKODYSTROPHY	0.0032548810000000003	0.12211060458889295
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0032548810000000003	0.12211060458889295
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0032548810000000003	0.12211060458889295
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0032548810000000003	0.12211060458889295
GLYCINE ENCEPHALOPATHY; GCE	0.0032548810000000003	0.12211060458889295
CODAS SYNDROME	0.0032548810000000003	0.12211060458889295
STIMMLER SYNDROME	0.00310559	0.11650978100435007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00310559	0.11650978100435007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00310559	0.11650978100435007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00310559	0.11650978100435007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.00310559	0.11650978100435007
BRESEK SYNDROME	0.00310559	0.11650978100435007
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00310559	0.11650978100435007
OKAMOTO SYNDROME	0.00310559	0.11650978100435007
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00310559	0.11650978100435007
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00310559	0.11650978100435007
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00310559	0.11650978100435007
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00310559	0.11650978100435007
PHENYLKETONURIA	0.00310559	0.11650978100435007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00310559	0.11650978100435007
JUBERG-MARSIDI SYNDROME	0.00310559	0.11650978100435007
TRISOMY XQ28	0.00310559	0.11650978100435007
NEPHROSIALIDOSIS	0.00310559	0.11650978100435007
HOLMES-GANG SYNDROME	0.00310559	0.11650978100435007
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00310559	0.11650978100435007
%613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	0.00310559	0.11650978100435007
WARBURG MICRO SYNDROME 2; WARBM2	0.00310559	0.11650978100435007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00310559	0.11650978100435007
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00310559	0.11650978100435007
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00310559	0.11650978100435007
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00310559	0.11650978100435007
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00310559	0.11650978100435007
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00310559	0.11650978100435007
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00310559	0.11650978100435007
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.0030581	0.11472813902975053
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0030581	0.11472813902975053
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0030581	0.11472813902975053
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0030581	0.11472813902975053
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0030581	0.11472813902975053
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0030581	0.11472813902975053
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.0030581	0.11472813902975053
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0030581	0.11472813902975053
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0030581	0.11472813902975053
MENTAL RETARDATION, X-LINKED 73	0.0030581	0.11472813902975053
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975053
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0030581	0.11472813902975053
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0030581	0.11472813902975053
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0030581	0.11472813902975053
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0030581	0.11472813902975053
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.0030581	0.11472813902975053
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.0030581	0.11472813902975053
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0030581	0.11472813902975053
OTOFACIOCERVICAL SYNDROME	0.0030581	0.11472813902975053
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0030581	0.11472813902975053
CHAR SYNDROME	0.0030581	0.11472813902975053
BLOOM SYNDROME	0.0030581	0.11472813902975053
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.0030581	0.11472813902975053
BONNEMANN-MEINECKE-REICH SYNDROME	0.0030581	0.11472813902975053
PEROXISOME BIOGENESIS DISORDER 14B	0.0030581	0.11472813902975053
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.0030581	0.11472813902975053
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0030581	0.11472813902975053
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0030581	0.11472813902975053
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0030581	0.11472813902975053
BLOOM SYNDROME	0.0030581	0.11472813902975053
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0030581	0.11472813902975053
WOODHOUSE-SAKATI SYNDROME	0.0030581	0.11472813902975053
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0030581	0.11472813902975053
SPINOCEREBELLAR ATAXIA TYPE 27	0.0030581	0.11472813902975053
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0030581	0.11472813902975053
WEILL-MARCHESANI SYNDROME	0.0030581	0.11472813902975053
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0030581	0.11472813902975053
AUROCEPHALOSYNDACTYLY	0.0030581	0.11472813902975053
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0030581	0.11472813902975053
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0030581	0.11472813902975053
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975053
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0030581	0.11472813902975053
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0030581	0.11472813902975053
MUCOLIPIDOSIS III GAMMA	0.0030581	0.11472813902975053
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0030581	0.11472813902975053
MICROPHTHALMIA-ANKYLOBLEPHARON-INTELLECTUAL DISABILITY SYNDROME	0.0030581	0.11472813902975053
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0030581	0.11472813902975053
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0030581	0.11472813902975053
BOUCHER-NEUHAUSER SYNDROME	0.0030581	0.11472813902975053
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0030581	0.11472813902975053
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0030581	0.11472813902975053
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.0030581	0.11472813902975053
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0030581	0.11472813902975053
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0030581	0.11472813902975053
VAN BOGAERT-HOZAY SYNDROME	0.0030581	0.11472813902975053
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.0030581	0.11472813902975053
3MC SYNDROME 1	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.0030581	0.11472813902975053
ISOLATED HEMIHYPERPLASIA	0.0030581	0.11472813902975053
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0030581	0.11472813902975053
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.0030581	0.11472813902975053
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0030581	0.11472813902975053
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.0030581	0.11472813902975053
MENTAL RETARDATION, X-LINKED 58	0.0030581	0.11472813902975053
H SYNDROME	0.0030581	0.11472813902975053
%300115 MENTAL RETARDATION, X-LINKED 50; MRX50	0.0030581	0.11472813902975053
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0030581	0.11472813902975053
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.0030581	0.11472813902975053
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0030581	0.11472813902975053
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0030581	0.11472813902975053
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0030581	0.11472813902975053
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.0030581	0.11472813902975053
ALOPECIA-INTELLECTUAL DISABILITY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.0030581	0.11472813902975053
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.0030581	0.11472813902975053
DISTAL MONOSOMY 6P	0.0030581	0.11472813902975053
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.0030581	0.11472813902975053
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0030581	0.11472813902975053
OTOPALATODIGITAL SYNDROME TYPE 1	0.0030581	0.11472813902975053
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0030581	0.11472813902975053
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0030581	0.11472813902975053
HEMIHYPERPLASIA, ISOLATED	0.0030581	0.11472813902975053
NAKAJO-NISHIMURA SYNDROME	0.0030581	0.11472813902975053
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0030581	0.11472813902975053
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0030581	0.11472813902975053
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0030581	0.11472813902975053
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0030581	0.11472813902975053
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0030581	0.11472813902975053
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.0030581	0.11472813902975053
OTOONYCHOPERONEAL SYNDROME	0.0030581	0.11472813902975053
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0030581	0.11472813902975053
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0030581	0.11472813902975053
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0030581	0.11472813902975053
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.0030581	0.11472813902975053
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.0030581	0.11472813902975053
MIRROR MOVEMENTS 1; MRMV1	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0030581	0.11472813902975053
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0030581	0.11472813902975053
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0030581	0.11472813902975053
ERMINE PHENOTYPE	0.0030581	0.11472813902975053
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0030581	0.11472813902975053
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0030581	0.11472813902975053
RFT1-CDG	0.0030554090000000002	0.1146271830694716
ADRENOMYODYSTROPHY	0.0030554090000000002	0.1146271830694716
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0030554090000000002	0.1146271830694716
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0030554090000000002	0.1146271830694716
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.0030554090000000002	0.1146271830694716
KRABBE DISEASE	0.0030554090000000002	0.1146271830694716
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.003038924	0.11400872933286865
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.003038924	0.11400872933286865
MATTHEW-WOOD SYNDROME	0.003038924	0.11400872933286865
JOHANSON-BLIZZARD SYNDROME	0.003038924	0.11400872933286865
MARDEN-WALKER SYNDROME	0.003038924	0.11400872933286865
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003038924	0.11400872933286865
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.003032007	0.113749230121702
DUPLICATION/INVERSION 15Q11	0.003032007	0.113749230121702
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.003032007	0.113749230121702
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.003032007	0.113749230121702
TETRASOMY 9P	0.003032007	0.113749230121702
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0030320069999999998	0.11374923012170197
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0030320069999999998	0.11374923012170197
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0030320069999999998	0.11374923012170197
IMMUNODEFICIENCY 23; IMD23	0.003015522	0.11313077638509905
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003015522	0.11313077638509905
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.003015522	0.11313077638509905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.003015522	0.11313077638509905
AU-KLINE SYNDROME; AUKS	0.003015522	0.11313077638509905
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.003015522	0.11313077638509905
WARSAW BREAKAGE SYNDROME; WABS	0.003015522	0.11313077638509905
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0030155219999999996	0.11313077638509902
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0030155219999999996	0.11313077638509902
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0030155219999999996	0.11313077638509902
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0028160499999999996	0.1056473548656777
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0028160499999999996	0.1056473548656777
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0028160499999999996	0.1056473548656777
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0028160499999999996	0.1056473548656777
TREACHER-COLLINS SYNDROME	0.0028160499999999996	0.1056473548656777
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0028160499999999996	0.1056473548656777
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0028160499999999996	0.1056473548656777
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0028160499999999996	0.1056473548656777
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002789957	0.10466844595762916
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.002789957	0.10466844595762916
INFANTILE LIVER FAILURE SYNDROME 1	0.002789957	0.10466844595762916
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.002789957	0.10466844595762916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002789957	0.10466844595762916
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.002789957	0.10466844595762916
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.002789957	0.10466844595762916
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002789957	0.10466844595762916
DDOST-CDG	0.002789957	0.10466844595762916
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002789957	0.10466844595762916
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002789957	0.10466844595762916
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.002789957	0.10466844595762916
COFFIN-SIRIS SYNDROME 8; CSS8	0.002789957	0.10466844595762916
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002789957	0.10466844595762916
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002789957	0.10466844595762916
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.002789957	0.10466844595762916
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002789957	0.10466844595762916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002789957	0.10466844595762916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002789957	0.10466844595762916
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.002789957	0.10466844595762916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002789957	0.10466844595762916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002789957	0.10466844595762916
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002789957	0.10466844595762916
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002773472	0.10404999222102622
JACOBSEN SYNDROME	0.002773472	0.10404999222102622
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002773472	0.10404999222102622
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.002773472	0.10404999222102622
MARINESCO-SJOGREN SYNDROME; MSS	0.002773472	0.10404999222102622
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.002773472	0.10404999222102622
SHWACHMAN-DIAMOND SYNDROME	0.002773472	0.10404999222102622
XIA-GIBBS SYNDROME	0.002773472	0.10404999222102622
MOEBIUS SYNDROME	0.00275604	0.10339601069015196
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00275604	0.10339601069015196
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00275604	0.10339601069015196
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00275604	0.10339601069015196
NOONAN SYNDROME	0.00275604	0.10339601069015196
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00275604	0.10339601069015196
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002729947	0.10241710178210339
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002729947	0.10241710178210339
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002729947	0.10241710178210339
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002729947	0.10241710178210339
VISCERAL STEATOSIS, CONGENITAL	0.002729947	0.10241710178210339
GM2-GANGLIOSIDOSIS, AB VARIANT	0.002729947	0.10241710178210339
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002729947	0.10241710178210339
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002729947	0.10241710178210339
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002729947	0.10241710178210339
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002729947	0.10241710178210339
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002729947	0.10241710178210339
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002729947	0.10241710178210339
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002729947	0.10241710178210339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002729947	0.10241710178210339
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002729947	0.10241710178210339
XYLOSIDASE DEFICIENCY	0.002729947	0.10241710178210339
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.002713462	0.10179864804550046
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.002713462	0.10179864804550046
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.002713462	0.10179864804550046
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.002713462	0.10179864804550046
JOUBERT SYNDROME 3; JBTS3	0.002713462	0.10179864804550046
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.002713462	0.10179864804550046
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.002713462	0.10179864804550046
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.002713462	0.10179864804550046
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.002713462	0.10179864804550046
JOUBERT SYNDROME 6	0.002713462	0.10179864804550046
MUCOLIPIDOSIS IV; ML4	0.002713462	0.10179864804550046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002713462	0.10179864804550046
LESCH-NYHAN SYNDROME; LNS	0.002713462	0.10179864804550046
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002713462	0.10179864804550046
JOUBERT SYNDROME 5	0.002713462	0.10179864804550046
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002713462	0.10179864804550046
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.002713462	0.10179864804550046
SPINOCEREBELLAR ATAXIA 13	0.002713462	0.10179864804550046
MATERNAL PHENYLKETONURIA	0.002595403	0.09736952886505727
CORNELIA DE LANGE SYNDROME 3	0.002595403	0.09736952886505727
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002595403	0.09736952886505727
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002595403	0.09736952886505727
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002595403	0.09736952886505727
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.002595403	0.09736952886505727
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.002595403	0.09736952886505727
PFEIFFER SYNDROME TYPE 2	0.002595403	0.09736952886505727
PFEIFFER SYNDROME TYPE 3	0.002595403	0.09736952886505727
OROFACIODIGITAL SYNDROME I; OFD1	0.002595403	0.09736952886505727
RENPENNING SYNDROME 1; RENS1	0.002595403	0.09736952886505727
8P11.2 DELETION SYNDROME	0.002595403	0.09736952886505727
15Q24 MICRODELETION SYNDROME	0.002595403	0.09736952886505727
GLASS SYNDROME	0.002595403	0.09736952886505727
SECKEL SYNDROME 1; SCKL1	0.002595403	0.09736952886505727
CHROMOSOME 1P35 DELETION SYNDROME	0.002595403	0.09736952886505727
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002595403	0.09736952886505727
ZIMMERMANN-LABAND SYNDROME	0.002595403	0.09736952886505727
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.002595403	0.09736952886505727
DUBOWITZ SYNDROME	0.002595403	0.09736952886505727
FRYNS SYNDROME	0.002595403	0.09736952886505727
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.002595403	0.09736952886505727
OROFACIODIGITAL SYNDROME TYPE 1	0.002595403	0.09736952886505727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.002595403	0.09736952886505727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0025954029999999996	0.09736952886505726
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0025954029999999996	0.09736952886505726
HAWKINSINURIA	0.00251399	0.09431522652607911
INFANTILE SYSTEMIC HYALINOSIS	0.00251399	0.09431522652607911
HYPERCALCEMIA, INFANTILE 2	0.00251399	0.09431522652607911
IMMUNODEFICIENCY 9; IMD9	0.00251399	0.09431522652607911
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00251399	0.09431522652607911
ISOLATED COMPLEX I DEFICIENCY	0.00251399	0.09431522652607911
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00251399	0.09431522652607911
PEARSON SYNDROME	0.00251399	0.09431522652607911
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002490588	0.09343727357830953
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002490588	0.09343727357830953
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002490588	0.09343727357830953
MYOPATHY, CENTRONUCLEAR, 5	0.002490588	0.09343727357830953
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002490588	0.09343727357830953
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.002490588	0.09343727357830953
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002490588	0.09343727357830953
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.002490588	0.09343727357830953
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002490588	0.09343727357830953
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.002490588	0.09343727357830953
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.002490588	0.09343727357830953
MLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002490588	0.09343727357830953
CAP MYOPATHY	0.002490588	0.09343727357830953
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.002490588	0.09343727357830953
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002490588	0.09343727357830953
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.002490588	0.09343727357830953
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.002490588	0.09343727357830953
LATERAL MENINGOCELE SYNDROME	0.002490588	0.09343727357830953
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002490588	0.09343727357830953
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.002490588	0.09343727357830953
PITUITARY STALK INTERRUPTION SYNDROME	0.002353353	0.08828874470098444
COG8-CDG	0.002353353	0.08828874470098444
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002353353	0.08828874470098444
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002353353	0.08828874470098444
CITRULLINEMIA, CLASSIC	0.002353353	0.08828874470098444
OCULOCEREBRORENAL SYNDROME OF LOWE	0.002353353	0.08828874470098444
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002353353	0.08828874470098444
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002353353	0.08828874470098444
EDINBURGH MALFORMATION SYNDROME	0.002353353	0.08828874470098444
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.002353353	0.08828874470098444
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.002353353	0.08828874470098444
HYPERLEUCINE-ISOLEUCINEMIA	0.002353353	0.08828874470098444
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.002353353	0.08828874470098444
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002353353	0.08828874470098444
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.002353353	0.08828874470098444
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.002353353	0.08828874470098444
RAMON SYNDROME	0.002353353	0.08828874470098444
ALG11-CDG	0.002353353	0.08828874470098444
LOWE OCULOCEREBRORENAL SYNDROME	0.002353353	0.08828874470098444
ARGININOSUCCINIC ACIDURIA	0.002353353	0.08828874470098444
SMITH-LEMLI-OPITZ SYNDROME	0.002293343	0.08603740052545869
MEVALONIC ACIDURIA	0.0022933429999999998	0.08603740052545868
22Q11.2 MICRODUPLICATION SYNDROME	0.0022933429999999998	0.08603740052545868
1P36 MICRODELETION SYNDROME	0.0022933429999999998	0.08603740052545868
CONGENITAL RUBELLA SYNDROME	0.0022933429999999998	0.08603740052545868
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0022933429999999998	0.08603740052545868
GRISCELLI SYNDROME	0.0022933429999999998	0.08603740052545868
MAPLE SYRUP URINE DISEASE	0.0022933429999999998	0.08603740052545868
DYSEQUILIBRIUM SYNDROME	0.0022933429999999998	0.08603740052545868
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
ACROCARDIOFACIAL SYNDROME	0.0022933429999999998	0.08603740052545868
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0022933429999999998	0.08603740052545868
HARTNUP DISEASE	0.0022933429999999998	0.08603740052545868
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0022933429999999998	0.08603740052545868
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0022933429999999998	0.08603740052545868
SEVERE CANAVAN DISEASE	0.0022933429999999998	0.08603740052545868
POTOCKI-SHAFFER SYNDROME	0.0022933429999999998	0.08603740052545868
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0022933429999999998	0.08603740052545868
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0022933429999999998	0.08603740052545868
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
DPAGT1-CDG	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0022933429999999998	0.08603740052545868
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0022933429999999998	0.08603740052545868
2Q31.1 MICRODELETION SYNDROME	0.0022933429999999998	0.08603740052545868
15Q11Q13 MICRODUPLICATION SYNDROME	0.0022933429999999998	0.08603740052545868
WALKER-WARBURG SYNDROME	0.0022933429999999998	0.08603740052545868
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0022933429999999998	0.08603740052545868
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0022933429999999998	0.08603740052545868
49,XXXXY SYNDROME	0.0022933429999999998	0.08603740052545868
COFFIN-SIRIS SYNDROME	0.0022933429999999998	0.08603740052545868
LEBER CONGENITAL AMAUROSIS	0.0022933429999999998	0.08603740052545868
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.0022933429999999998	0.08603740052545868
SIALIDOSIS TYPE 1	0.0022933429999999998	0.08603740052545868
SJGREN-LARSSON SYNDROME	0.0022933429999999998	0.08603740052545868
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME	0.0022933429999999998	0.08603740052545868
LINEAR NEVUS SEBACEUS SYNDROME	0.0022933429999999998	0.08603740052545868
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0022933429999999998	0.08603740052545868
ISOLATED SPINA BIFIDA	0.0022933429999999998	0.08603740052545868
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0022933429999999998	0.08603740052545868
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0022933429999999998	0.08603740052545868
CAMOS SYNDROME	0.0022933429999999998	0.08603740052545868
DISTAL MONOSOMY 19P13.3	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0022933429999999998	0.08603740052545868
INCONTINENTIA PIGMENTI	0.0022933429999999998	0.08603740052545868
JOUBERT SYNDROME WITH RENAL DEFECT	0.0022933429999999998	0.08603740052545868
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0022933429999999998	0.08603740052545868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002248538	0.0843564894142367
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.002248538	0.0843564894142367
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002248538	0.0843564894142367
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002248538	0.0843564894142367
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.002248538	0.0843564894142367
MULTIMINICORE MYOPATHY	0.002248538	0.0843564894142367
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.002248538	0.0843564894142367
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.002248538	0.0843564894142367
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.002248538	0.0843564894142367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.002248538	0.0843564894142367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.002248538	0.0843564894142367
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002248538	0.0843564894142367
NAVAJO NEUROHEPATOPATHY	0.002248538	0.0843564894142367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.002248538	0.0843564894142367
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.002248538	0.0843564894142367
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.002248538	0.0843564894142367
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002248538	0.0843564894142367
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.002248538	0.0843564894142367
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.002248538	0.0843564894142367
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.002248538	0.0843564894142367
RITSCHER-SCHINZEL SYNDROME 1	0.0021885280000000003	0.08210514523871094
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0021885280000000003	0.08210514523871094
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0021885280000000003	0.08210514523871094
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0021885280000000003	0.08210514523871094
GLYCOGEN STORAGE DISEASE II	0.0021885280000000003	0.08210514523871094
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0021885280000000003	0.08210514523871094
SENGERS SYNDROME	0.0021885280000000003	0.08210514523871094
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0021885280000000003	0.08210514523871094
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0021885280000000003	0.08210514523871094
CEREBELLAR HYPOPLASIA	0.0021885280000000003	0.08210514523871094
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0021885280000000003	0.08210514523871094
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0021885280000000003	0.08210514523871094
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0021885280000000003	0.08210514523871094
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0021885280000000003	0.08210514523871094
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021885280000000003	0.08210514523871094
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0021885280000000003	0.08210514523871094
STUVE-WIEDEMANN SYNDROME	0.0021885280000000003	0.08210514523871094
PSEUDOTRISOMY 13 SYNDROME	0.0021885280000000003	0.08210514523871094
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0021885280000000003	0.08210514523871094
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0021885280000000003	0.08210514523871094
CRANIOFRONTONASAL SYNDROME; CFNS	0.0021885280000000003	0.08210514523871094
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0021885280000000003	0.08210514523871094
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0021885280000000003	0.08210514523871094
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0021885280000000003	0.08210514523871094
OPSISMODYSPLASIA; OPSMD	0.0021885280000000003	0.08210514523871094
PIERSON SYNDROME	0.0021885280000000003	0.08210514523871094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0021885280000000003	0.08210514523871094
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0021885280000000003	0.08210514523871094
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0021885280000000003	0.08210514523871094
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0021885280000000003	0.08210514523871094
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0021885280000000003	0.08210514523871094
CHIARI MALFORMATION TYPE II	0.0021885280000000003	0.08210514523871094
ACID PHOSPHATASE DEFICIENCY	0.0021885280000000003	0.08210514523871094
GLYCOGEN STORAGE DISEASE IXC	0.0021885280000000003	0.08210514523871094
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0021885280000000003	0.08210514523871094
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.08210514523871094
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0021885280000000003	0.08210514523871094
CRANIOSYNOSTOSIS 6; CRS6	0.0021885280000000003	0.08210514523871094
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.08210514523871094
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0021885280000000003	0.08210514523871094
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0021885280000000003	0.08210514523871094
SPINOCEREBELLAR ATAXIA 1	0.0021885280000000003	0.08210514523871094
MICROPHTHALMIA, SYNDROMIC 3	0.0021885280000000003	0.08210514523871094
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.002070469	0.07767602605826775
HYPEREKPLEXIA 4; HKPX4	0.002070469	0.07767602605826775
CATEL-MANZKE SYNDROME; CATMANS	0.002070469	0.07767602605826775
PERRAULT SYNDROME 5; PRLTS5	0.002070469	0.07767602605826775
CRISPONI SYNDROME	0.002070469	0.07767602605826775
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002070469	0.07767602605826775
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.002070469	0.07767602605826775
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002070469	0.07767602605826775
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002070469	0.07767602605826775
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002070469	0.07767602605826775
LIPOID PROTEINOSIS	0.002070469	0.07767602605826775
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.002070469	0.07767602605826775
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.002070469	0.07767602605826775
RABSON-MENDENHALL SYNDROME	0.002053984	0.07705757232166481
PSEUDOAMINOPTERIN SYNDROME	0.002053984	0.07705757232166481
ALAZAMI-YUAN SYNDROME	0.002053984	0.07705757232166481
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.002053984	0.07705757232166481
MENTAL RETARDATION, X-LINKED 2	0.002053984	0.07705757232166481
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.002053984	0.07705757232166481
MENTAL RETARDATION, X-LINKED 45	0.002053984	0.07705757232166481
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.002053984	0.07705757232166481
SECKEL SYNDROME 5; SCKL5	0.002053984	0.07705757232166481
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002053984	0.07705757232166481
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.002053984	0.07705757232166481
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002053984	0.07705757232166481
POLYVALVULAR HEART DISEASE SYNDROME	0.002053984	0.07705757232166481
MONOSOMY 22	0.002053984	0.07705757232166481
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.002053984	0.07705757232166481
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.002053984	0.07705757232166481
FRONTOMETAPHYSEAL DYSPLASIA	0.002053984	0.07705757232166481
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.002053984	0.07705757232166481
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.002053984	0.07705757232166481
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.002053984	0.07705757232166481
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.002053984	0.07705757232166481
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.002053984	0.07705757232166481
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.002053984	0.07705757232166481
FEINGOLD SYNDROME 1; FGLDS1	0.002053984	0.07705757232166481
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.002053984	0.07705757232166481
FRASER SYNDROME	0.002053984	0.07705757232166481
OTOFACIOCERVICAL SYNDROME	0.002053984	0.07705757232166481
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002053984	0.07705757232166481
ROBERTS SYNDROME; RBS	0.002053984	0.07705757232166481
MOSAIC TRISOMY 9	0.002053984	0.07705757232166481
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002027891	0.07607866341361624
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.002027891	0.07607866341361624
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002027891	0.07607866341361624
JOUBERT SYNDROME 30; JBTS30	0.002027891	0.07607866341361624
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002027891	0.07607866341361624
ADENYLOSUCCINATE LYASE DEFICIENCY	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002027891	0.07607866341361624
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002027891	0.07607866341361624
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002027891	0.07607866341361624
HOLOPROSENCEPHALY 1; HPE1	0.002027891	0.07607866341361624
MENTAL RETARDATION, X-LINKED 1	0.002027891	0.07607866341361624
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002027891	0.07607866341361624
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002027891	0.07607866341361624
XQ25 DUPLICATION SYNDROME	0.002027891	0.07607866341361624
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002027891	0.07607866341361624
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002027891	0.07607866341361624
TENORIO SYNDROME; TNORS	0.002027891	0.07607866341361624
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002027891	0.07607866341361624
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002027891	0.07607866341361624
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002027891	0.07607866341361624
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002027891	0.07607866341361624
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002027891	0.07607866341361624
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002027891	0.07607866341361624
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002027891	0.07607866341361624
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002027891	0.07607866341361624
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002027891	0.07607866341361624
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002027891	0.07607866341361624
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.002027891	0.07607866341361624
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002027891	0.07607866341361624
COFFIN-SIRIS SYNDROME 2; CSS2	0.002027891	0.07607866341361624
COFFIN-SIRIS SYNDROME 3; CSS3	0.002027891	0.07607866341361624
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.002027891	0.07607866341361624
COFFIN-SIRIS SYNDROME 4; CSS4	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002027891	0.07607866341361624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002027891	0.07607866341361624
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002027891	0.07607866341361624
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.002027891	0.07607866341361624
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002027891	0.07607866341361624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002027891	0.07607866341361624
AICARDI-GOUTIERES SYNDROME 7	0.002027891	0.07607866341361624
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.002027891	0.07607866341361624
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.002027891	0.07607866341361624
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.002027891	0.07607866341361624
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002027891	0.07607866341361624
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002027891	0.07607866341361624
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.002027891	0.07607866341361624
GRISCELLI SYNDROME TYPE 1	0.002027891	0.07607866341361624
IMMUNODEFICIENCY 49; IMD49	0.002027891	0.07607866341361624
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002027891	0.07607866341361624
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.002027891	0.07607866341361624
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002027891	0.07607866341361624
TIMOTHY SYNDROME; TS	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002027891	0.07607866341361624
SHASHI-PENA SYNDROME; SHAPNS	0.002027891	0.07607866341361624
LISSENCEPHALY 5; LIS5	0.002027891	0.07607866341361624
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002027891	0.07607866341361624
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002027891	0.07607866341361624
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.002027891	0.07607866341361624
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002027891	0.07607866341361624
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002027891	0.07607866341361624
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002027891	0.07607866341361624
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002027891	0.07607866341361624
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002027891	0.07607866341361624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002027891	0.07607866341361624
ADENYLOSUCCINASE DEFICIENCY	0.002027891	0.07607866341361624
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002027891	0.07607866341361624
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001828419	0.0685952418941949
NEPHROGENIC DIABETES INSIPIDUS	0.001828419	0.0685952418941949
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.001828419	0.0685952418941949
CONGENITAL DISORDER OF GLYCOSYLATION	0.001828419	0.0685952418941949
ATAXIA-TELANGIECTASIA	0.001828419	0.0685952418941949
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.0685952418941949
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.0685952418941949
HYPER-BETA-ALANINEMIA	0.001828419	0.0685952418941949
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001828419	0.0685952418941949
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001828419	0.0685952418941949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001828419	0.0685952418941949
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001828419	0.0685952418941949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001828419	0.0685952418941949
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.0685952418941949
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.0685952418941949
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001828419	0.0685952418941949
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001828419	0.0685952418941949
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001828419	0.0685952418941949
PROPIONIC ACIDEMIA	0.001828419	0.0685952418941949
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.001828419	0.0685952418941949
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.0685952418941949
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001828419	0.0685952418941949
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.0685952418941949
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001828419	0.0685952418941949
GAUCHER DISEASE, TYPE II	0.001828419	0.0685952418941949
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.0685952418941949
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001828419	0.0685952418941949
SANDHOFF DISEASE	0.001828419	0.0685952418941949
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001828419	0.0685952418941949
MOGS-CDG	0.001828419	0.0685952418941949
COPPER DEFICIENCY, FAMILIAL BENIGN	0.001828419	0.0685952418941949
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001828419	0.0685952418941949
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001828419	0.0685952418941949
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001828419	0.0685952418941949
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001828419	0.0685952418941949
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.001828419	0.0685952418941949
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0018119339999999999	0.06797678815759196
NOONAN SYNDROME 8; NS8	0.0018119339999999999	0.06797678815759196
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0018119339999999999	0.06797678815759196
FACIOCARDIORENAL SYNDROME	0.0018119339999999999	0.06797678815759196
OTOPALATODIGITAL SYNDROME TYPE 2	0.0018119339999999999	0.06797678815759196
CHYLOMICRON RETENTION DISEASE	0.0018119339999999999	0.06797678815759196
JOHNSON NEUROECTODERMAL SYNDROME	0.0018119339999999999	0.06797678815759196
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.0018119339999999999	0.06797678815759196
KAPUR-TORIELLO SYNDROME	0.0018119339999999999	0.06797678815759196
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0018119339999999999	0.06797678815759196
ELLIS VAN CREVELD SYNDROME	0.0018119339999999999	0.06797678815759196
FARBER DISEASE	0.0018119339999999999	0.06797678815759196
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0018119339999999999	0.06797678815759196
HOYERAAL-HREIDARSSON SYNDROME	0.0018119339999999999	0.06797678815759196
PSEUDOPROGERIA SYNDROME	0.0018119339999999999	0.06797678815759196
GALACTOSEMIA	0.0018119339999999999	0.06797678815759196
TOWNES-BROCKS SYNDROME	0.0018119339999999999	0.06797678815759196
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0018119339999999999	0.06797678815759196
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0018119339999999999	0.06797678815759196
MPDU1-CDG	0.001768409	0.06634389771866915
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06634389771866915
TRIPLE A SYNDROME	0.001768409	0.06634389771866915
ALG3-CDG	0.001768409	0.06634389771866915
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06634389771866915
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001768409	0.06634389771866915
COFS SYNDROME	0.001768409	0.06634389771866915
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06634389771866915
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06634389771866915
ONDINE SYNDROME	0.001768409	0.06634389771866915
DPM1-CDG	0.001768409	0.06634389771866915
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001768409	0.06634389771866915
20P12.3 MICRODELETION SYNDROME	0.001768409	0.06634389771866915
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866915
ALG9-CDG	0.001768409	0.06634389771866915
CENTRONUCLEAR MYOPATHY	0.001768409	0.06634389771866915
CANAVAN DISEASE	0.001768409	0.06634389771866915
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06634389771866915
LEIGH SYNDROME	0.001768409	0.06634389771866915
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06634389771866915
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001768409	0.06634389771866915
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06634389771866915
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06634389771866915
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06634389771866915
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06634389771866915
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06634389771866915
PHACE SYNDROME	0.001768409	0.06634389771866915
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001768409	0.06634389771866915
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06634389771866915
CHARGE SYNDROME	0.0017519240000000002	0.06572544398206623
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.0017519240000000002	0.06572544398206623
JUNG SYNDROME	0.0017519240000000002	0.06572544398206623
SMITH-MAGENIS SYNDROME	0.0017519240000000002	0.06572544398206623
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0017519240000000002	0.06572544398206623
9Q SUBTELOMERIC DELETION SYNDROME	0.0017519240000000002	0.06572544398206623
PERMANENT CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206623
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0017519240000000002	0.06572544398206623
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0017519240000000002	0.06572544398206623
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0017519240000000002	0.06572544398206623
PIEBALDISM	0.0017519240000000002	0.06572544398206623
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.0017519240000000002	0.06572544398206623
HURLER SYNDROME	0.0017519240000000002	0.06572544398206623
ARTERIAL TORTUOSITY SYNDROME	0.0017519240000000002	0.06572544398206623
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0017519240000000002	0.06572544398206623
ALPHA-MANNOSIDOSIS	0.0017519240000000002	0.06572544398206623
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.0017519240000000002	0.06572544398206623
MARINESCO-SJGREN SYNDROME	0.0017519240000000002	0.06572544398206623
OROFACIODIGITAL SYNDROME TYPE 14	0.0017519240000000002	0.06572544398206623
PENTASOMY X	0.0017519240000000002	0.06572544398206623
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0017519240000000002	0.06572544398206623
MUCOLIPIDOSIS TYPE IV	0.0017519240000000002	0.06572544398206623
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0017519240000000002	0.06572544398206623
MONOSOMY 13Q14	0.0017519240000000002	0.06572544398206623
COOPER-JABS SYNDROME	0.0017519240000000002	0.06572544398206623
LAURIN-SANDROW SYNDROME	0.0017519240000000002	0.06572544398206623
GOLDENHAR SYNDROME	0.0017519240000000002	0.06572544398206623
FAMILIAL THYROID DYSHORMONOGENESIS	0.0017519240000000002	0.06572544398206623
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.0017519240000000002	0.06572544398206623
VELOCARDIOFACIAL SYNDROME	0.0017519240000000002	0.06572544398206623
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00152905	0.057364069514875264
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00152905	0.057364069514875264
SAY-BARBER-MILLER SYNDROME	0.00152905	0.057364069514875264
NON-DISTAL TRISOMY 10Q	0.00152905	0.057364069514875264
NON-DISTAL TRISOMY 13Q	0.00152905	0.057364069514875264
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00152905	0.057364069514875264
PFEIFFER SYNDROME TYPE 1	0.00152905	0.057364069514875264
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00152905	0.057364069514875264
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00152905	0.057364069514875264
TYPICAL NEMALINE MYOPATHY	0.00152905	0.057364069514875264
ADULT-ONSET NEMALINE MYOPATHY	0.00152905	0.057364069514875264
DISTAL TRISOMY 18Q	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00152905	0.057364069514875264
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00152905	0.057364069514875264
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00152905	0.057364069514875264
SHELDON-HALL SYNDROME	0.00152905	0.057364069514875264
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00152905	0.057364069514875264
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00152905	0.057364069514875264
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00152905	0.057364069514875264
ULBRIGHT-HODES SYNDROME	0.00152905	0.057364069514875264
OROFACIODIGITAL SYNDROME IV; OFD4	0.00152905	0.057364069514875264
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00152905	0.057364069514875264
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00152905	0.057364069514875264
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00152905	0.057364069514875264
LOEYS-DIETZ SYNDROME 3; LDS3	0.00152905	0.057364069514875264
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00152905	0.057364069514875264
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00152905	0.057364069514875264
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00152905	0.057364069514875264
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00152905	0.057364069514875264
EMERY-NELSON SYNDROME	0.00152905	0.057364069514875264
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00152905	0.057364069514875264
BRANCHIOOTORENAL SYNDROME 1	0.00152905	0.057364069514875264
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00152905	0.057364069514875264
LANGER MESOMELIC DYSPLASIA	0.00152905	0.057364069514875264
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00152905	0.057364069514875264
HAMAMY SYNDROME; HMMS	0.00152905	0.057364069514875264
RAINE SYNDROME	0.00152905	0.057364069514875264
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00152905	0.057364069514875264
MYOPATHY, DISTAL, 1; MPD1	0.00152905	0.057364069514875264
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00152905	0.057364069514875264
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00152905	0.057364069514875264
PFEIFFER SYNDROME	0.00152905	0.057364069514875264
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00152905	0.057364069514875264
GORDON SYNDROME	0.00152905	0.057364069514875264
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00152905	0.057364069514875264
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00152905	0.057364069514875264
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00152905	0.057364069514875264
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00152905	0.057364069514875264
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00152905	0.057364069514875264
LAING EARLY-ONSET DISTAL MYOPATHY	0.00152905	0.057364069514875264
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00152905	0.057364069514875264
ATELOSTEOGENESIS TYPE III	0.00152905	0.057364069514875264
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00152905	0.057364069514875264
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00152905	0.057364069514875264
FRONTOMETAPHYSEAL DYSPLASIA	0.00152905	0.057364069514875264
NEMALINE MYOPATHY 1; NEM1	0.00152905	0.057364069514875264
MARSHALL SYNDROME	0.00152905	0.057364069514875264
NEU-LAXOVA SYNDROME 2; NLS2	0.00152905	0.057364069514875264
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00152905	0.057364069514875264
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00152905	0.057364069514875264
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00152905	0.057364069514875264
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00152905	0.057364069514875264
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00152905	0.057364069514875264
TRISOMY 8Q	0.00152905	0.057364069514875264
OROFACIODIGITAL SYNDROME IX; OFD9	0.00152905	0.057364069514875264
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00152905	0.057364069514875264
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00152905	0.057364069514875264
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00152905	0.057364069514875264
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00152905	0.057364069514875264
HYPOGLOSSIA WITH SITUS INVERSUS	0.00152905	0.057364069514875264
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00152905	0.057364069514875264
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00152905	0.057364069514875264
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00152905	0.057364069514875264
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00152905	0.057364069514875264
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00152905	0.057364069514875264
PSEUDOXANTHOMA ELASTICUM	0.00152905	0.057364069514875264
9P13 MICRODELETION SYNDROME	0.00152905	0.057364069514875264
OCULOCUTANEOUS ALBINISM TYPE 5	0.00152905	0.057364069514875264
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00152905	0.057364069514875264
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00152905	0.057364069514875264
EVEN-PLUS SYNDROME	0.00152905	0.057364069514875264
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00152905	0.057364069514875264
SWEENEY-COX SYNDROME; SWCOS	0.00152905	0.057364069514875264
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00152905	0.057364069514875264
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00152905	0.057364069514875264
LERI-WEILL DYSCHONDROSTEOSIS	0.00152905	0.057364069514875264
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00152905	0.057364069514875264
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00152905	0.057364069514875264
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00152905	0.057364069514875264
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00152905	0.057364069514875264
CZEIZEL-LOSONCI SYNDROME	0.00152905	0.057364069514875264
ACRORENAL-MANDIBULAR SYNDROME	0.00152905	0.057364069514875264
ASCHER SYNDROME	0.00152905	0.057364069514875264
RHIZOMELIC SYNDROME, URBACH TYPE	0.00152905	0.057364069514875264
RIN2 SYNDROME	0.00152905	0.057364069514875264
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00152905	0.057364069514875264
BRANCHIO-OCULO-FACIAL SYNDROME	0.00152905	0.057364069514875264
ACRO-RENAL-MANDIBULAR SYNDROME	0.00152905	0.057364069514875264
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00152905	0.057364069514875264
MANDIBULOACRAL DYSPLASIA	0.00152905	0.057364069514875264
608028 THAI SYMPHALANGISM SYNDROME	0.00152905	0.057364069514875264
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00152905	0.057364069514875264
NOONAN SYNDROME 3; NS3	0.00152905	0.057364069514875264
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00152905	0.057364069514875264
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00152905	0.057364069514875264
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00152905	0.057364069514875264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001502957	0.05638516060682672
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001502957	0.05638516060682672
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001502957	0.05638516060682672
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.05638516060682672
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001502957	0.05638516060682672
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001502957	0.05638516060682672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.05638516060682672
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001502957	0.05638516060682672
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001502957	0.05638516060682672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001502957	0.05638516060682672
TAY-SACHS DISEASE; TSD	0.001502957	0.05638516060682672
SULFOCYSTEINURIA	0.001502957	0.05638516060682672
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001502957	0.05638516060682672
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001502957	0.05638516060682672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001502957	0.05638516060682672
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001502957	0.05638516060682672
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001502957	0.05638516060682672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001502957	0.05638516060682672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001502957	0.05638516060682672
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001502957	0.05638516060682672
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001502957	0.05638516060682672
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001502957	0.05638516060682672
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.05638516060682672
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001502957	0.05638516060682672
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001502957	0.05638516060682672
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.05638516060682672
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.05638516060682672
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001502957	0.05638516060682672
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.05638516060682672
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001502957	0.05638516060682672
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.05638516060682672
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.05638516060682672
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001502957	0.05638516060682672
PSEUDO-TORCH SYNDROME 2	0.001502957	0.05638516060682672
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001502957	0.05638516060682672
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.05638516060682672
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001502957	0.05638516060682672
SHUKLA-VERNON SYNDROME; SHUVER	0.001502957	0.05638516060682672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001502957	0.05638516060682672
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001502957	0.05638516060682672
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.05638516060682672
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001502957	0.05638516060682672
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001502957	0.05638516060682672
RING CHROMOSOME 22 SYNDROME	0.001502957	0.05638516060682672
SIALIDOSIS TYPE 2	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001502957	0.05638516060682672
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001502957	0.05638516060682672
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001502957	0.05638516060682672
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.05638516060682672
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001502957	0.05638516060682672
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001502957	0.05638516060682672
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001502957	0.05638516060682672
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.05638516060682672
GLUTAMINE DEFICIENCY, CONGENITAL	0.001502957	0.05638516060682672
ADAMS-OLIVER SYNDROME 2; AOS2	0.001502957	0.05638516060682672
RAPID-ONSET DYSTONIA-PARKINSONISM	0.001502957	0.05638516060682672
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.05638516060682672
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001502957	0.05638516060682672
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001502957	0.05638516060682672
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001502957	0.05638516060682672
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001502957	0.05638516060682672
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.001502957	0.05638516060682672
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.05638516060682672
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001502957	0.05638516060682672
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.05638516060682672
EPISODIC ATAXIA, TYPE 6	0.001502957	0.05638516060682672
JOUBERT SYNDROME 21	0.001486472	0.055766706870223774
JOUBERT SYNDROME 28	0.001486472	0.055766706870223774
GOLDBERG-SHPRINTZEN SYNDROME	0.001486472	0.055766706870223774
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001486472	0.055766706870223774
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.001486472	0.055766706870223774
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001486472	0.055766706870223774
GIANT AXONAL NEUROPATHY	0.001486472	0.055766706870223774
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001486472	0.055766706870223774
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001486472	0.055766706870223774
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.001486472	0.055766706870223774
JOUBERT SYNDROME 27	0.001486472	0.055766706870223774
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.001486472	0.055766706870223774
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001486472	0.055766706870223774
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001486472	0.055766706870223774
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.001486472	0.055766706870223774
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001486472	0.055766706870223774
JOUBERT SYNDROME 7	0.001486472	0.055766706870223774
JOUBERT SYNDROME 15	0.001486472	0.055766706870223774
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001486472	0.055766706870223774
SIFRIM-HITZ-WEISS SYNDROME	0.001486472	0.055766706870223774
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001486472	0.055766706870223774
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001486472	0.055766706870223774
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001486472	0.055766706870223774
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001486472	0.055766706870223774
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001486472	0.055766706870223774
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.001486472	0.055766706870223774
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001486472	0.055766706870223774
PERIPHERAL HYPOTHYROIDISM	0.001486472	0.055766706870223774
LAMB-SHAFFER SYNDROME	0.001486472	0.055766706870223774
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001486472	0.055766706870223774
COFFIN-SIRIS SYNDROME 10; CSS10	0.001486472	0.055766706870223774
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001486472	0.055766706870223774
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001486472	0.055766706870223774
OPTIC ATROPHY 11; OPA11	0.001486472	0.055766706870223774
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.001486472	0.055766706870223774
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001486472	0.055766706870223774
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001486472	0.055766706870223774
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.001486472	0.055766706870223774
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001486472	0.055766706870223774
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.001486472	0.055766706870223774
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080244
MELNICK-NEEDLES SYNDROME	0.001287	0.04828328535080244
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001287	0.04828328535080244
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080244
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080244
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.001287	0.04828328535080244
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080244
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.001287	0.04828328535080244
MEIER-GORLIN SYNDROME 5; MGORS5	0.001287	0.04828328535080244
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080244
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080244
CYSTIC FIBROSIS	0.001287	0.04828328535080244
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080244
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080244
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080244
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080244
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080244
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080244
ACROOSTEOLYSIS DOMINANT TYPE	0.001287	0.04828328535080244
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080244
PRUNE BELLY SYNDROME	0.001287	0.04828328535080244
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080244
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001287	0.04828328535080244
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080244
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080244
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001287	0.04828328535080244
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080244
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080244
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080244
IMMUNODEFICIENCY 58; IMD58	0.001287	0.04828328535080244
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.001287	0.04828328535080244
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080244
HAWKINSINURIA	0.001287	0.04828328535080244
SPINOCEREBELLAR ATAXIA TYPE 7	0.001287	0.04828328535080244
DIARRHEA 9; DIAR9	0.001287	0.04828328535080244
CATEL-MANZKE SYNDROME	0.001287	0.04828328535080244
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080244
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080244
MELORHEOSTOSIS	0.001287	0.04828328535080244
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080244
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080244
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080244
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080244
VALINEMIA	0.001287	0.04828328535080244
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080244
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080244
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080244
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001287	0.04828328535080244
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080244
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080244
PRIMARY PULMONARY HYPOPLASIA	0.001287	0.04828328535080244
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080244
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.001287	0.04828328535080244
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080244
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.001287	0.04828328535080244
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.001287	0.04828328535080244
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080244
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.001287	0.04828328535080244
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080244
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.001287	0.04828328535080244
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080244
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080244
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080244
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080244
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.001287	0.04828328535080244
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080244
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080244
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080244
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.001287	0.04828328535080244
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080244
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080244
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080244
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080244
MEIER-GORLIN SYNDROME 3; MGORS3	0.001287	0.04828328535080244
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.001287	0.04828328535080244
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.001287	0.04828328535080244
BARTH SYNDROME; BTHS	0.001287	0.04828328535080244
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080244
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.001287	0.04828328535080244
ATYPICAL WERNER SYNDROME	0.001287	0.04828328535080244
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080244
MEIER-GORLIN SYNDROME 2; MGORS2	0.001287	0.04828328535080244
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001287	0.04828328535080244
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080244
FREEMAN-SHELDON SYNDROME	0.001287	0.04828328535080244
PROGEROID SYNDROME, PETTY TYPE	0.001287	0.04828328535080244
PSEUDODIASTROPHIC DYSPLASIA	0.001287	0.04828328535080244
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080244
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001287	0.04828328535080244
ACTH-DEPENDENT CUSHING SYNDROME	0.001287	0.04828328535080244
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080244
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080244
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080244
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080244
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080244
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.001287	0.04828328535080244
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080244
BARBER-SAY SYNDROME	0.001287	0.04828328535080244
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080244
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080244
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.001287	0.04828328535080244
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080244
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080244
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080244
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.001287	0.04828328535080244
BRADDOCK SYNDROME	0.001287	0.04828328535080244
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001287	0.04828328535080244
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080244
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080244
POPOV-CHANG SYNDROME; POPCHAS	0.001287	0.04828328535080244
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080244
HARDIKAR SYNDROME	0.001287	0.04828328535080244
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080244
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.001287	0.04828328535080244
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080244
OMENN SYNDROME	0.001287	0.04828328535080244
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080244
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001287	0.04828328535080244
OROTIC ACIDURIA	0.001287	0.04828328535080244
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080244
RAVINE SYNDROME	0.001287	0.04828328535080244
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080244
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080244
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080244
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.001287	0.04828328535080244
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080244
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080244
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080244
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001287	0.04828328535080244
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY	0.001287	0.04828328535080244
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080244
PRIMARY HYPEROXALURIA TYPE 1	0.001287	0.04828328535080244
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001287	0.04828328535080244
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080244
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080244
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080244
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080244
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080244
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001287	0.04828328535080244
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080244
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080244
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080244
CASPASE 8 DEFICIENCY	0.001287	0.04828328535080244
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.001287	0.04828328535080244
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.001287	0.04828328535080244
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080244
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080244
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080244
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080244
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080244
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080244
ISOTRETINOIN SYNDROME	0.00122699	0.04603194117527668
KENNEDY DISEASE	0.00122699	0.04603194117527668
FETAL METHYLMERCURY SYNDROME	0.00122699	0.04603194117527668
NON-DISTAL MONOSOMY 10Q	0.00122699	0.04603194117527668
TOLUENE EMBRYOPATHY	0.00122699	0.04603194117527668
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04603194117527668
KEARNS-SAYRE SYNDROME	0.00122699	0.04603194117527668
IMAGE SYNDROME	0.00122699	0.04603194117527668
8Q12 MICRODUPLICATION SYNDROME	0.00122699	0.04603194117527668
CENTRAL CORE DISEASE	0.00122699	0.04603194117527668
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04603194117527668
WAARDENBURG-SHAH SYNDROME	0.00122699	0.04603194117527668
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04603194117527668
STVE-WIEDEMANN SYNDROME	0.00122699	0.04603194117527668
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.04603194117527668
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527668
OPSISMODYSPLASIA	0.00122699	0.04603194117527668
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.04603194117527668
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00122699	0.04603194117527668
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.04603194117527668
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.04603194117527668
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04603194117527668
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.04603194117527668
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527668
ALG12-CDG	0.00122699	0.04603194117527668
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527668
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04603194117527668
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00122699	0.04603194117527668
TETRASOMY X	0.00122699	0.04603194117527668
ALG6-CDG	0.00122699	0.04603194117527668
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04603194117527668
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.04603194117527668
ANTISYNTHETASE SYNDROME	0.00122699	0.04603194117527668
3Q13 MICRODELETION SYNDROME	0.00122699	0.04603194117527668
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00122699	0.04603194117527668
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04603194117527668
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.04603194117527668
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.04603194117527668
14Q22Q23 MICRODELETION SYNDROME	0.00122699	0.04603194117527668
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00122699	0.04603194117527668
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.04603194117527668
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00122699	0.04603194117527668
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04603194117527668
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00122699	0.04603194117527668
B4GALT1-CDG	0.00122699	0.04603194117527668
COLE-CARPENTER SYNDROME	0.00122699	0.04603194117527668
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00122699	0.04603194117527668
THAKKER-DONNAI SYNDROME	0.00122699	0.04603194117527668
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.04603194117527668
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04603194117527668
KYPHOMELIC DYSPLASIA	0.00122699	0.04603194117527668
INTESTINAL BOTULISM	0.00122699	0.04603194117527668
INFANT BOTULISM	0.00122699	0.04603194117527668
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00122699	0.04603194117527668
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00122699	0.04603194117527668
THYROID HEMIAGENESIS	0.00122699	0.04603194117527668
DIASTROPHIC DWARFISM	0.00122699	0.04603194117527668
ABETALIPOPROTEINEMIA	0.00122699	0.04603194117527668
COG7-CDG	0.00122699	0.04603194117527668
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00122699	0.04603194117527668
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04603194117527668
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00122699	0.04603194117527668
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.04603194117527668
SPONASTRIME DYSPLASIA	0.00122699	0.04603194117527668
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.04603194117527668
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.04603194117527668
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04603194117527668
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00122699	0.04603194117527668
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.04603194117527668
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.04603194117527668
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04603194117527668
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.04603194117527668
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04603194117527668
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04603194117527668
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00122699	0.04603194117527668
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00122699	0.04603194117527668
CODAS SYNDROME	0.00122699	0.04603194117527668
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04603194117527668
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00122699	0.04603194117527668
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00122699	0.04603194117527668
CRIGLER-NAJJAR SYNDROME TYPE 1	0.001066353	0.040005459350181995
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001066353	0.040005459350181995
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.001066353	0.040005459350181995
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001066353	0.040005459350181995
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.001066353	0.040005459350181995
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001066353	0.040005459350181995
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.001066353	0.040005459350181995
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001066353	0.040005459350181995
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350181995
ACROMELIC FRONTONASAL DYSPLASIA	0.001066353	0.040005459350181995
SJOGREN-LARSSON SYNDROME; SLS	0.001066353	0.040005459350181995
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001066353	0.040005459350181995
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001066353	0.040005459350181995
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001066353	0.040005459350181995
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001066353	0.040005459350181995
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001066353	0.040005459350181995
PHENYLKETONURIA	0.001066353	0.040005459350181995
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001066353	0.040005459350181995
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001066353	0.040005459350181995
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001066353	0.040005459350181995
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.001066353	0.040005459350181995
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001066353	0.040005459350181995
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001066353	0.040005459350181995
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001066353	0.040005459350181995
SCHIZENCEPHALY	0.001066353	0.040005459350181995
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.001066353	0.040005459350181995
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001066353	0.040005459350181995
GALACTOSIALIDOSIS	0.001066353	0.040005459350181995
EPILEPSY-TELANGIECTASIA SYNDROME	0.001066353	0.040005459350181995
WOLFRAM SYNDROME	0.001066353	0.040005459350181995
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001066353	0.040005459350181995
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001066353	0.040005459350181995
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.001066353	0.040005459350181995
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.001066353	0.040005459350181995
ANGELMAN SYNDROME (TYPE 1)	0.001066353	0.040005459350181995
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001066353	0.040005459350181995
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.001066353	0.040005459350181995
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001066353	0.040005459350181995
AUTISM	0.001066353	0.040005459350181995
ACQUIRED PARTIAL LIPODYSTROPHY	0.001066353	0.040005459350181995
DERMOTRICHIC SYNDROME	0.001066353	0.040005459350181995
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001066353	0.040005459350181995
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001066353	0.040005459350181995
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.001066353	0.040005459350181995
DONNAI-BARROW SYNDROME	0.001066353	0.040005459350181995
GLUTATHIONE SYNTHETASE DEFICIENCY	0.001066353	0.040005459350181995
HENNEKAM SYNDROME	0.001066353	0.040005459350181995
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001066353	0.040005459350181995
611961 STEVENSON-CAREY SYNDROME	0.001066353	0.040005459350181995
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001066353	0.040005459350181995
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001066353	0.040005459350181995
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001066353	0.040005459350181995
COFFIN-SIRIS SYNDROME 5	0.001066353	0.040005459350181995
POTOCKI-SHAFFER SYNDROME	0.001066353	0.040005459350181995
ATYPICAL JUVENILE PARKINSONISM	0.001066353	0.040005459350181995
CYSTATHIONINURIA	0.001066353	0.040005459350181995
ANGELMAN SYNDROME (TYPE 2)	0.001066353	0.040005459350181995
LISSENCEPHALY 8; LIS8	0.001066353	0.040005459350181995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.001066353	0.040005459350181995
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 100	0.001066353	0.040005459350181995
ICHTHYOSIS AND MALE HYPOGONADISM	0.001066353	0.040005459350181995
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.001066353	0.040005459350181995
WAISMAN SYNDROME; WSMN	0.001066353	0.040005459350181995
PORENCEPHALY	0.001066353	0.040005459350181995
CEDNIK SYNDROME	0.001066353	0.040005459350181995
LISSENCEPHALY 1; LIS1	0.001066353	0.040005459350181995
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.001066353	0.040005459350181995
SMITH-FINEMAN-MYERS SYNDROME	0.001066353	0.040005459350181995
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001066353	0.040005459350181995
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001066353	0.040005459350181995
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001066353	0.040005459350181995
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.001066353	0.040005459350181995
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.001066353	0.040005459350181995
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.001066353	0.040005459350181995
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001066353	0.040005459350181995
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001066353	0.040005459350181995
224250 DYSMYELINATION WITH JAUNDICE	0.001066353	0.040005459350181995
NETHERTON SYNDROME	0.001066353	0.040005459350181995
311450 PALLISTER W SYNDROME;;W SYNDROME	0.001066353	0.040005459350181995
LEUKOCYTE ADHESION DEFICIENCY	0.001066353	0.040005459350181995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001066353	0.040005459350181995
STURGE-WEBER SYNDROME	0.001066353	0.040005459350181995
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.001066353	0.040005459350181995
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.001066353	0.040005459350181995
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001066353	0.040005459350181995
INCONTINENTIA PIGMENTI; IP	0.001066353	0.040005459350181995
HYPERPROLINEMIA, TYPE II	0.001066353	0.040005459350181995
17Q11.2 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.001066353	0.040005459350181995
PRIMARY CUTIS VERTICIS GYRATA	0.001066353	0.040005459350181995
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.001066353	0.040005459350181995
MENTAL RETARDATION, FRA12A TYPE	0.001066353	0.040005459350181995
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.001066353	0.040005459350181995
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.001066353	0.040005459350181995
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001066353	0.040005459350181995
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.001066353	0.040005459350181995
MOYAMOYA DISEASE	0.001066353	0.040005459350181995
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001066353	0.040005459350181995
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.001066353	0.040005459350181995
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001066353	0.040005459350181995
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.001066353	0.040005459350181995
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001066353	0.040005459350181995
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.001066353	0.040005459350181995
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.001066353	0.040005459350181995
L1 SYNDROME	0.001066353	0.040005459350181995
MULTIPLE SULFATASE DEFICIENCY	0.001066353	0.040005459350181995
CEREBROTENDINOUS XANTHOMATOSIS	0.001066353	0.040005459350181995
XP21 MICRODELETION SYNDROME	0.001066353	0.040005459350181995
MICROPHTHALMIA, LENZ TYPE	0.001066353	0.040005459350181995
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.001066353	0.040005459350181995
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.001066353	0.040005459350181995
OCULODENTODIGITAL DYSPLASIA	0.001066353	0.040005459350181995
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001066353	0.040005459350181995
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.001066353	0.040005459350181995
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.001066353	0.040005459350181995
KBG SYNDROME	0.001066353	0.040005459350181995
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001066353	0.040005459350181995
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350181995
TYROSINEMIA TYPE 2	0.001066353	0.040005459350181995
ASPARTYLGLUCOSAMINURIA	0.001066353	0.040005459350181995
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001066353	0.040005459350181995
WYBURN-MASON SYNDROME	0.001066353	0.040005459350181995
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001066353	0.040005459350181995
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.001066353	0.040005459350181995
BETA-MANNOSIDOSIS	0.001066353	0.040005459350181995
AYME-GRIPP SYNDROME; AYGRP	0.001066353	0.040005459350181995
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.040005459350181995
17Q12 MICRODELETION SYNDROME	0.001066353	0.040005459350181995
17Q12 MICRODUPLICATION SYNDROME	0.001066353	0.040005459350181995
EPILEPSY-TELANGIECTASIA	0.001066353	0.040005459350181995
GURRIERI SYNDROME	0.001066353	0.040005459350181995
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001066353	0.040005459350181995
FOUNTAIN SYNDROME	0.001066353	0.040005459350181995
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001066353	0.040005459350181995
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001066353	0.040005459350181995
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001066353	0.040005459350181995
SUPRABULBAR PARESIS, CONGENITAL	0.001066353	0.040005459350181995
SRD5A3-CDG	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.001066353	0.040005459350181995
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 82	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.001066353	0.040005459350181995
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.001066353	0.040005459350181995
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.001066353	0.040005459350181995
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001066353	0.040005459350181995
RECOMBINANT 8 SYNDROME	0.001066353	0.040005459350181995
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001066353	0.040005459350181995
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 96; MRX96	0.001066353	0.040005459350181995
STURGE-WEBER SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 88	0.001066353	0.040005459350181995
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001066353	0.040005459350181995
HEREDITARY HYPEREKPLEXIA	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001066353	0.040005459350181995
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.001066353	0.040005459350181995
ZLOTOGORA-OGUR SYNDROME	0.001066353	0.040005459350181995
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001066353	0.040005459350181995
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001066353	0.040005459350181995
TETRASOMY 18P	0.001066353	0.040005459350181995
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.001066353	0.040005459350181995
PAPILLORENAL SYNDROME	0.001066353	0.040005459350181995
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001066353	0.040005459350181995
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 72	0.001066353	0.040005459350181995
CONGENITAL HYDROCEPHALUS	0.001066353	0.040005459350181995
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001066353	0.040005459350181995
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001066353	0.040005459350181995
CROUZON SYNDROME	0.001066353	0.040005459350181995
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.001066353	0.040005459350181995
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.001066353	0.040005459350181995
COCKAYNE SYNDROME A; CSA	0.001066353	0.040005459350181995
CROME SYNDROME	0.001066353	0.040005459350181995
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001066353	0.040005459350181995
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001066353	0.040005459350181995
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001066353	0.040005459350181995
ATYPICAL RETT SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.001066353	0.040005459350181995
RUVALCABA SYNDROME	0.001066353	0.040005459350181995
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001066353	0.040005459350181995
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.001066353	0.040005459350181995
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001066353	0.040005459350181995
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001066353	0.040005459350181995
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001066353	0.040005459350181995
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001066353	0.040005459350181995
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.040005459350181995
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001066353	0.040005459350181995
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001066353	0.040005459350181995
KIFAFA SEIZURE DISORDER	0.001066353	0.040005459350181995
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001066353	0.040005459350181995
BARAITSER-WINTER SYNDROME 2; BRWS2	0.001066353	0.040005459350181995
GENITOPATELLAR SYNDROME	0.001066353	0.040005459350181995
IMMUNODEFICIENCY 47	0.001066353	0.040005459350181995
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.001066353	0.040005459350181995
SANJAD-SAKATI SYNDROME	0.001066353	0.040005459350181995
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.001066353	0.040005459350181995
MENTAL RETARDATION, X-LINKED 103	0.001066353	0.040005459350181995
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001066353	0.040005459350181995
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001066353	0.040005459350181995
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001066353	0.040005459350181995
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.03607320406343425
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.03607320406343425
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.03607320406343425
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343425
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0009615380000000001	0.03607320406343425
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.03607320406343425
ETHANOLAMINOSIS	0.0009615380000000001	0.03607320406343425
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.03607320406343425
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	0.03607320406343425
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.03607320406343425
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.03607320406343425
SUSAC SYNDROME	0.0009615380000000001	0.03607320406343425
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.03607320406343425
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.03607320406343425
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.03607320406343425
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.03607320406343425
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.03607320406343425
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.03607320406343425
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.03607320406343425
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.03607320406343425
RIGID SPINE SYNDROME	0.0009615380000000001	0.03607320406343425
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.03607320406343425
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.03607320406343425
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.03607320406343425
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.03607320406343425
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.03607320406343425
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	0.03607320406343425
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.03607320406343425
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.03607320406343425
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0009615380000000001	0.03607320406343425
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.03607320406343425
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.03607320406343425
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.03607320406343425
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.03607320406343425
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.03607320406343425
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.03607320406343425
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.03607320406343425
CHITAYAT SYNDROME	0.0009615380000000001	0.03607320406343425
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.03607320406343425
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.03607320406343425
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.03607320406343425
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.03607320406343425
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0009615380000000001	0.03607320406343425
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.03607320406343425
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.03607320406343425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.03607320406343425
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	0.03607320406343425
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	0.03607320406343425
SPINOCEREBELLAR ATAXIA TYPE 29	0.0009615380000000001	0.03607320406343425
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.03607320406343425
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	0.03607320406343425
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.03607320406343425
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0009615380000000001	0.03607320406343425
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.03607320406343425
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	0.03607320406343425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.03607320406343425
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0009615380000000001	0.03607320406343425
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.03607320406343425
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.03607320406343425
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.03607320406343425
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.03607320406343425
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.03607320406343425
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.03607320406343425
SYDENHAM CHOREA	0.0009615380000000001	0.03607320406343425
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.03607320406343425
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.03607320406343425
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.03607320406343425
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0009615380000000001	0.03607320406343425
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.03607320406343425
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.03607320406343425
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.03607320406343425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0009615380000000001	0.03607320406343425
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	0.03607320406343425
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.03607320406343425
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.03607320406343425
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 26	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 4	0.0009615380000000001	0.03607320406343425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.03607320406343425
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.03607320406343425
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.03607320406343425
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.03607320406343425
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.03607320406343425
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343425
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.03607320406343425
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.03607320406343425
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.03607320406343425
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.03607320406343425
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.03607320406343425
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0009615380000000001	0.03607320406343425
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.03607320406343425
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 25	0.0009615380000000001	0.03607320406343425
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.03607320406343425
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.03607320406343425
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.03607320406343425
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.03607320406343425
JOUBERT SYNDROME 24	0.0009615380000000001	0.03607320406343425
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.03607320406343425
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.03607320406343425
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.02031195654339247
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02031195654339247
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02031195654339247
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02031195654339247
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02031195654339247
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02031195654339247
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.02031195654339247
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.02031195654339247
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.02031195654339247
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02031195654339247
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02031195654339247
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02031195654339247
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02031195654339247
MYASTHENIA GRAVIS	0.000541419	0.02031195654339247
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02031195654339247
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.02031195654339247
PALLISTER-HALL SYNDROME	0.000541419	0.02031195654339247
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02031195654339247
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02031195654339247
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.02031195654339247
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.02031195654339247
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02031195654339247
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02031195654339247
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.02031195654339247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.02031195654339247
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.02031195654339247
HEREDITARY COPROPORPHYRIA	0.000541419	0.02031195654339247
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339247
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02031195654339247
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02031195654339247
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02031195654339247
BERNARD-SOULIER SYNDROME	0.000541419	0.02031195654339247
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02031195654339247
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02031195654339247
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.02031195654339247
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.02031195654339247
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02031195654339247
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.02031195654339247
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02031195654339247
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02031195654339247
MILLER-DIEKER SYNDROME	0.000541419	0.02031195654339247
HYDRANENCEPHALY	0.000541419	0.02031195654339247
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02031195654339247
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.02031195654339247
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02031195654339247
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.02031195654339247
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02031195654339247
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.02031195654339247
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02031195654339247
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02031195654339247
CADASIL	0.000541419	0.02031195654339247
NASU-HAKOLA DISEASE	0.000541419	0.02031195654339247
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02031195654339247
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02031195654339247
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02031195654339247
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.02031195654339247
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02031195654339247
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.02031195654339247
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02031195654339247
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02031195654339247
RABIES	0.000541419	0.02031195654339247
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.02031195654339247
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02031195654339247
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02031195654339247
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02031195654339247
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.02031195654339247
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02031195654339247
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.02031195654339247
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.02031195654339247
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.02031195654339247
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02031195654339247
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.02031195654339247
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02031195654339247
EPISODIC ATAXIA TYPE 6	0.000541419	0.02031195654339247
EPENDYMOMA	0.000541419	0.02031195654339247
PARIETAL FORAMINA	0.000541419	0.02031195654339247
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02031195654339247
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.02031195654339247
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02031195654339247
DIAMINOPENTANURIA	0.000541419	0.02031195654339247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02031195654339247
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02031195654339247
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02031195654339247
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.02031195654339247
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.02031195654339247
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02031195654339247
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02031195654339247
OPTIC PATHWAY GLIOMA	0.000541419	0.02031195654339247
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02031195654339247
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02031195654339247
KBG SYNDROME	0.000541419	0.02031195654339247
DEND SYNDROME	0.000541419	0.02031195654339247
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.02031195654339247
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.02031195654339247
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.02031195654339247
DUANE RETRACTION SYNDROME	0.000541419	0.02031195654339247
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.02031195654339247
EPISODIC ATAXIA TYPE 3	0.000541419	0.02031195654339247
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02031195654339247
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.02031195654339247
ALZHEIMER DISEASE 3; AD	0.000541419	0.02031195654339247
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.02031195654339247
LHERMITTE-DUCLOS DISEASE	0.000541419	0.02031195654339247
SUBEPENDYMOMA	0.000541419	0.02031195654339247
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02031195654339247
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02031195654339247
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02031195654339247
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02031195654339247
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02031195654339247
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02031195654339247
PORPHYRIA	0.000541419	0.02031195654339247
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02031195654339247
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02031195654339247
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02031195654339247
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02031195654339247
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02031195654339247
BOWEN-CONRADI SYNDROME	0.000541419	0.02031195654339247
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339247
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02031195654339247
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02031195654339247
CRANIOSYNOSTOSIS 2	0.000541419	0.02031195654339247
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02031195654339247
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02031195654339247
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.02031195654339247
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.02031195654339247
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02031195654339247
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.02031195654339247
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.02031195654339247
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02031195654339247
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02031195654339247
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.02031195654339247
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02031195654339247
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02031195654339247
SNEDDON SYNDROME	0.000541419	0.02031195654339247
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.02031195654339247
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.02031195654339247
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.02031195654339247
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02031195654339247
HARTNUP DISORDER	0.000541419	0.02031195654339247
HOLOPROSENCEPHALY 7	0.000541419	0.02031195654339247
KUFOR-RAKEB SYNDROME	0.000541419	0.02031195654339247
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02031195654339247
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.02031195654339247
PHACE ASSOCIATION	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.02031195654339247
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02031195654339247
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02031195654339247
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02031195654339247
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.02031195654339247
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.02031195654339247
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.02031195654339247
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.02031195654339247
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.02031195654339247
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.02031195654339247
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02031195654339247
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02031195654339247
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.02031195654339247
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02031195654339247
WORSTER-DROUGHT SYNDROME	0.000541419	0.02031195654339247
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02031195654339247
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02031195654339247
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339247
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.02031195654339247
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02031195654339247
KNOBLOCH SYNDROME	0.000541419	0.02031195654339247
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02031195654339247
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02031195654339247
ISOVALERIC ACIDEMIA	0.000541419	0.02031195654339247
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02031195654339247
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02031195654339247
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02031195654339247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.02031195654339247
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02031195654339247
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02031195654339247
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02031195654339247
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.02031195654339247
PORPHYRIA VARIEGATA	0.000541419	0.02031195654339247
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02031195654339247
MERCURY POISONING	0.000541419	0.02031195654339247
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.02031195654339247
THYROCEREBRORENAL SYNDROME	0.000541419	0.02031195654339247
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.02031195654339247
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02031195654339247
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000541419	0.02031195654339247
ADRENOLEUKODYSTROPHY	0.000541419	0.02031195654339247
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.02031195654339247
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.02031195654339247
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.02031195654339247
ROSA-DORFMAN DISEASE	0.000541419	0.02031195654339247
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02031195654339247
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02031195654339247
SECONDARY SYRINGOMYELIA	0.000541419	0.02031195654339247
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02031195654339247
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02031195654339247
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339247
ENCEPHALITIS LETHARGICA	0.000541419	0.02031195654339247
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02031195654339247
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02031195654339247
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02031195654339247
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02031195654339247
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.02031195654339247
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02031195654339247
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.02031195654339247
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02031195654339247
PERRAULT SYNDROME 3	0.000541419	0.02031195654339247
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.02031195654339247
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02031195654339247
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02031195654339247
NIPAH VIRUS DISEASE	0.000541419	0.02031195654339247
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.02031195654339247
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02031195654339247
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02031195654339247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.02031195654339247
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02031195654339247
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02031195654339247
THREONINEMIA	0.000541419	0.02031195654339247
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02031195654339247
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02031195654339247
GLIOBLASTOMA	0.000541419	0.02031195654339247
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339247
ALEXANDER DISEASE	0.000541419	0.02031195654339247
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339247
HYPERPROLINEMIA TYPE 1	0.000541419	0.02031195654339247
CHDIAK-HIGASHI SYNDROME	0.000541419	0.02031195654339247
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02031195654339247
SCRUB TYPHUS	0.000541419	0.02031195654339247
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02031195654339247
DYSTONIA-APHONIA SYNDROME	0.000541419	0.02031195654339247
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02031195654339247
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02031195654339247
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02031195654339247
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.02031195654339247
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.02031195654339247
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.02031195654339247
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02031195654339247
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02031195654339247
FRONTAL ENCEPHALOCELE	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.02031195654339247
FLYNN-AIRD SYNDROME	0.000541419	0.02031195654339247
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02031195654339247
PROLACTINOMA	0.000541419	0.02031195654339247
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.02031195654339247
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.02031195654339247
EPILEPSY, READING	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02031195654339247
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02031195654339247
ALG2-CDG	0.000541419	0.02031195654339247
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02031195654339247
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.02031195654339247
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.02031195654339247
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02031195654339247
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02031195654339247
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02031195654339247
HHHH SYNDROME	0.000541419	0.02031195654339247
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02031195654339247
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02031195654339247
ALG1-CDG	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.02031195654339247
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02031195654339247
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.02031195654339247
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02031195654339247
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02031195654339247
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.02031195654339247
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02031195654339247
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02031195654339247
FABRY DISEASE	0.000541419	0.02031195654339247
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02031195654339247
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02031195654339247
HUNTINGTON DISEASE; HD	0.000541419	0.02031195654339247
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.02031195654339247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02031195654339247
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02031195654339247
WHIM SYNDROME	0.000541419	0.02031195654339247
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02031195654339247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.02031195654339247
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02031195654339247
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.02031195654339247
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.02031195654339247
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02031195654339247
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02031195654339247
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02031195654339247
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.02031195654339247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.02031195654339247
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.02031195654339247
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02031195654339247
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.02031195654339247
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02031195654339247
MACDERMOT-WINTER SYNDROME	0.000541419	0.02031195654339247
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.02031195654339247
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02031195654339247
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.02031195654339247
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02031195654339247
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339247
LUJO HEMORRHAGIC FEVER	0.000541419	0.02031195654339247
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02031195654339247
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.02031195654339247
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02031195654339247
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02031195654339247
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02031195654339247
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000541419	0.02031195654339247
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.02031195654339247
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.02031195654339247
THUMB DEFORMITY AND ALOPECIA	0.000524934	0.019693502806789533
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000524934	0.019693502806789533
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.000524934	0.019693502806789533
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.019693502806789533
DISTAL MONOSOMY 10P	0.000524934	0.019693502806789533
TELECANTHUS	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000524934	0.019693502806789533
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.019693502806789533
CEREBROCOSTOMANDIBULAR SYNDROME	0.000524934	0.019693502806789533
LELIS SYNDROME	0.000524934	0.019693502806789533
CURRY-JONES SYNDROME	0.000524934	0.019693502806789533
DESBUQUOIS SYNDROME	0.000524934	0.019693502806789533
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000524934	0.019693502806789533
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000524934	0.019693502806789533
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.000524934	0.019693502806789533
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.000524934	0.019693502806789533
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000524934	0.019693502806789533
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000524934	0.019693502806789533
DYSSPONDYLOENCHONDROMATOSIS	0.000524934	0.019693502806789533
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
SPONDYLO-OCULAR SYNDROME	0.000524934	0.019693502806789533
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.019693502806789533
CEREBROFACIOTHORACIC DYSPLASIA	0.000524934	0.019693502806789533
CRANIODIAPHYSEAL DYSPLASIA	0.000524934	0.019693502806789533
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000524934	0.019693502806789533
ANE SYNDROME	0.000524934	0.019693502806789533
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.000524934	0.019693502806789533
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.000524934	0.019693502806789533
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.019693502806789533
OTOMANDIBULAR SYNDROME	0.000524934	0.019693502806789533
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.000524934	0.019693502806789533
FEINGOLD SYNDROME 2; FGLDS2	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.019693502806789533
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.000524934	0.019693502806789533
RUVALCABA SYNDROME	0.000524934	0.019693502806789533
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.000524934	0.019693502806789533
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.019693502806789533
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.019693502806789533
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.019693502806789533
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000524934	0.019693502806789533
SOTOS SYNDROME 3	0.000524934	0.019693502806789533
TOWNES-BROCKS SYNDROME 1; TBS1	0.000524934	0.019693502806789533
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.000524934	0.019693502806789533
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.000524934	0.019693502806789533
BASAL CELL NEVUS SYNDROME	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.019693502806789533
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.019693502806789533
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000524934	0.019693502806789533
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.019693502806789533
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.019693502806789533
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000524934	0.019693502806789533
RAHMAN SYNDROME	0.000524934	0.019693502806789533
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000524934	0.019693502806789533
CEREBELLOFACIODENTAL SYNDROME	0.000524934	0.019693502806789533
MECKEL SYNDROME 13; MKS13	0.000524934	0.019693502806789533
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000524934	0.019693502806789533
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.000524934	0.019693502806789533
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000524934	0.019693502806789533
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.019693502806789533
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000524934	0.019693502806789533
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000524934	0.019693502806789533
8P23.1 DUPLICATION SYNDROME	0.000524934	0.019693502806789533
NF1-MICRODELETION SYNDROME	0.000524934	0.019693502806789533
CRI DU CHAT SYNDROME (5P DELETION)	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000524934	0.019693502806789533
WILLIAMS-BEUREN SYNDROME (WBS)	0.000524934	0.019693502806789533
22Q11 DUPLICATION SYNDROME	0.000524934	0.019693502806789533
WAGR 11P13 DELETION SYNDROME	0.000524934	0.019693502806789533
8P23.1 DELETION SYNDROME	0.000524934	0.019693502806789533
CHROMOSOME 15Q14 DELETION SYNDROME	0.000524934	0.019693502806789533
CAT-EYE SYNDROME (TYPE I)	0.000524934	0.019693502806789533
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.019693502806789533
LIG4 SYNDROME	0.000524934	0.019693502806789533
2Q37 MONOSOMY	0.000524934	0.019693502806789533
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000524934	0.019693502806789533
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000524934	0.019693502806789533
MYOTONIA PERMANENS	0.000524934	0.019693502806789533
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000524934	0.019693502806789533
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000524934	0.019693502806789533
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.019693502806789533
ATR-16 SYNDROME	0.000524934	0.019693502806789533
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.019693502806789533
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.019693502806789533
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA TYPE 2	0.000524934	0.019693502806789533
2P15-16.1 MICRODELETION SYNDROME	0.000524934	0.019693502806789533
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000524934	0.019693502806789533
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000524934	0.019693502806789533
FRONTONASAL DYSPLASIA 1; FND1	0.000524934	0.019693502806789533
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000524934	0.019693502806789533
MEGALENCEPHALY	0.000524934	0.019693502806789533
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000524934	0.019693502806789533
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000524934	0.019693502806789533
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000524934	0.019693502806789533
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000524934	0.019693502806789533
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.019693502806789533
WAARDENBURG SYNDROME TYPE 3	0.000524934	0.019693502806789533
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.019693502806789533
HEMIFACIAL MICROSOMIA	0.000524934	0.019693502806789533
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.000524934	0.019693502806789533
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000524934	0.019693502806789533
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000524934	0.019693502806789533
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000524934	0.019693502806789533
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.019693502806789533
BAMFORTH-LAZARUS SYNDROME	0.000524934	0.019693502806789533
BJRNSTAD SYNDROME	0.000524934	0.019693502806789533
BARTSOCAS-PAPAS SYNDROME	0.000524934	0.019693502806789533
APERT SYNDROME	0.000524934	0.019693502806789533
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000524934	0.019693502806789533
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.019693502806789533
OROFACIODIGITAL SYNDROME V; OFD5	0.000524934	0.019693502806789533
FEINGOLD SYNDROME	0.000524934	0.019693502806789533
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000524934	0.019693502806789533
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.019693502806789533
FRAXE INTELLECTUAL DISABILITY	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.019693502806789533
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000524934	0.019693502806789533
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.000524934	0.019693502806789533
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000524934	0.019693502806789533
ACRODYSOSTOSIS	0.000524934	0.019693502806789533
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.019693502806789533
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
HOLOPROSENCEPHALY 3; HPE3	0.000524934	0.019693502806789533
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000524934	0.019693502806789533
HYPOCHONDROPLASIA	0.000524934	0.019693502806789533
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000524934	0.019693502806789533
NEPHRONOPHTHISIS 18; NPHP18	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000524934	0.019693502806789533
FIBULAR HEMIMELIA	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000524934	0.019693502806789533
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.000524934	0.019693502806789533
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000524934	0.019693502806789533
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000524934	0.019693502806789533
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000524934	0.019693502806789533
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000524934	0.019693502806789533
MICROPHTHALMIA, SYNDROMIC 12	0.000524934	0.019693502806789533
LARYNGEAL ABDUCTOR PARALYSIS	0.000524934	0.019693502806789533
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000524934	0.019693502806789533
STICKLER SYNDROME TYPE 1	0.000524934	0.019693502806789533
SECKEL SYNDROME 8; SCKL8	0.000524934	0.019693502806789533
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.019693502806789533
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.000524934	0.019693502806789533
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.019693502806789533
LYSINE MALABSORPTION SYNDROME	0.000524934	0.019693502806789533
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000524934	0.019693502806789533
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.019693502806789533
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.019693502806789533
245800 LAURENCE-MOON SYNDROME	0.000524934	0.019693502806789533
LAMBERT SYNDROME	0.000524934	0.019693502806789533
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.000524934	0.019693502806789533
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000524934	0.019693502806789533
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000524934	0.019693502806789533
MICROPHTHALMIA, SYNDROMIC 4	0.000524934	0.019693502806789533
RICHARDS-RUNDLE SYNDROME; RRNS	0.000524934	0.019693502806789533
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.000524934	0.019693502806789533
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000524934	0.019693502806789533
MASA SYNDROME	0.000524934	0.019693502806789533
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.019693502806789533
KID SYNDROME	0.000524934	0.019693502806789533
3MC SYNDROME 3	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000524934	0.019693502806789533
CHROMOSOME XP11.3 DELETION SYNDROME	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 63	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 84	0.000524934	0.019693502806789533
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000524934	0.019693502806789533
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 92	0.000524934	0.019693502806789533
BRUNNER SYNDROME; BRNRS	0.000524934	0.019693502806789533
MCDONOUGH SYNDROME	0.000524934	0.019693502806789533
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000524934	0.019693502806789533
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.000524934	0.019693502806789533
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000524934	0.019693502806789533
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.019693502806789533
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.019693502806789533
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.019693502806789533
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.019693502806789533
N SYNDROME	0.000524934	0.019693502806789533
COWCHOCK SYNDROME; COWCK	0.000524934	0.019693502806789533
OPTIC ATROPHY 2	0.000524934	0.019693502806789533
PROTEUS-LIKE SYNDROME	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.000524934	0.019693502806789533
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.000524934	0.019693502806789533
HYDROXYPROLINEMIA	0.000524934	0.019693502806789533
SCARF SYNDROME	0.000524934	0.019693502806789533
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000524934	0.019693502806789533
3MC SYNDROME	0.000524934	0.019693502806789533
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.019693502806789533
HOMOCARNOSINOSIS	0.000524934	0.019693502806789533
VAN DEN BOSCH SYNDROME	0.000524934	0.019693502806789533
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.000524934	0.019693502806789533
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000524934	0.019693502806789533
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.019693502806789533
IMINOGLYCINURIA	0.000524934	0.019693502806789533
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.019693502806789533
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.000524934	0.019693502806789533
FOCAL DERMAL HYPOPLASIA; FDH	0.000524934	0.019693502806789533
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.019693502806789533
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.000524934	0.019693502806789533
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789533
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.000524934	0.019693502806789533
PTEN HAMARTOMA TUMOR SYNDROME	0.000524934	0.019693502806789533
WOODHOUSE-SAKATI SYNDROME	0.000524934	0.019693502806789533
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.000524934	0.019693502806789533
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.019693502806789533
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000524934	0.019693502806789533
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.019693502806789533
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000524934	0.019693502806789533
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.019693502806789533
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.000524934	0.019693502806789533
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.000524934	0.019693502806789533
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000524934	0.019693502806789533
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000524934	0.019693502806789533
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.019693502806789533
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.019693502806789533
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000524934	0.019693502806789533
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.019693502806789533
ALDH18A1-RELATED DE BARSY SYNDROME	0.000524934	0.019693502806789533
HYPOCHONDROPLASIA	0.000524934	0.019693502806789533
X-LINKED ADRENOLEUKODYSTROPHY	0.000524934	0.019693502806789533
COENZYME Q10 DEFICIENCY	0.000524934	0.019693502806789533
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.000524934	0.019693502806789533
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000524934	0.019693502806789533
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.019693502806789533
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000524934	0.019693502806789533
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000524934	0.019693502806789533
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.019693502806789533
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.000524934	0.019693502806789533
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.019693502806789533
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000524934	0.019693502806789533
3MC SYNDROME 2	0.000524934	0.019693502806789533
GORLIN SYNDROME	0.000524934	0.019693502806789533
OROFACIODIGITAL SYNDROME III	0.000524934	0.019693502806789533
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000524934	0.019693502806789533
OLIVER SYNDROME	0.000524934	0.019693502806789533
OCULORENOCEREBELLAR SYNDROME	0.000524934	0.019693502806789533
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.000524934	0.019693502806789533
RODRIGUES BLINDNESS	0.000524934	0.019693502806789533
SACCHAROPINURIA	0.000524934	0.019693502806789533
OCULOPALATOCEREBRAL SYNDROME	0.000524934	0.019693502806789533
SONODA SYNDROME	0.000524934	0.019693502806789533
PENDRED SYNDROME	0.000524934	0.019693502806789533
ATTENUATED CHDIAK-HIGASHI SYNDROME	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 16, X-LINKED	0.000524934	0.019693502806789533
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.019693502806789533
VAN DEN BOSCH SYNDROME	0.000524934	0.019693502806789533
VACTERL WITH HYDROCEPHALUS	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.019693502806789533
NIJMEGEN BREAKAGE SYNDROME	0.000524934	0.019693502806789533
JAWAD SYNDROME	0.000524934	0.019693502806789533
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.000524934	0.019693502806789533
MICROCEPHALY-CARDIOMYOPATHY	0.000524934	0.019693502806789533
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.019693502806789533
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000524934	0.019693502806789533
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.019693502806789533
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000524934	0.019693502806789533
WEISMANN-NETTER SYNDROME	0.000524934	0.019693502806789533
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.019693502806789533
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.019693502806789533
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.019693502806789533
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000524934	0.019693502806789533
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000524934	0.019693502806789533
DE SANCTIS-CACCHIONE SYNDROME	0.000524934	0.019693502806789533
MMEP SYNDROME	0.000524934	0.019693502806789533
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.000524934	0.019693502806789533
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.000524934	0.019693502806789533
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000524934	0.019693502806789533
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.000524934	0.019693502806789533
CHANARIN-DORFMAN SYNDROME	0.000524934	0.019693502806789533
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.019693502806789533
T-SUBSTANCE ANOMALY	0.000524934	0.019693502806789533
TYROSINE TRANSAMINASE DEFICIENCY	0.000524934	0.019693502806789533
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.000524934	0.019693502806789533
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000524934	0.019693502806789533
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.000524934	0.019693502806789533
ISOLATED BRACHYCEPHALY	0.000524934	0.019693502806789533
ISOLATED PLAGIOCEPHALY	0.000524934	0.019693502806789533
PROPIONIC ACIDEMIA	0.000524934	0.019693502806789533
MUCOLIPIDOSIS III ALPHA/BETA	0.000524934	0.019693502806789533
MORQUIO SYNDROME C	0.000524934	0.019693502806789533
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.019693502806789533
LEBER OPTIC ATROPHY AND DYSTONIA	0.000524934	0.019693502806789533
CONGENITAL VARICELLA SYNDROME	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.019693502806789533
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000524934	0.019693502806789533
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.019693502806789533
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.019693502806789533
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.000524934	0.019693502806789533
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000524934	0.019693502806789533
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.000524934	0.019693502806789533
CAHMR SYNDROME	0.000524934	0.019693502806789533
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000524934	0.019693502806789533
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.019693502806789533
DYSTONIA 16	0.000524934	0.019693502806789533
IRIDA SYNDROME	0.000524934	0.019693502806789533
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000524934	0.019693502806789533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000524934	0.019693502806789533
BIEMOND SYNDROME II	0.000524934	0.019693502806789533
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000524934	0.019693502806789533
HYDROXYKYNURENINURIA	0.000524934	0.019693502806789533
GEMIGNANI SYNDROME	0.000524934	0.019693502806789533
CEPHALIN LIPIDOSIS	0.000524934	0.019693502806789533
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000524934	0.019693502806789533
HYPERTRICHOSIS CUBITI	0.000524934	0.019693502806789533
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.000524934	0.019693502806789533
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000524934	0.019693502806789533
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.019693502806789533
USHER SYNDROME TYPE 1	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.000524934	0.019693502806789533
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.019693502806789533
ARGININOSUCCINIC ACIDURIA	0.000524934	0.019693502806789533
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.019693502806789533
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000524934	0.019693502806789533
ICF SYNDROME	0.000524934	0.019693502806789533
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.019693502806789533
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.000524934	0.019693502806789533
CHARGE SYNDROME	0.000524934	0.019693502806789533
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000524934	0.019693502806789533
PROLIDASE DEFICIENCY	0.000524934	0.019693502806789533
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.019693502806789533
BEHR SYNDROME	0.000524934	0.019693502806789533
FLOATING-HARBOR SYNDROME	0.000524934	0.019693502806789533
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.019693502806789533
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.019693502806789533
DYSOSTEOSCLEROSIS	0.000524934	0.019693502806789533
FRONTONASAL DYSPLASIA 2; FND2	0.000524934	0.019693502806789533
GILLESPIE SYNDROME; GLSP	0.000524934	0.019693502806789533
MEDNIK SYNDROME	0.000524934	0.019693502806789533
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.019693502806789533
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000524934	0.019693502806789533
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000524934	0.019693502806789533
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.019693502806789533
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000524934	0.019693502806789533
TRISOMY 12P	0.000524934	0.019693502806789533
ALPHA-METHYLACETOACETIC ACIDURIA	0.000524934	0.019693502806789533
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000524934	0.019693502806789533
CHROMOSOME 13Q14 DELETION SYNDROME	0.000524934	0.019693502806789533
AGENESIS OF CEREBRAL WHITE MATTER	0.000524934	0.019693502806789533
DERMATOLEUKODYSTROPHY	0.000524934	0.019693502806789533
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000524934	0.019693502806789533
207790 ARACHNOID CYSTS, INTRACRANIAL	0.000524934	0.019693502806789533
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000524934	0.019693502806789533
PHENOBARBITAL EMBRYOPATHY	0.000524934	0.019693502806789533
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.000524934	0.019693502806789533
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.000524934	0.019693502806789533
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.019693502806789533
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.000524934	0.019693502806789533
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000524934	0.019693502806789533
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.000524934	0.019693502806789533
FETAL IODINE SYNDROME	0.000524934	0.019693502806789533
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.000524934	0.019693502806789533
EEC SYNDROME	0.000524934	0.019693502806789533
OROFACIODIGITAL SYNDROME XI; OFD11	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.019693502806789533
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.000524934	0.019693502806789533
LOWRY-WOOD SYNDROME	0.000524934	0.019693502806789533
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.000524934	0.019693502806789533
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.000524934	0.019693502806789533
JUBERG-HAYWARD SYNDROME	0.000524934	0.019693502806789533
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.000524934	0.019693502806789533
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000524934	0.019693502806789533
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.000524934	0.019693502806789533
OSTEOPETROSIS AND RELATED DISORDERS	0.000524934	0.019693502806789533
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.019693502806789533
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000524934	0.019693502806789533
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.000524934	0.019693502806789533
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000524934	0.019693502806789533
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000524934	0.019693502806789533
FETAL IODINE DEFICIENCY DISORDER	0.000524934	0.019693502806789533
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000524934	0.019693502806789533
MONILETHRIX	0.000524934	0.019693502806789533
OCULOFACIOCARDIODENTAL SYNDROME	0.000524934	0.019693502806789533
MUCOPOLYSACCHARIDOSIS TYPE 1	0.000524934	0.019693502806789533
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000524934	0.019693502806789533
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000524934	0.019693502806789533
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000524934	0.019693502806789533
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.019693502806789533
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.000524934	0.019693502806789533
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.000524934	0.019693502806789533
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.019693502806789533
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.000524934	0.019693502806789533
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.000524934	0.019693502806789533
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.000524934	0.019693502806789533
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000524934	0.019693502806789533
LOWRY-MACLEAN SYNDROME	0.000524934	0.019693502806789533
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000524934	0.019693502806789533
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.000524934	0.019693502806789533
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.019693502806789533
PFEIFFER-PALM-TELLER SYNDROME	0.000524934	0.019693502806789533
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.000524934	0.019693502806789533
GERODERMA OSTEODYSPLASTICUM; GO	0.000524934	0.019693502806789533
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000524934	0.019693502806789533
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000524934	0.019693502806789533
CONE-ROD DYSTROPHY 1; CORD1	0.000524934	0.019693502806789533
GLUTATHIONURIA	0.000524934	0.019693502806789533
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
RHOMBENCEPHALOSYNAPSIS	0.000524934	0.019693502806789533
16P13.11 MICRODUPLICATION SYNDROME	0.000524934	0.019693502806789533
TRISOMY 9P	0.000524934	0.019693502806789533
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000524934	0.019693502806789533
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.000524934	0.019693502806789533
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.019693502806789533
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.019693502806789533
ACROGERIA	0.000524934	0.019693502806789533
DEAFNESS AND MYOPIA; DFNMYP	0.000524934	0.019693502806789533
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000524934	0.019693502806789533
FRONTONASAL DYSPLASIA	0.000524934	0.019693502806789533
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.019693502806789533
MASA SYNDROME	0.000524934	0.019693502806789533
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000524934	0.019693502806789533
CYSTEINE PEPTIDURIA	0.000524934	0.019693502806789533
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.019693502806789533
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.019693502806789533
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000524934	0.019693502806789533
PENDRED SYNDROME	0.000524934	0.019693502806789533
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000524934	0.019693502806789533
DERMATOLEUKODYSTROPHY	0.000524934	0.019693502806789533
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000524934	0.019693502806789533
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000524934	0.019693502806789533
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.000524934	0.019693502806789533
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000524934	0.019693502806789533
N SYNDROME	0.000524934	0.019693502806789533
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.019693502806789533
MIETENS SYNDROME	0.000524934	0.019693502806789533
ENCEPHALOMALACIA, MULTILOCULAR	0.000524934	0.019693502806789533
ELLIS-VAN CREVELD SYNDROME	0.000524934	0.019693502806789533
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.000524934	0.019693502806789533
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.019693502806789533
DIBASIC AMINO ACIDURIA I	0.000524934	0.019693502806789533
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000524934	0.019693502806789533
CREE MENTAL RETARDATION SYNDROME	0.000524934	0.019693502806789533
HURLER SYNDROME	0.000524934	0.019693502806789533
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.000524934	0.019693502806789533
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.000524934	0.019693502806789533
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000524934	0.019693502806789533
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.019693502806789533
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.019693502806789533
